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Diabetes is a term used to describe a group of metabolic diseases characterised by high 
blood glucose levels. Regulation of blood glucose levels is facilitated by the insulin stimulation 
of target tissues, such as skeletal muscle tissue and fat cells. A decrease in the effective working 
of insulin on target tissues can lead to a variety of symptoms, including damage or dysfunction 
of organs, such as the eyes, kidneys, nerves, and the heart and ultimately leads to the 
development of type 2 diabetes. Blood glucose homeostasis is predominately regulated by the 
metabolic activity of skeletal muscle fibres (70 – 80%). Therefore, there is an interest to 
investigate the dysfunctions caused by insulin resistance in skeletal muscle cells. 
In this thesis we present the kinetic characterisation of the glycolytic enzymes in C2C12 
skeletal muscle fibres. The kinetic rate equations, describing the dynamic behaviour of each 
enzyme, was compiled into a kinetic model. The development of a novel HPLC analytical 
technique for the separation and quantification of glycolytic intermediates and cofactors was 
also presented in the thesis. This HPLC technique enables the separation and quantification of 
the glycolytic cofactors; ATP, ADP, AMP, NAD+ and NADH via UV/Vis detection, along with 
the separation and quantification of 13 glycolytic species derived from glucose, including ACA 
and ETOH, as well as GLY and G3P via the use and detection of 14C-radioactive labelling. The 
novel HPLC technique was used to validate the kinetic model describing glycolysis in C2C12 
skeletal muscle cells by comparing model simulations to experimental data. 3 incubations of 
C2C12 skeletal muscle extract was analysed under different concentrations of GLC, FBP, ATP 
and NAD+ via the HPLC technique and compared to the corresponding model simulations. A 
good comparison between experimental data and model simulations was obtained, validating 
the glycolytic model describing glycolysis in C2C12 skeletal muscle extract. 
Metabolic control analysis was performed on the validated model and showed that the 
majority of flux control was held by the demand for ATP, described by the ATPase reaction 





Diabetes is `n term wat gebruik word om `n groep metaboliese siektes, gekenmerk deur 
hoë bloed glukose vlakke te beskryf. Regulasie van bloed glukose vlakke word gehandhaaf deur 
die werking van insulien op teiken weefsels, soos spierweefsel en vetselle. `n Afname in the 
effektiewe werking van insulin op teikenweefsels lei tot `n wye verskeidenheid van simptome, 
insluitend skade of versaking van organe soos die oë, niere, senuwees en die hart en lei tot die 
ontwikkeling van tipe 2 diabetes. Die regulasie van bloed glukose homeostase word oorwegend 
deur die metaboliese aktiwiteit van skelet spierweefsel (70 – 80%) genhandhaaf. Daarom is 
daar groot belang in die ondersoek van die versaking van insulin werking, afkomstig van 
insulien weerstandbediendheid in skelet spierweefsel. 
In hierdie tesis lê ons die biochemiese karakterisering van die glikolitiese ensieme in 
C2C12 skelet spiervesels voor. Die kinetiese tempovergelykings, wat die dinamiese gedrag van 
elke ensiem beskryf, was in `n kinetiese model saamgestel. Die ontwikkeling van `n nuwe 
HPLC analise tegniek vir die skeiding en kwantifisering van glikolitiese intermediate en 
kofaktore in selekstrak word ook in hierdie tesis voorgelê. Dié HPLC tegniek handhaaf die 
skeiding en kwantifisering van die glikolitiese kofaktore; ATP, ADP, AMP, NAD+ en NADH 
d.m.v. UV/Vis opname, sowel as die skeiding en kwantifisering van 13 glikolitiese spesies 
afgelei van glukose, insluited ACA en ETOH, saam met GLY en G3P d.m.v. die gebruik en 
opsporing van 14C- radioaktiewe etikettering. Die nuwe HPLC tegniek was gebruik vir die 
validering van die kinetiese model wat glikoliese in C2C12 skelet spierselle beskryf, deurom 
model simulasies met ekserimentele data te vergelyk. 3 inkubasies van C2C12 skelet 
spierveselekstrak onder verskeie konsentrasies van GLC, FBP, ATP en NAD+ was d.m.v die 
HPLC tegniek geanaliseer en vergelyk met die ooreenstemende model simulasies. `n goeie 
ooreensteming tussen eksperimentele data en model simulasies was bevind en valideer die 
glikolities model van C2C12 skelet spierveselekstrak.  
Metaboliese kontrole analise van die gevalideerde model was onderneem en dui tot `n 
meerderheids fluksie kontrolle wat deur die aanvraag van ATP, beskryf deur die ATPase reaksie 
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Chapter 1  
General introduction 
The term diabetes is used to describe a group of metabolic diseases characterised by 
hyperglycaemia that results from defective insulin action to control blood glucose 
concentrations. Chronic hyperglycaemia is associated with numerous health risks and can lead 
to damage and failure of organs, including the eyes, kidneys, nerves, heart and blood vessels. 
Insufficient insulin action can arise from defects in insulin secretion, insulin stimulation, or 
both. Autoimmune destruction of the β-cells of the pancreas leads to decreased insulin 
secretion, whereas a resistance to insulin in tissues such as skeletal muscle and adipocytes leads 
to a decreased efficacy of insulin stimulation. The deficient action of insulin on target tissues 
leads to abnormalities in the metabolism of carbohydrates, fats and proteins1. Failing of insulin 
secretion by the β-cells of the pancreas is referred to as type 1 diabetes and often results from 
an autoimmune pathologic process that occurs in the pancreatic islets. Type 2 diabetes on the 
other hand, is caused by a combination of insulin resistance in target tissues and an inadequate 
secretion of insulin in response. Type 2 diabetes accounts for 90 – 95% of diabetes patients and 
the onset is generally in the later stages of life1. The majority of patients that suffer from type 
2 diabetes are obese, and obesity is therefore related to insulin resistance2. The regulation of 
blood glucose homeostasis is predominantly dependent on the metabolic activity of skeletal 
muscle cells3,4. Therefore, it is of critical importance to investigate the dysfunctions caused by 
insulin resistance in skeletal muscle cells.  
We investigated the mechanistic behaviour of skeletal muscle cells under basal conditions 
to define the reference state of C2C12 skeletal muscle metabolism. The focus of the project was 
to elucidate the defects associated with insulin resistance in skeletal muscle cells and to 
contribute to a mechanistic understanding of the cellular processes that are affected by insulin 
resistance. The elucidation of insulin stimulated metabolism of skeletal muscle can be broken 
up into 3 subsections: Investigation of the insulin dependent stimulation of GLUT4 
translocation in a time- and dose dependent manner, quantification of the glucose uptake rate 
under various insulin-stimulated conditions, and investigation of the control and regulatory 
behaviour of glycolysis in skeletal muscle cells. This thesis forms part of our greater objective 
to understand insulin resistance in target tissues and how this relates to changes in the 
physiology observed in type 2 diabetic patients. A sister study, undertaken by Stefan Kuhn, 
focussed on the investigation of the insulin signalling cascade, GLUT4 translocation dynamics 
Stellenbosch University https://scholar.sun.ac.za
2 
and glucose uptake. The primary objective of our joined endeavours was to construct a 
metabolic model describing basal and insulin stimulated glucose metabolism in skeletal muscle 
cells. This metabolic model will then be expanded to describe muscle metabolism under an 
insulin resistant state.  
Within the scope of this thesis we will be focussing on the metabolism of glucose inside 
the cell using a molecular systems biology bottom-up approach. This will entail a detailed 
kinetic characterisation of each enzyme present in glycolysis. Furthermore, the dynamic 
behaviour of each enzyme will be integrated with the other enzymes in the pathway by 
constructing a detailed kinetic model of glycolysis in C2C12 skeletal muscle cell extract. To test 
whether the detailed kinetic model accurately describes the pathway in C2C12 skeletal muscle 
extract, a new method was developed for the quantification of metabolite dynamics to correlate 
these results with the detailed kinetic model and to test the predictive accuracy of the kinetic 
model. 
The aim of this study was to construct and validate a detailed kinetic model of glycolysis 
in non-diabetic skeletal muscle cells to characterise the reference state. The objectives of this 
study are listed below. 
• Develop a metabolomic technique for the separation and quantification of the glycolytic 
intermediates and cofactors present in glycolysis. 
• Characterisation of the glycolytic enzymes in differentiated C2C12 skeletal muscle cells. 
• Construction of a detailed kinetic model to describe glycolysis in differentiated C2C12 
skeletal muscle cells from the kinetic characterisation of the glycolytic enzymes. 
• Validation of the glycolytic model by comparing model simulations with experimental 
data.  
• Analysis of the kinetic model by performing metabolic control analysis. 
The thesis is divided into three research chapters (Chapter 3 -5) that are presented in paper 
format. In addition to the research chapters I present an overview of the current literature on 
type 2 diabetes in the context of the broader project in Chapter 2, and skeletal muscle 
metabolism and metabolomics in the context of this study. The general discussion of the 
outcomes of this thesis is discussed in Chapter 6. In Chapter 3 I present the development of a 
novel metabolomics technique for the identification and quantification of the glycolytic 
intermediates and cofactors present in glycolysis. In Chapter 4 the construction of a detailed 
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kinetic model that describes glycolysis in skeletal muscle extract is presented. In Chapter 5 I 
focus on the validation and analysis of the detailed kinetic model, using metabolic control 
analysis and the novel metabolomics technique developed in Chapter 3. 
1. 1. References 
1  American diabetes association., Diagnosis and classification of diabetes mellitus., Diabetes Care, 33:S62-
S69, 2010 
2  Simoneau JA and Kelley DE., Altered glycolytic and oxidative capacities of skeletal muscle contribute to 
insulin resistance in NIDDM., J. Appl. Physiol. 83:166–171, 1997 
3  DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J and Felber JP., The effect of insulin on the 
disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous 
catheterization., Diabetes 30: 1000–1007, 1981 
4  Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teras M, Voipio-Pulkki LM, Haaparanta M, 
Solin O, Wegelius U and Yki-Jarvinen H., Effect of antilipolysis on heart and skeletal muscle glucose 




Chapter 2  
Literature Review of the regulation of glucose metabolism in 
mammalian tissue 
2. 1. Preamble 
The literature review presented in this chapter discusses the relevant literature associated 
with glucose transport and insulin signalling (Sections 2.3 – 2.5) within the scope of the broader 
focus of this study. This is required for the research topics discussed in Chapter 6 of this thesis. 
The relevant literature pertaining to this study is discussed in Sections 2.6 – 2.10. 
2. 2. Background 
Within the body, the regulation of glucose homeostasis is of critical importance to 
maintain a normal and healthy physiology. After a meal, the majority of the glucose introduced 
into the body (70 – 80%) is consumed via the metabolic activity of skeletal muscle cells1,2. 
Alterations to the blood glucose levels have a direct effect on the physiology of the body and 
can lead to chronic hyperglycaemia, the predominant metabolic state associated with type 2 
diabetes mellitus. The development of this progressive metabolic disorder has been attributed 
to both environmental lifestyle factors along with undetermined genetic factors3. This involves 
defective action in the major organs associated with metabolic control including; skeletal 
muscle, adipose tissue, the liver and β-cells. An early defect in type 2 diabetic patients is the 
impairment of insulin to activate an increase in the metabolic rate of skeletal muscle. Intrinsic 
impairment of insulin activity on skeletal muscle has been established by clinical trials that 
focussed on the relatives of type 2 diabetic patients who showed a resistance to insulin action, 
relating the progression of type 2 diabetes to genetic factors45- 6. Moreover, hyperglycaemia, 
hyperinsulinemia, altered lipid profiles, and other metabolic abnormalities can also aggravate 
the defective disposal of glucose in insulin-regulated tissues by interfering with the insulin 
mechanism regulating glucose transport and thus disrupting glucose uptake7,8. 
Traditional biochemical and physiological techniques have delivered several essential 
findings on muscle biology, for example, the discovery of glycolysis regulation by fructose-
2,6-bisphosphate9,10, the description of mechanisms of glucose transport into myofibres10, and 
many others. Thus far, conclusions on muscle biology were based on the analysis of the activity, 
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cellular localization and/or biological functions of only a limited number of enzymes or 
proteins. To have a concise understanding of the mechanistic interactions related to maintaining 
blood glucose homeostasis in the body, a standardised study of the glucose metabolism of 
skeletal muscle myofibres is required. This includes the transport of glucose into the muscle 
fibres, the regulation of glucose transport through insulin dependent and insulin independent 
mechanisms and a thorough kinetic understanding of how glucose is metabolised via glycolysis 
in muscle fibres. 
To further our understanding of the biological framework in which insulin operates, 
specifically with regards to skeletal muscle, a detailed investigation of the literature available 
on this topic will be discussed in this chapter. 
2. 3. Glucose transporters in muscle cells 
The rate at which glucose is taken up by cellular tissue from the extracellular fluids, is a 
crucial regulating step in the control of glucose and glucose metabolism within the cell. The 
uptake of glucose occurs via glucose transporters in the plasma membrane of animal cells11,12. 
These carrier-mediated facilitated diffusion glycoproteins are a family of structurally related 
glucose transport proteins. The type of glucose transporters expressed is tissue-specific and 
differ in their transcriptional and posttranscriptional regulation1314- 15. Apart from liver cells, 
skeletal muscle is the most intensely studied tissue regarding metabolism and protein 
composition. Studies on the physiology, histochemistry and enzymology of muscle cells in the 
late 1970’s have resulted in a framework describing muscle metabolism1617- 18. Within this 
framework, insulin has been shown to accelerate glucose transport into the cell through the cell 
membrane1920-2122. Furthermore, Randle and Smith23 demonstrated that an increase in glucose 
uptake is also observed under anoxic conditions. They attributed this observation to the 
acceleration of the glucose transport process over the cell membrane induced by anoxia itself, 
as later confirmed by Morgan et al.24. Through a kinetic investigation of the glucose transport 
in rat heart muscle, Morgan et al.25 examined the behaviour of glucose transport under basal-, 
insulin stimulated- and anoxic conditions. Under basal conditions, glucose flux is controlled by 
glucose transport. However, under both insulin-stimulated, and anoxic conditions, glucose 
transport is upregulated and glucose phosphorylation, holds most of the control over glucose 
flux. Moreover, Morgan et al.25 concluded that anoxia stimulated glucose phosphorylation, the 
first step in glycolysis. 
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Within skeletal muscle cells glucose transport is facilitated predominantly by the GLUT1 
and GLUT4 glucose transporters, two members of the glucose transporter family11. The GLUT1 
glucose transporter is universally distributed in the plasma membrane of various cell types, 
including skeletal muscle, and is responsible for basal glucose transport over the plasma 
membrane26. The expression of GLUT4 is excessive in insulin-stimulated cell types, such as 
skeletal muscle, cardiac muscle and adipocytes27. The concentration of the GLUT4 isoform in 
the plasma membrane is low under basal conditions, with high concentrations of the GLUT4 
isoform located within the intracellular compartments of the cell. Under activated conditions, 
resulting from insulin stimulation, muscle contraction or hypoxia, the translocation of the 
GLUT4 transporter from the intracellular compartments to the plasma membrane is promoted. 
The increase of GLUT4 glucose transporters on the cell surface results in an increase in the 
uptake of glucose by the cell28. The insulin-resistant characteristics of type 2 diabetes can be 
attributed to defects in the insulin-induced GLUT4 translocation process in skeletal muscle29. 
2. 4. Insulin dependent GLUT4 translocation 
The insulin signalling pathway in skeletal muscle cells plays a crucial regulatory role in 
several cellular processes, such as: glucose metabolism, protein synthesis and gene expressing. 
The insulin-induced GLUT4 translocation process is predominantly dependent on 
phosphatidylinositol (PI) 3-kinase in both adipocytes and skeletal muscle30. The insulin 
signalling cascade is facilitated by a series of phosphorylation reactions starting with the initial 
activation of the tyrosine kinase, insulin receptor (IR), through the binding of insulin to IR. The 
insulin signal is then carried through the insulin-receptor substrate (IRS), a regulatory docking 
protein. The tyrosine phosphorylation of IRS by the IR is central to the differentiation of the 
insulin signal towards either metabolic events or gene regulatory events3. 
Tyrosine phosphorylation of the IRS enables this regulatory docking protein to recruit 
signalling molecules containing SH2 domains to form active signalling complexes. PI 3-kinase 
is one such protein, which catalyses the conversion of phosphatidylinositol-4,5-bisphosphate 
(PI2P) to phosphatidylinositol-3,4,5-triphosphate (PI3P) upon active signalling complex 
formation. This is a crucial step in the insulin stimulated GLUT4 translocation process. PI3P is 
an allosteric regulator of phosphoinositide-dependent kinase (PDK), a downstream target of PI 
3-kinase. PDK was originally described as a phosphoinositide-dependent serine/threonine 
kinase PKB/Akt activator31, However, PDK was later found to be an activator of other 
molecules in the AGC serine/ threonine kinase super-family, comprising the prototypes protein 
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kinase A (PKA), G (PKG), and C (PKC) associated with regulating glucose uptake32. The 
insulin signal is carried forward through the phosphorylation of Akt by PDK at the  
Ser-473 and Thr-308 residues33. After activation of Akt, the insulin signal is carried forward 
through the phosphorylation of Akt Substrate (AS) 160, which contains GTPase-activating 
proteins (GAP) for Rabs. AS160 is sometimes also abbreviated as TBC1D4 relating to its Tre-
2/Bub2/Cdc16 (TBC) domain, a highly conserved domain responsible for GAP activity34,35. 
Rabs are small G proteins that are directly associated with the membrane trafficking of, in this 
case GLUT435. A schematic representation of the insulin signalling cascade in given in Figure 
2.1. 
It has been noted that the insulin induced PI 3-kinase activation does not sufficiently 
account for the metabolic activity observed under insulin stimulated conditions36,37. This 
suggests that there are novel cascades that contribute to the amplification of insulin stimulated 
GLUT4 translocation which are independent of the PI 3-kinase cascade. Even though several 
regulatory reactions running in tandem have been elucidated, there is still many unknowns in 




Figure 2.1: A schematic illustration of the insulin-signalling cascade. This scheme illustrates the series of phosphorylation reactions initialised by the binding 
of insulin to the IR and ending with translocation of the GLUT4 transporter to the cell membrane as discussed in the text above. This first step is the binding of 
insulin to the insulin receptor (IR) resulting in phosphorylation of the IR. This results in the phosphorylation of the insulin receptor substrate (IRS-1) and binding 
of IRS-1 to PI3-kinase (PI3 K). The subsequent step involves the phosphorylation of PI2P to PI3P and binding of PDK to PI3P. The PI3P/PDK complex 
phosphorylates AKT, resulting in the phosphorylation of Akt substrate 160 (AS 160). AS160 activates Rabs proteins which results in the trafficking of the GLUT4 
vesicles from the cytosol to the cell membrane 
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2. 5. AMPK activation of GLUT4 translocation 
The insulin-independent activation of GLUT4 translocation is thought to be facilitated by 
the activation of 5’-AMP-activated protein kinase (AMPK), independent from the PI 3-kinase 
signalling pathway 38,39. The insulin-independent AMPK activation of glucose uptake facilitates 
the enhanced translocation of the GLUT4 glucose transporter to the plasma membrane in 
response to metabolic stress3. AMPK phosphorylates key targets in diverse metabolic pathways, 
such as hepatic lipid metabolism and adipocyte lipolysis as well as fatty acid oxidation and 
glucose transport in skeletal muscle through the phosphorylation of Acetyl CoA Carboxylase 
(ACC)-β, thereby acting as a metabolic switch40. Several studies done on AMPK regulation 
noted that the signal is sensitive to increased energy demands by the skeletal muscle cells4142-4344. 
The regulation of the AMPK contribution to glucose uptake is thought to be dependent on the 
balance between ATP demand (e.g. muscle contraction) and ATP supply from substrate 
oxidation (e.g. glycolysis)45. It is of interest to note that AMPK may also be involved in 
mitochondrial biogenesis and chronic adaptions to the skeletal muscle cells seen with exercise 
training and fitness4647- 48. 
The heterotrimeric AMPK enzyme consists of a catalytic α-subunit along with regulatory 
β- and γ- subunits which can be activated both allosterically and covalently. Covalent 
phosphorylation of AMPK is mediated by the up-stream AMPK kinase (AMPKK) which 
activates AMPK, via phosphorylation45. In-vitro studies investigating the allosteric regulation 
of AMPK concluded that AMP and creatine (Cr) act as activators of AMPK, whereas ATP and 
phosphocreatine (PCr) act as inhibitors of AMPK49,50. Moreover, AMP may also be an allosteric 
activator to AMPKK, and an allosteric inhibitor of protein phosphatase-2A (PP-2A), the protein 
responsible for the de-phosphorylation, and thus inactivation of AMPK51,52. Therefore, both 
allosteric and covalent regulation of AMPK is extremely sensitive to changes in the 
concentration of metabolites related to the cellular energy state of skeletal muscle cells (AMP, 
ATP, Cr and PCr)53,54. 
The concentrations of the allosteric regulators of AMPK namely, AMP and ATP along 
with ADP, is primarily dictated by the enzyme catalysed adenylate kinase (AK) reaction. 
During the AK reaction, phosphate (Pi) transfer from one ADP molecule to another ADP 
molecule occurs, resulting in the formation of AMP and ATP. In skeletal muscle, the activity 
of AK is noted to be extremely high, even at high energy demands. Therefore, it can be expected 
that the AK reaction is always at equilibrium and the concentration of AMP becomes a function 
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of ADP concentration dictated by the cellular energy state5556- 57. Furthermore, the reaction 
creatine kinase (CK) regulates ATP concentration during transitions in energy demands, 
through a Pi transfer reaction between ADP and PCr, resulting in the formation of ATP and Cr. 
With an increase in muscle contraction CK will regulate the formation of ATP in accordance 
with the demands, resulting in a decrease in PCr concentrations and an increase in Cr 
concentrations, further contributing to the allosteric activation of AMPK44,58,59. Similarly, to 
AK, the activity of CK in skeletal muscle cells is extremely high and is accepted to be at 
equilibrium under most energy demands. In summary, an increase in muscle contraction results 
in a higher demand for ATP. The resulting increase in ADP concentration is regulated through 
the enzymes AK and CK, resulting in the reduction of ADP and PCr and the formation of AMP, 
ATP and Cr. The formation of ATP further drives muscle metabolism, whereas the formation 
of AMP within the cell subsequently activates AMPKK and deactivates PP-2A, resulting in the 
covalent activation of AMPK54,60. Furthermore, allosteric activators (AMP, Cr) of AMPK are 
increased and allosteric inhibitors (ATP, PCr) of AMPK are decreased. The elevated activity 
of AMPK facilitates the translocation of the GLUT4 glucose transporter to the cell surface, 
resulting in an enhanced glucose transport rate. 
Similar to AS160, TCB1D1 contains a TBC Domain for the GTPase activation of Rabs 
that facilitates trafficking to the GLUT4 transporter to the cell membrane. There is a significant 
structural similarity between AS160 and TCB1D1 specifically with regards to the Rab-GAP 
domain. However, the distribution of AS160 and TCB1D1 varies significantly between 
different tissue types. AS160 is expressed to a similar degree in a multiple of mammalian tissue 
types, whereas the expression of TCB1D1 is several times higher is skeletal muscle compared 
to other muscle types61,62. A study performed by An et. al.63 to elucidate the functionality and 
role of TCB1D1 in the insulin-stimulated and AMPK activated GLUT 4 translocation process 
found that TCB1D1 plays a role in both insulin-stimulated GLUT4 translocation and AMPK 
activated GLUT 4 translocation. TCB1D1 can act as an analogue of AS160 that can be 
phosphorylated by Akt. Furthermore, TCB1D1 also acts as a substrate of AMPK to facilitate 
the AMPK activated GLUT 4 translocation process. A schematic illustration of the AMPK 




Figure 2.2: A schematic illustration of AMPK signalling pathway. This scheme illustrates the allosteric regulation of AMPK by AMP, ATP, creatine (Cr) and 
phosphocreatine (PCr), and the covalent activation of AMPK via AMPK kinase (AMPKK) and deactivation by protein phosphatase 2A (PP-2A). The activated 
form of AMPK phosphorylates TCB1D1 which in turn activates Rabs proteins resulting in trafficking of the GLUT4 vesicles from the cytosol to the cell membrane 
The AMPK pathway is stimulated under conditions of high metabolic activity resulting in the translocation of the GLUT4 transporter to the cell membrane as 
discussed in the text above. 
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2. 6. Glycolysis 
Glycolysis plays a central role in metabolism as an important production process for ATP 
and key metabolites in all cell types64,65. Apart from the biochemical understanding of 
carbohydrate utilization, studying the regulation of glycolysis has found applications in 
biotechnological processes66 and in biomedical research, e.g. drug development for cancer 
therapies67. The term glycolysis describes the series of connected reactions which forms a 
pathway that systematically converts glucose to pyruvate. Pyruvate can then be further 
metabolised to CO2 via oxidative phosphorylation in the tricarboxylic acid (TCA) cycle or to 
lactate via glucose fermentation68. Glycolysis can be divided into 2 parts namely upper- and 
lower glycolysis. Upper glycolysis comprises the enzymes hexokinase (HK), 
phosphoglucoisomerase (PGI), phosphofructokinase (PFK), aldolase (ALD) and 
triosephosphate isomerase (TPI), which utilises ATP as a substrate (HK and PFK) for the 
phosphorylation of glucose (GLC) and fructose-6-phosphate (F6P). Lower glycolysis 
comprises the enzymes glyceraldehyde-3-phosphate (GAPDH), 3-phosphoglycerate kinase 
(PGK), 3-phosphglycerate mutase (PGM), enolase (ENO) and pyruvate kinase (PK), which 
produces ATP as a product during the formation of 3-phosphoglycerate (P3G) via PGK and 
pyruvate (PYR) via PK. There are several branch pathways that flow out of glycolysis, such as 
the conversion of glucose-6-phosphate (G6P) to glucose-1-phosphate (G1P) catalysed by the 
enzyme phosphoglucomutase (PGLM) for the synthesis of glycogen. Another branched 
pathway is the conversion of dihydroxyacetone phosphate (DHAP) to form glycerol (GLY). A 
schematic representation of glycolysis is shown in Figure 2.3 illustrating the conversion of GLC 
to PYR (Glycolysis) and the branched pathway leading from glycolysis (glycogen synthesis, 
glycerol synthesis and the TCA cycle). 
The traditional biochemistry approach to understanding the dynamic behaviours of 
metabolic pathways, such as glycolysis, relies on studying the properties of each enzyme in 
isolation69. However, the in vivo properties of enzymatic reactions can differ significantly from 
the in vitro measurements70. The regulation of enzyme activity by metabolites arising from 
unrelated metabolic process, the effects of molecular crowding, pH and temperature, and the 
spatial distribution and compartmentalisation of enzymes within the cell contribute to 
discrepancies between the in vitro measurement of enzyme activities and their in vivo realised 
activities70. To address these concerns van Eunen et. al.71 have developed a protocol for the 
measurement of in vitro enzyme activities. This includes measuring enzyme activity at a 
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physiological pH and temperature, in a buffer matrix that mimics the chemical composition of 
the cytosol. Several investigations on the characterisation glycolysis is specified cell lines have 
successfully been performed69,72. A study performed by Teusink et. al.69 investigated whether 
in vivo glycolysis can be understood from the in vitro characterisation of the glycolytic enzymes 
in yeast. Teusink et. al.69 concluded that some enzymatic reactions showed a satisfactory 
comparison between in vitro description and in vivo activity, whereas other enzymes did not 
compare so favourably. Another study performed by Penkler et. al.72 used a similar approach 
as mentioned above69 to investigate the activity of glycolytic enzymes in plasmodium 
falciparum for the identification of novel antimalarial drug targets.  
2. 7. Glycolysis in skeletal muscle cells 
With regards to mammalian cells, glycolytic and glycogenolytic regulation studies have 
predominantly focussed on skeletal muscle as a key experimental model. This is because of the 
glycogenolytic ATP production flux increase of two orders of magnitude that can be observed 
during transitions between the resting state and the activated state of skeletal muscle within the 
seconds timescale66,73,74. The activated state of skeletal muscle that arises from performing 
exercise results in a rapid increase in ATP utilization that is buffered and balanced through 
multiple ATP synthetic pathways, including glycolysis and oxidative phosphorylation73,74. To 
compensate for the increased utilization of ATP an increased production of ATP is required to 
uphold a cellular energy balance for prolonged muscle activity75. Therefore, it is anticipated 
that the exceptionally rapid and large operational range of ATP utilization will result in stringent 
control mechanisms in place for regulating the flux through the glycolytic pathway76.  
Insulin exposure to muscle cells increases the rate of glycogen synthesis to produce 
glycogen inside the cell77. The discussion surrounding the importance of insulin-stimulated 
glycogen synthesis compared to GLUT4 mediated glucose transport remains controversial78. A 
2-fold increase in the rate of glycogen synthesis was observed upon insulin exposure of C2C12 
skeletal muscle77. Several studies7980-8182 focussed on evaluating the effect of insulin stimulation 
of mammalian cells on the activity of glycolytic enzymes have been published. Printz et. al.79 
investigated the regulation of the hexokinase isoform, HK II, by insulin in the 3T3-F442A 
adipose cell line and observed a 4-fold increase of HK II activity when cells were treated with 
100 nM insulin. A follow-up study established that insulin increases the rate of HK II gene 
transcription80. An investigation performed by Elstrom et. al.81 into the activation of glycolysis 
by Akt, suggested that Akt activity, regulated by insulin stimulation, directly stimulates the 
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cellular rate of glycolysis. Furthermore, the exposure of cultured rat hepatocytes to insulin 
resulted in a 4-fold increase in the activity of 6-phosphofructo-2-kinase and its product fructose-
2,6-bisphosphate82. Fructose-2,6-bisphosphate is a potent PFK activator and it is postulated that 
the higher levels of fructose-2,6-bisphosphate present in insulin stimulated cell will lead to 
increase PFK activity.  
 
Figure 2.3: Schematic representation of glycolysis as discussed in the text above. The conversion of 
GLC to PYR (Glycolysis) is shown along with the branched pathways (glycogen synthesis, glycerol 




Considering the characteristics of heterogeneous skeletal muscle, the distinct mechanical 
and energetic properties under activated conditions is of note when investigating the metabolic 
workings of skeletal muscle. Metabolically, fast twitch muscle (type II) relies heavily on 
glycolysis for ATP generation, whereas slow twitch muscle (type I) predominantly relies on 
oxidative phosphorylation to generate ATP to drive contractile activation of the muscle83. The 
difference in ATP production mechanisms observed in type I and II muscle is further supported 
by the measured enzyme activities and protein isoforms present in the different muscle  
types8485-8687. Furthermore, the rates of glycolysis and ATPase in type I and type II muscle are 
identical at rest. However, under actively contracting conditions the rates of ATPase and 
glycolysis are significantly higher in type I fibres compared to type II fibres88. Vinnakota et 
al.88 measured the concentrations of ATP, phosphocreatine (PCr) and inorganic phosphate (Pi) 
as a function of time using 31P nuclear magnetic resonance (31P NMR) spectroscopy. Swiss 
Webster mice were dissected, and type I and type II muscle were harvested. 31P-NMR 
measurements were performed on the muscle biopsies, along with pH measurements, following 
the induction of anoxia by replacing the oxygen rich environment with nitrogen. The difference 
measured in the rates of ATPase and lactate production in type I muscle were reported to be a 
factor of 3 – 4 times higher compared to type II muscle. 
Extensive detailed studies of the ATP synthetic pathways and its kinetic regulation have 
been done by several research groups and several in silico models have been constructed for 
cellular ATP synthesis and regulation75,8990-9192. Vicini and Kushmerick75 constructed a minimal 
mechanistic model to describe the cellular energy balance regulation processes studied in 
individuals as they transition from the resting state to the activated state and back to the resting 
state. The minimal model focussed on the interplay between the reactions of oxidative 
phosphorylation, ATP utilization (ATPase) and creatine kinase activity and successfully 
described the time dependent intracellular concentrations of PCr and Pi as obtained from the 
test subjects using 31P-NMR. Lambeth and Kushmeric89 constructed a detailed kinetic model 
of glycolysis in skeletal muscle using kinetic parameters obtained in literature from 
predominantly mammalian cell lines and biopsies. The kinetic parameters were later updated 
to better reflect the parameters determined in mammalian skeletal muscle in a follow-up 
publication93. Their model findings indicated that the flux control through glycolysis is 
predicated solely on the ATPase reaction describing ATP demand within the system (95 – 99% 
of control). As noted by Lambeth and Kushmeric89 several limitations to their in-situ 
investigations were present. The lack of standardised kinetic data in a specified cell line for the 
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construction of a glycolytic model will be required to improve the model. Furthermore, several 
simplifications to the mechanistic descriptions of the enzymes were included due to a lack of 
literature data available. However, modifications to the model included in the follow-up 
publication93 have improved on the above-mentioned limitations and the predictive capabilities 
of the model and was tested using time dependent concentrations of PCR and Pi obtained with 
31P-NMR. The research performed by Selivanov et al.91 focussed on the changes observed to 
glycolytic flux under different exercise regimes. The kinetic parameters for this study were 
obtained from work published by Parra et al.94. Interestingly Parra et al.94 have observed a 2-
fold increase in phosphofructo-kinase (PFK) activity measured after training as compared to 
the PFK activity before training (at rest). However, this increase in PFK activity did not 
correlate with fructose-1,6-bisphosphate (FBP) concentrations measured at rest. In both 
simulation cases performed by Selivanov et al.91 the FBP concentration at rest was under 
predicted eluding to a wrongful measurement of PFK activity at rest91. The model simulations 
performed by Selivanov et al.91 support the findings of Lambeth and Kushmeric89 that 
glycolytic regulation is almost exclusively controlled by ATP demand. An in-silico 
investigation conducted by Schmitz et. al.92 illustrated the important role that the regulation of 
PFK and PK activity play in silencing glycolytic flux in resting skeletal muscle. The in-silico 
models in literature75,8990-9192 discussed here focus exclusively on the regulation of skeletal muscle 
metabolism under exercise conditions where the predominant driving force of metabolism is 
the generation of ATP for muscle activity. In the case of insulin stimulation of skeletal muscle, 
the predominant driving force of skeletal muscle is not the generation of ATP but rather the 
consumption and processing of glucose. Therefore, we can speculate that the regulatory effects 
observed during exercise will be significantly different in comparison to the regulatory effects 
required to deal with the increased demand for glucose processing afforded by insulin 
stimulation. 
2. 8. Metabolic syndrome 
Extensive in-vivo and in-silico investigations into the development and metabolic 
behaviour of metabolic syndrome has been conducted by Rozendaal et. al.95,96. Their endevours 
resulted in the successful description of metabolic changes that arise from the development of 
metabolic syndrome95,96. This resulted in a model capable of describing the development of 




Metabolic syndrome is a common metabolic disease that arise from an increasing 
incidence of obesity and characterised by insulin resistance, hypertension and glucose 
intolerance, among other symptoms97. Lillioja et al. 98 have observed a positive correlation 
between the presence of insulin resistance and the percentage of type I muscle fibres vs. type II 
muscle fibres obtained from muscle biopsies. Their study suggests that in the presence of 
decreased insulin sensitivity, the higher glycolytic activity of type I muscle is favoured 
compared to the oxidative activity of type II muscle. Furthermore, a shift to higher glycolytic 
activity has also been observed to occur during aging and physical inactivity99. In contrast, 
physical exercise enhances the expression of oxidative enzymes in relation to glycolytic 
enzymes associated with an increased sensitivity to insulin99. The metabolic capacity of skeletal 
muscle does not necessarily rely on fibre type distribution per se, but rather on the oxidative 
and glycolytic capacity of skeletal muscle. A study performed by Simoneau et al.100 identified 
a strong relationship between the presence of insulin resistance and increased glycolytic enzyme 
activity and decreased oxidative enzyme activity in the skeletal muscle of obese women. 
Furthermore, the oxidative enzyme capacity of individuals suffering from non-insulin 
dependent diabetes mellitus (NIDDIM) is measurably lower compared to healthy individuals101. 
Another study performed by Simoneau et al.101 measured the activities of glycolytic and 
oxidative marker enzymes in lean non-diabetic, obese non-diabetic and NIDDIM patients. The 
activities of glycolytic enzymes (HK, GAPDH, PFK) showed higher activity in obese non-
diabetic patients compered to lean non-diabetic patients, with the highest activity measured in 
NIDDIM patients. The inverse trend was observed for oxidative enzymes (citrate synthase 
(CS), cytochrome c oxidase (COx), creatine kinase (CK)) with the lowest activities measured 
in NIDDIM patients and the highest activities measured in lean non-diabetic patients101. This 
suggests that the ratio of glycolytic vs. oxidative activities strongly correlates with the metabolic 
capabilities of skeletal muscle, with increased glycolytic to oxidative activities observed in 
obese and NIDDIM patients101. However, a mechanism responsible for the increased glycolytic 
to oxidative ratio remains unelucidated. 
There has been significant debate amongst researchers whether the development of 
insulin resistance and type 2 diabetes results from the diminished activity of glucose transport 
or the defective glucose metabolism of skeletal muscle102103-104105. Several studies performed by the 
research group of Youn106107-108109 have focussed on the hypothesis that impaired intracellular 
glucose metabolism precedes the observed suppression of insulin stimulated glucose transport 
in skeletal muscle. Kim et al.106 have shown that insulin stimulated glycolysis is suppressed in 
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rats reared on a high-fat diet prior to the onset of insulin resistance. A significant reduction of 
approximately 30% in the whole-body glucose metabolism, under insulin stimulated 
conditions, was measured after 2 days of starting the high fat diet, whereas an insignificant 
decrease in the insulin stimulated glucose uptake was measured within this timeframe and the 
onset of insulin resistance was only observable on day 7 of the experiment. Furthermore, the 
suppression of glycolysis (via intralipid infusion) or glycogen synthesis (via amylin infusion) 
under insulin stimulated conditions in conscious rats resulted in a decreased glucose uptake rate 
of approximately 30%107. A further study also reported that during growth hormone infusion, 
the onset of diminished glycogen synthesis activity occurred prior to the development of insulin 
resistance108. The hypothesis that defective glucose metabolism leads to insulin resistance was 
further tested by Lombardi et al.110 through an investigation of the inhibitory effects of lactate 
on glycolysis and how this relates to insulin resistance. Chronic lactate infusion over a 24h 
period in rat biopsies have shown no difference in glucose utilization compared to the control. 
However, when the biopsies were treated with insulin a 72% reduction in glucose utilization 
was observed when compared to the control. This observation suggests that lactate inhibition 
of glycolysis is correlated with skeletal muscle’s inability to dispose of glucose effectively 
under insulin stimulated conditions110. The cause of lactate induced insulin resistance is 
hypothesised to occur via feedback inhibition of glycolysis through the inhibition of PFK-1 
thereby decreasing the glucose flux through glycolysis109. Correlations between PFK-1 
deficiencies and insulin resistance has also been observed in human studies by Ristow et 
al.111,112. Furthermore, lactate induced insulin resistance is associated with a significant 
decrease in the extent of IRS-1 – and IRS-2 associated PI 3-kinase activities along with down-
stream Akt phosphorylation. However, the mechanism correlating lactate inhibition of 
glycolysis and decreased insulin signalling is still unclear109. A detailed study performed by 
Choi et al.109 on the effect of lactate infusion on insulin signalling in rats showed that lactate 
infusion under hyperinsulinemic conditions did not result in changes in the extent of IR, IRS-1 
and IRS-2 phosphorylation. However, IRS-1 – and IRS-2 associated PI 3-kinase activities were 
significantly lower in the presence of lactate infusions, translated with a measured reduction in 
Akt phosphorylation109. The study performed by Choi et al. strongly suggests that lactate can 
induce insulin resistance in skeletal muscle. 
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2. 9. Molecular systems biology 
As laid out by J. C. Smuts in his book ‘Holism and Evolution’113 the animated does not 
differ from the unanimated in terms of structure, but in terms of functionality. Within the field 
of biology, organisms can be considered from both the perspective of the components that the 
organism is comprised of (structure) as well as the activities that these components perform 
(function). The cell can be perceived as a system of co-operation among the constituent 
components leading to function. Therefore, investigation of the components in isolation will 
not give a clear indication of its functionality within the whole, hence the term ‘Holism’. 
However, the cell exists in a seemingly directionless state. Each component operates with little 
to no comprehension of the other components surrounding it. The functionality aspect observed 
in living states that arises from a seemingly chaotic assembly of components is governed by a 
system of organic regulation and co-ordination among these components. The organism is 
maintained in an active state with all its innumerable components finely constrained and 
adjusted to one another to form a harmonious, balanced process, which maintains a balanced 
functionality, not only in the life-span of a single individual, but improves and increases in 
complexity in the duration of its future generations. This is what we conceptualise as “life”. 
This active, balanced state that governs life can be seen in all levels of complexity in an 
organism, from the intake of food as fuel and the excretion of by-products, to the chemical 
reactions mediated by enzymes. Therefore, to maintain the proper working of an organism all 
these processes must be maintained in a balanced state within each level and across different 
levels. Systems biology operates within this framework and is focussed on elucidating the 
functional and regulatory characteristics of each component in order to understand its role 
within a greater whole. This process occurs over several levels and utilizes different techniques 
and strategies with an ultimate goal of describing and understanding the whole. The levels that 




Figure 2.4: Representation of the modelling approaches of systems biology across different levels. A 
top-down modelling approach relies on starting at a higher level and moving down to describe lower 
levels of complexity. A bottom-up approach entails starting at a lower level and building up the higher 
levels of complexity. 
There are 2 main approaches that systems biologists use, namely; top-down and bottom-
up. The top-down approach emerged as the dominant method for systems biology with the 
introduction of new omics analysis. With the ability to measure genome-wide experimental 
data, top-down modelling infers a bird’s eye view of the behaviour of the system. Therefore, 
the aim of top-down systems biology is to discover and characterise biological mechanisms at 
the bottom level using an iterative cycle of analysis between experimental data and data analysis 
to identify correlations between concentrations of molecules. This enables the formulation of 
hypotheses regarding the regulation of groups of molecules. These hypotheses can then be 
tested experimentally to generate further data about the regulation of groups of molecules 
within the system. Top-down modelling approaches aims to discover patterns of behaviour that 
are generic enough to accurately predict biological mechanisms present in the system114115- 116, 
or, to uncover functionally related processes under the control of a common set of transcription 
factors117118- 119. The strengths of top-down systems biology approaches arise from having a near 
complete overhead view of the system that addresses the metabolome, fluxome, transcriptome 
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and proteome. Therefore, top-down modelling is faced with analysing large experimental 
datasets for a single organism under specified conditions120. The conditions can be genetic 
(knockout studies, gene overexpression), environmental (changes in nutrients) or as a result of 
RNA interference. However, it is difficult to obtain a large number of perturbations to 
accurately elucidate the correlative regulatory processes present in the system. This results in a 
perception of large insight into the mechanistic workings of a living organism, but generally 
yields only fractional increases in our understanding of how these living systems are organised 
and regulated. Due to a lack of mechanistic data, top-down systems biology is 
phenomenological, describing the correlations between molecular components rather than the 
mechanistic relationship between those molecular components. These correlations are mapped 
onto a virtual mechanism which describes the correlation but could be far from reality. As such 
top-down modelling approaches are mostly used in cellular systems that lack a high level of 
mechanistic characterisation121. 
In contrast to top-down systems biology approaches, which give insights into correlations 
between components through induction, bottom-up systems biology investigates the functional 
properties of a system that could arise by having a high level of mechanistic detail about the 
molecular processes involved. Thus, bottom-up modelling addresses the elucidation of a system 
from the bottom, looking at the interactive behaviour of the components involved in each 
process. This is typically accomplished through the use of rate equations that describe the 
mechanistic behaviour of each component and integrating these rate equations to predict the 
behaviour of the whole system. The ultimate aim of the bottom-up modelling approach is to 
combine the components present in a system into a model that describes the whole system. 
Therefore, the main concern of bottom-up modelling is accuracy between model predictions 
and reality121. Bottom-up models are mechanism based rather than phenomenological. 
However, there are difficulties regarding parameter estimation. Due to the simplification of 
mechanistic models, along with the inability to measure enzyme activities in situ, the 
mechanistic description of the enzyme along with kinetic parameter determination can vary 
from the biologically concise parameters of the enzyme. Therefore, model validation to ensure 
that model predictions accurately reflect the reality of the system is imperative. It should be 
noted that bottom-up model behaviour is not fitted but predicted. Bottom-up models allow for 
the prediction of changes in the concentrations of system variables based on a mechanistic 
understanding of the components involved and how these components interact. Model 
validation is thus used to determine how accurately the model predicts the system in reality. 
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The typical bottom-up modelling approach reflects the actual stoichiometric relationship 
between variables, along with an accurate reflection of the structure of allosteric regulation. 
However, this is dependent on the complexity of the experimental efforts required to determine 
precise kinetic parameters and enzyme mechanisms under standardised conditions that mimic 
the complexity of the cytosolic environment in which the enzyme is active. The complexity of 
bottom-up modelling approaches is often alleviated by obtaining kinetic parameters from 
literature, measured under non-cytosolic-like conditions, or by fitting kinetic parameters to 
simplified catalytic mechanisms. This brings in question the accuracy of some bottom-up 
studies. Therefore, a strong emphasis should be placed on model validation, i.e. determining 
the predictive accuracy of bottom-up models. 
This has led to the development of the silicon cell program122. The explicit aim of the 
silicon cell program is to construct computer-based models that replicate the mechanistic 
behaviour of cellular pathways. This includes the experimentally determined properties of all 
molecular components123. The silicon cell programs bring together groups globally to construct 
precise biological models which, after the peer-review process by associated journals, are then 
made available on model databases and simulation platforms, such as Biomodels124 and JWS 
online125. JWS online aims to provide curated models constructed from experimentally 
determined parameter values, refereed by scientific journals to enable in silico simulation-based 
experimentation. The silicon cell approach has shown significant advancements in 
understanding the metabolic behaviour of organisms such as Plasmodium falciparum in red 
blood cells126 and bloodstream form Trypanosoma brucei 127128- 129. Similarly, using detailed 
kinetic models on metabolism, EGF receptor signal transduction and the eukaryotic life cycle 
in Saccharomyces cerevisiae have demonstrated the silicon cell program122. 
Validation and determination of the predictive accuracy of bottom-up models relies 
heavily on the availability of analytical techniques that offer metabolomic data of the biological 
system in question. Metabolome analysis allows for direct access to the metabolic phenotype 
expressed under specific environmental conditions. The outcome of cellular regulatory 
processes present at different levels of expression is reflected in the metabolic phenotype of the 
cell130,131. This has significant value to molecular systems biology in terms of both a top-down 
phenomenological approach, identifying potential metabolic bottlenecks and elucidating new 
regulatory processes present in a pathway, as well as bottom-up mechanistic modelling to 
compare model predictions with metabolome data to validate models.  
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Metabolic control analysis (MCA) allows for the quantitative identification of how 
control over the flux through a metabolic pathway is distributed over the components (e.g. 
enzymes) in the pathway. MCA was developed by Kacser and Burns132, and Heinrich and 
Rapoport133. The control exerted by each model component over the flux of the substrate or 
systematic parameter (e.g. metabolite concentration) results in quantification of control each 
component has over the pathway as control coefficients. Control coefficients describe the 
fractional control each component has over the pathway134. Refer to the review by Cascante et. 
al.134for further information on MCA and its application in drug discovery and disease. 
2. 10. Metabolomics 
The completion of the human genome sequence135, has increased efforts to determine the 
function of orphan genes as molecular targets for therapeutic intervention, and the search for 
biological markers as indicators of disease response or progression136. This post genomic era 
has increasingly shown the need for analytical methods to quantify the concentrations of 
intracellular and extracellular metabolites of living organisms and continues to be more 
apparent as advances in our detailed understanding of metabolic processes in biological systems 
progress137. Analytical approaches in the fields of gene sequencing (genomics), gene expression 
(transcriptomics) and protein translation (proteomics) have become important tools for 
understanding and quantifying the regulation of biological systems, but a similar approach to 
metabolomics has remained problematic. Development of the polymerase chain reaction (PCR) 
and automated sequencing for genomic analysis138,139 and array-based proteomics140 offers an 
automated analytical strategy for the elucidation of the genome or proteome of a biological 
system. In contrast, the chemical complexity and heterogeneity of metabolites make it 
impossible to develop an automated analytical strategy for the quantification of all possible 
metabolites in a cellular system136.  
Analysis of a biological system at the transcriptomic, proteomic and metabolomic level 
in conjunction with a systems biology approach offers a method of bridging the genotype-to-
phenotype gap141. However, the staggering number of metabolites in any given system and their 
relationship and interactions with other metabolites (metabolism) and biochemical species 
makes this a dauting challenge. The major effort of metabolomic investigations aims to 
qualitatively and/ or quantitatively identify the phenotypic expression and biological function 
biochemical species142. Metabolomics, in particular, is of importance to systems biologists as it 
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is the result of gene expression and it is expected that changes to the metabolome will be 
amplified in conjunction to changes in the transcriptome and proteome143.  
The metabolome is an overarching term that includes many different biomolecules and 
there is active discussion in the research community on what exactly constitutes the term 
‘Metabolome’136. The term was first defined by Oliver et. al.144 as the concentration profile of 
all low molecular weight molecules present in cells at a specific physiological state at a given 
time. However, the wide ranges of physiochemical properties associated with the metabolome 
makes the determination of the metabolic profile complicated. This has allowed for the 
development of different metabolomic strategies with varying degrees of quantitative ability, 
and number of metabolites included in the analysis, depending on the study and the need. 
Untargeted metabolomic studies, or metabolic profiling is focussed on acquiring 
analytical data in relation to a wide range of metabolites in the metabolome and is applied in 
inductive studies. Therefore, untargeted metabolomic techniques are developed for the 
detection of hundreds to thousands of metabolites in a single analysis at the cost of lower 
precision and accuracy in comparison to targeted studies. Untargeted metabolomic studies are 
often carried out on samples with a lack of metabolite composition beforehand and the large 
number of metabolites under analysis mean that sample preparation is limited to reduce 
metabolite losses. This typically results in the acquisition qualitative or semi quantitative data 
that measures relative changes in the metabolome as opposed to concentrations, since the 
technical difficulty of preparing standards and setting up calibration curves for each metabolite 
is impossible142. This metabolomics approach does offer a large amount of data on the 
metabolites present in a sample, which makes it ideal for quality control applications, for 
example the measurement of flavonols and anthocyanins present in grapes145. Another example 
of an untargeted study is the investigation carried out by Lisec et. al.146 on the metabolic profile 
of plants in which gas chromatography mass spectrometry (GC-MS) was employed for the 
routine determination of relative levels of between 300 and 500 metabolites. 
Targeted metabolomic studies is placed on the other side of the metabolomic analytical 
spectrum and emphasises high specificity, precision and accuracy to quantify metabolite 
concentrations of a select number of metabolites142. Targeted metabolomic studies rely on 
traditional analytical biochemical methods applied to deductive studies where the metabolites 
of interest are known. Sample preparation is typically more extensive to separate the 
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metabolites of interest from the sample matrix. Furthermore, calibration curves and internal 
standards are used to ensure that quantitative data is obtained142.  
Recent metabolomic studies, such as the study performed by Sabatine et. al.147 for the 
identification of novel biomarkers of coronary heart disease, have resulted in an intermediate 
strategy to metabolomic analysis, sometimes referred to as semi-targeted metabolomic analysis. 
The experimental methodologies employed offers higher specificity, precision and accuracy 
compared to untargeted metabolomics and provide quantitative or semi-quantitative 
concentrations of metabolites142. 
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Chapter 3  
Development of an ion pairing reverse phase liquid chromatography 
method for the quantification of glycolytic intermediates and cofactors. 
3.1 Preamble 
To validate the glycolytic model that was constructed in this study we needed a method 
to dynamically follow glycolytic intermediates. Here we present how that method was 
developed. 
3.2 Introduction 
The need for analytical methods to quantify the concentrations of intracellular and 
extracellular metabolites of living organisms is becoming more apparent as advances in our 
detailed understanding of metabolic processes in biological systems increase1. Analytical 
approaches in the fields of genomics, transcriptomics and proteomics have become important 
tools for understanding and quantifying the regulation of biological systems, but a similar 
approach to metabolomics has remained problematic. Due to the chemical complexity and 
heterogeneity of the metabolites present in a biological sample, it is impossible to develop a 
simple automated analytical strategy to quantify all the possible metabolites in such a sample2. 
Metabolome analysis allows for direct access to the metabolic phenotype expressed under 
specific environmental conditions and therefore, reflect the outcome of cellular regulatory 
processes present at different levels of expression, e.g. at the transcriptional or translational 
level34- 5. This has significant value to molecular systems biology as knowledge of intracellular 
metabolite concentrations enables identification of potential metabolic bottlenecks and provides 
the basis for a quantitative understanding of intracellular reaction rates and the control of 
metabolic fluxes6. The ability of utilizing a metabolomic approach in tandem with dynamic 
metabolic models allows for the identification and elucidation of new metabolic pathways and 
a better understanding of the metabolic regulation of new and existing metabolic pathways7,8. 
Targeted studies focussed on the quantification of specific metabolites in a metabolic 
pathway, such as glycolysis, are also of interest for the validation of metabolic models. The 
ability to compare model predictions to experimentally obtained metabolite concentrations 
increases confidence in the use of such models. Various approaches attempting to analyse 
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multiple metabolites simultaneously have been published including thin-layer 
chromatography9,10, nuclear magnetic resonance spectroscopy1112- 13, capillary electrophoreses 
tandem mass spectrometry (MS)14 and high-performance liquid chromatography (LC) with 
various modes of detection151617-1819. An extensive analysis of LC-MS approaches to metabolomics 
conducted by Bajad et. al.20 found that ionic interactions on the column are required to obtain 
sufficient separation of water-soluble cellular metabolites21. Among their trails, amino-column 
based separations in HILIC mode performed best whereas C-18 reverse phase separations 
showed little to no separation efficiency. However, with the aid of an ion-pairing agent, the 
separation efficiency of C-18 reverse phase columns are greatly improved. Lu et. al.22 
developed a reverse phase LC method, assisted with tributylamine as ion pairing agent, 
followed by the stand-alone analysis via orbitrap mass spectrometry for the separation of water-
soluble species involved in the core metabolism of Baker’s yeast, including several of the 
glycolytic species of interest to this study.  
Within the field of metabolomics, NMR and MS has become the methods of choice. This 
is in part, due to the uniform detection obtained for a specific NMR active nucleus, regardless 
of chemical structure5. However, poor sensitivity is a drawback to using NMR. In contrast, MS 
offers high sensitivity to select classes of analytes, but the technique is prone to matrix effects2. 
Both techniques mentioned above have their advantages for screening large amounts of 
metabolites, but alternative methods of detection exist for targeted studies. Radio-isotope 
detection offers high sensitivity to labelled metabolites with no interference from matrix effects 
and makes a good alternative technique for targeted metabolomic studies. The metabolism of 
montelukast, a potent cysteinyl leukotreine1 receptor antagonist, was investigated using a 
RPLC- radioactivity detector to analyse human bile23. 
In this chapter we present a new method for the quantitative detection of glycolytic 
intermediates and cofactors. A novel ion-pairing reverse phase LC (IP-RPLC) method with 
UV-Vis and radio-labelled detection was developed for targeted metabolomic studies of 
glycolytic intermediates and tested in yeast extract. This method offers the advantages of 
robustness from RPLC analysis with the high sensitivity and limited matrix interference from 
radio-isotope detection.  
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3.3 Materials and Methods 
3.3.1. Materials 
Water used for the preparation of mobile phases was prepared via reverse osmosis 
filtration. HPLC grade acetonitrile was obtained from Romil. Tetrabutylammonium (TBA) 
bisulfate, formic acid, metabolites, purified enzymes and all additional media components were 
sourced from Sigma-Aldrich. 14C- glucose, 14C-pyruvate and 14C-glycerol was obtained from 
American Radiolabelled Chemicals Inc. (ARC). 
3.3.2. HPLC instrumentation and methodology 
All chromatographic analysis was performed on a SpectraSYSTEM HPLC setup 
containing the following instrumental components; SpectraSYSTEM P4000 pump with low 
pressure mixing of the mobile phase reservoirs, SpectraSYSTEM AS3000 Autosampler, 
connected to a SpectraSYSTEM UV6000LP UV-Vis detector followed by a LabLogic β-RAM 
model 5 radio-labelled detector. A reverse phase Phenomenex Luna C18 column (5 µm) was 
used for all chromatographic separations. 
The ion-pairing RPLC (IP-RPLC) method was optimized through a trial and error 
approach. The mobile phase composition is as follow: Solvent A is 25 mM TBA in water 
adjusted to a pH of 7.3 (± 0.1); Solvent B is 97.5% Acetonitrile and 2.5% water; Solvent C is 
0.1% formic acid in water and was used for a routine wash after every set of samples. The total 
run time is 20 min at a flow rate of 1 mL/ min. A gradient is employed to expedite the analysis 
by lowering the retention of the late eluting chemical species. The gradient is as follow:  
at 0 - 4.5 min 95% A and 5% B; 5 - 12 min 70% A and 30% B; 13 - 20 min 95% A and 5% B. 
UV-Vis detection of the column effluent was measured at 254 nm. The radiolabelled detector 
is set to start at a runtime of 1 min and is terminated at a runtime of 13 min. Scintillation fluid 
is mixed with the column effluent in a 3:1 ratio. 
3.3.3. Quantification of the glycolytic intermediates via IP-RPLC-radiolabelled detection. 
The retention times of the glycolytic intermediates were determined by radiolabelled 
detection of the IP-RPLC eluent. Radiolabelled measurement was initialised 1 min after 
injection. Therefore, the radiolabelled chromatographic traces have a 1 min offset in 
comparison to the UV/Vis chromatographic traces. The 14C-labeled glycolytic intermediates 
Stellenbosch University https://scholar.sun.ac.za
38 
were synthesised from 14C-glucose (14C-GLC), 14C-glycerol (14C-GLY) and 14C-pyruvate (14C-
PYR) through a series of enzymatic reactions. The stepwise conversion of the 14C-labeled 
starting materials allowed for the synthesis of all required glycolytic intermediates, with the 
exception of bisphosphoglycerate (BPG). The synthesised 14C-labelled glycolytic intermediates 
were separated via IP-RPLC analysis and detected with the radiolabelled detector connected to 
the column. The resulting chromatographic traces were integrated to determine the relative 
concentrations of the metabolites associated with the peaks present in each of the 
chromatographic traces. 
Integration of the chromatographic traces were done via an in-house developed script in 
Wolfram Mathematica. Tailing of the peaks were present in the chromatographic traces and as 
a result the peaks were described by skewed normal distribution functions, rather than normal- 
or gaussian distribution functions. The function describing the probability density of a skewed 
normal distribution, which represents an estimation of the area under the peak, is given in Eq. 
3.1 and Eq. 3.2 and includes a shape parameter that relates to the slant of the peak. Each peak 
obtained in the chromatographic trace was described by 1 or more skewed normal distribution 
functions. In the case where more than 1 skewed normal distribution was required, the function 
was described as the summation of multiple skewed normal distribution functions with 
independent parameters for each skewed normal distribution function. 
Probability density x =  ( + erf 𝛼 x − 𝜇√ ∙ 𝜎 ) ∙ (− x−𝜇 22𝜎2 )                                        Eq. .  
erf z =  √𝜋 ∫ −t2z0 𝑡                                                                                                              Eq. .  
The function for a skewed normal distribution described in Eq. 3.1 and Eq. 3.2 determines 
the probability density (x), for an optimised set of parameters. The following parameters dictate 
the description of the skewed normal distribution: 
µ - represents the retention time of the peak. 
σ - represents the scale parameter or standard deviation of the peak. 
α - represents the shape parameter or slant of the peak. 
t – dictates the retention time boundaries of the peak. 
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The Nonlinearmodelfit function of Wolfram Mathematica was used to fit skewed normal 
distribution functions to the chromatographic traces by optimising the parameters (µ, σ, α) over 
the defined retention time range. In the majority of cases, the retention time had to be 
constrained to obtain an accurate description of the peaks in the chromatographic trace. 
Integration of the skewed normal distribution functions yielded the area corresponding to each 
metabolite. 
3.3.4. Quantification of the adenosine and nicotinamide metabolites via IP-RPLC-UV/Vis 
detection. 
Calibration standards of the metabolites ATP, ADP, AMP, NAD+ and NADH were 
prepared by dissolving 1 mM of each of the metabolites in a 100 mM phosphate buffer. A 
dilution series over the range of 1 mM – 0.05 mM was prepared and analysed via the IP-RPLC 
method. The chromatographic traces obtained for the adenosine and nicotinamide calibration 
standards were integrated using the ChromSolve integration software associated with the HPLC 
analysis software package. Calibration curves for each of the adenosine and nicotinamide 
moieties were constructed from the integration of the chromatographic traces obtained from the 
calibration standards. The areas under each peak obtained for the calibration standards were 
plotted against the corresponding known concentration of each adenosine and nicotinamide 
metabolite yielding a calibration curve for each chemical species over the range of 1 mM – 0.05 
mM.  
The limit of detection (LOD) and limit of quantification (LOQ) of the adenosine and 
nicotinamide metabolites were determined from the standard error (SE) of the intercept by using 
Eq. 3.3 – 3.5, where N refers to the amount of readings used for the construction of each 
calibration curve (N = 6). The linear calibration curves were used to determine the unknown 
concentrations of the adenosine and nicotinamide moieties in the biological samples using  
Eq. 3.6.  
Standard deviation SD  of intercept =  SE of intercept × √𝑁                                   Eq. .  
LOD = . × (SD of interceptGradient )                                                                                              Eq. .  
LOQ = × (SD of interceptGradient )                                                                                               Eq. .  
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Concentration =  Peak area − interceptgradient                                                                          Eq. .  
3.3.5. Quantification of the total GLC concentration in the 14C-GLC starting material. 
To determine the GLC concentration present in the 14C-starting material, a GLC 
calibration curve was constructed. Standards containing unlabelled GLC at concentrations of 1 
mM, 0.5 mM, 0.25 mM, 0.125mM and 0mM were prepared and treated with HK and G6PDH 
in the presence of excess ATP and NAD+. In the presence of HK and G6PDH, GLC is converted 
to phosphor-D-glucono-1,5-lactone (PGL) with the corresponding conversion of NAD+ to 
NADH at a stoichiometric ratio of 1:1. The NADH was visualised spectrophotometrically at 
340 nm, resulting in a linear relationship between the concentration of the GLC standards and 
the absorbance at 340 nm as shown in Figure 3.1. 
 
Figure 3.1: Plot of GLC standards vs. absorbance The calibration curve constructed for the 
quantification of GLC in unknown samples. The calibration curve was constructed by treating GLC 
samples of known concentrations with HK and G6PDH in the presence of excess ATP and NAD+ and 
measuring the absorbance at 340 nm. (Gradient = 0.735, Intercept = 0.154, r2 = 0.9996) 
The dilution samples prepared from the 14C-GLC stock solution were treated with HK 
and G6PDH in the presence of excess ATP and NAD+ and the absorbance was measured at 340 
nm via UV-Vis spectroscopy. The total concentration of GLC present in the 14C-GLC starting 
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material was determined by relating the measured absorbance to concentration using the 
calibration curve constructed for GLC in Figure 3.1. 
3.3.6. Preparation of yeast extract and quantification of the glycolytic intermediates via 
enzyme coupled assays. 
Yeast strain X2180 was cultured under aerobic conditions in a gyratory shaker at 30ºC in 
a yeast nitrogen base. Growth was monitored by measuring the optical density at 600 nm to 
ensure that growth is in the log phase. The yeast culture was harvested in the log growth phase 
and pelleted via centrifugation. Yeast lysate was prepared via glass bead extraction. Lysis was 
performed by resuspending the yeast cells and vortexing the cell suspension, in the presence of 
100mg glass beads/ 1 ml of cell suspension, for 1 minute followed by resting the suspension on 
ice for 15 seconds and repeating this cycle 6 times. The cell solution was then centrifuged at 
20 800 x g at 4ºC for 15 minutes to pellet the cell debris. After centrifugation the supernatant 
was removed and stored on ice. 
The concentrations of ATP, DHAP and FBP were determined via enzyme coupled assays 
to compare to concentrations obtained via the novel IP-RPLC technique. For DHAP 
determination, time course samples were treated with G3PDH in the presence of excess NAD+ 
for the conversion of DHAP to G3P associated with the conversion of NAD+ to NADH. The 
concentration of DHAP was determined by measuring the amount of NADH formed by UV-
Vis spectroscopy at 340 nm. For FBP determination, samples were treated with ALD in the 
presence of excess NAD+ after conversion of DHAP to G3P. The concentration of FBP was 
quantified by measuring the further increase in NADH concentration, considering the NADH 
resulting from the DHAP. The concentration of ATP was determined via coupled assay 
technique by treating samples with commercially obtained HK and G6PDH in the presence of 
excess GLC and NADP+. The conversion of ATP to ADP via HK is equivalent to the conversion 
of NADP+ to NADPH and the ATP concentration was determined from the increased 




3.4.1. IP-RPLC separation and quantification of the adenosine and nicotinamide metabolites 
via UV-Vis detection 
To determine the retention times of the adenosine and nicotinamide moieties, 
commercially available ATP, ADP, AMP, NAD+ and NADH salts were analysed via IP-RPLC 
separation in tandem with UV-Vis detection. A series of samples, each containing a single 
adenosine or nicotinamide compound, were injected onto the column. To match the sample 
preparation protocol used for the biological samples, 50 µL samples for each of the adenosine 
and nicotinamide standards were collected and treated with 7.5 µL of a 50% PCA solution, 
followed by neutralisation with 42.5 µL of a 1 M K2CO3 solution. IP-RPLC analysis of the 
standards resulted in a chromatographic trace corresponding to the specific compound in each 
standard. The chromatographic traces for ATP, ADP, AMP and NAD+ resulted in a single peak 
corresponding to that species. However, the chromatographic trace for NADH resulted in 3 
related peaks. NADH is known to degrade in acidic solutions to form related UV-Vis active 
chemical species and we suspect that the 3 peaks observed for NADH arise from the acid-
degradation of NADH24,25. Therefore, the area under the 3 peaks corresponding to NADH was 
summed to give the chromatographic signal for NADH. The retention times of the adenosine 
and nicotinamide moieties are listed in Table 3.1. 
Calibration curves for the quantification of the adenosine and nicotinamide moieties were 
constructed. Standards of the adenosine and nicotinamide moieties were made by preparing 
samples containing 1 mM, 0.75 mM, 0.5 mM, 0.25 mM, 0.1 mM and 0.05 mM of each of the 
5 chemical species. The calibration standards were treated with PCA and neutralised with 
K2CO3 prior to IP-RPLC analysis. 10 µl of each standard was injected onto the column and the 
resulting chromatographic traces obtained for the IP-RPLC analysis of the calibration standards 




Table 3.1: Summary of the retention times of the adenosine and nicotinamide moieties as separated by 







NADH (1) 440 
NADH (2) 454 





Figure 3.2: Chromatographic traces of the adenosine and nicotine moieties obtained from the IP-RPLC 
analysis of the calibration standards via UV-Vis detection at 254 nm. Standards containing 1.0 mM 
(Black), 0.75 mM (Blue), 0.5 mM (Purple), 0.25 mM (Red), 0.1 mM (Orange) and 0.05 mM (Green) of 




Figure 3.3: Calibration curves for each of the adenosine and nicotinamide moieties constructed from 
prepared standards at known concentrations of 1.0 mM, 0.75 mM, 0.5 mM, 0.25 mM, 0.1 mM and 0.05 
mM of each of the species. Areas were obtained by integrating the chromatographic traces measured 
via UV-Vis detection at 254 nm and plotting the resulting area against the corresponding known 
concentration of each chemical species. 
A linear relationship between the measured areas and concentrations of each adenosine 
and nicotinamide moiety described the calibration data well (r2 > 0.99). The resulting gradient 
and intercept of each calibration curve describes the relationship between peak area and 
concentration for each of the corresponding adenosine and nicotinamide moiety. The LOD and 
LOQ for each of the adenosine and nicotinamide metabolites were determined as described in 
Section 3.3.4. The values for the description of the calibration function (gradient and intercept) 
and the LOD and LOQ calculated for each of the adenosine and nicotinamide moiety are 




Table 3.2: Description of the calibration curves used for quantification of the unknown concentrations 
of the adenosine and nicotinamide moieties. The tabulated gradient and intercept values describe the 
relationship between peak area and concentration for each of the species. The LOD and LOQ values 
were determined for each of the adenosine and nicotinamide moieties. 
Species Gradient Intercept r2 LOD (mM) LOQ (mM) 
NAD+ 47069.36 1268.82 0.9902 0.225 0.683 
NADH 35752.62 2653.08 0.9929 0.192 0.582 
ATP 29689.95 606.68 0.9998 0.062 0.187 
ADP 86660.53 1209.04 0.9986 0.084 0.255 
AMP 21383.56 421.91 0.9993 0.030 0.091 
3.4.2. IP-RPC separation of the glycolytic intermediates prepared from 14C-Glucose for the 
determination of retention times 
A sample containing 14C-GLC and an excess amount of ATP was prepared for the 
stepwise synthesis of the 14C-labeled glycolytic intermediates as illustrated in Figure 3.4. IP-
RPLC analysis of the sample containing 14C-GLC resulted in a chromatographic trace with a 
peak at 38 second, corresponding to GLC, along with a peak at 90 seconds suspected to be an 
impurity present in the commercially obtained 14C-GLC stock solution. The peak at a retention 
time of 38 seconds is close to the dead time of the column and shows that GLC is not retained 
by the IP-RPLC separation method. HK was added to the sample to convert the 14C-GLC to 
14C-G6P and injected onto the column. This resulted in a peak at a retention time of 157 seconds 
that we assigned to be G6P. The sample was subsequently treated with PGI to convert the 14C-
G6P to 14C-F6P. IP-RPLC analysis of a representative sample showed incomplete conversion 
of 14C-G6P to 14C-F6P, with the emergence of a peak at a retention time of 182 seconds 
corresponding to F6P. Due to the low equilibrium constant of PGI (Keq = 0.314)26, incomplete 
conversion is expected. The chromatographic trace was integrated, and the ratio of the resulting 
areas were compared to the Keq for PGI. The ratio of the areas of the peaks assigned to G6P 
and F6P yielded a value of 0.292 which is close to the reported value of the Keq for PGI.  
The sample containing 14C-G6P and 14C-F6P was treated with PFK for the enzymatic 
conversion of 14C-F6P to 14C-FBP. Due to the presence of PGI in the sample, near full 
conversion to 14C-FBP was observed in the chromatographic trace obtained via IP-RPLC 
analysis. The resulting chromatographic trace resulted in the emergence of a peak at a retention 
time of 641 seconds assigned to FBP. ALD was added to the sample containing 14C-FBP for 
the conversion of 14C-FBP to 14C-DHAP and 14C-GAP. Only limited conversion of 14C-FBP 
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associated with the emergence of a peak at a retention time of 195 seconds was observed. All 
attempts to convert the sample containing 14C-FBP, 14C-DHAP and 14C-GAP to the lower 
glycolytic intermediates resulted in limited conversions and uncertainty surrounding the 
assignment of emerging peaks in the chromatographic trace. Therefore, the retention times of 
the lower glycolytic intermediates were determined by the enzymatic conversion of 14C-
GLY.The chromatographic traces and the integrated area corresponding to 14C-GLC and the 
glycolytic intermediates derived from 14C-GLC are shown in Figure 3.5  
 
Figure 3.4: Schematic illustration of the enzymatic reactions used for the synthesis of the radiolabelled 
glycolytic intermediates. 14C-GLC was converted to 14C-G6P, 14C-F6P, 14C-FBP, 14C-GAP and 
14C-DHAP and separation with the IP-RPLC method coupled to a radiolabelled detector for the 
determination of the corresponding retention times of each glycolytic intermediate. The corresponding 




Figure 3.5: Stacked plot of the chromatographic traces and integrated areas corresponding to the 
species; GLC, G6P, F6P and FBP synthesised by the step-wise enzymatic reaction of 14C-GLC with 
HK, PGI and PFK as discussed in the text above. The grey dots represent the chromatographic traces. 
The black shaded area represents the integrated area corresponding to 14C-GLC. The blue shaded 
area represents to integrated area corresponding to 14C-G6P. The red shaded area represents to 
integrated area corresponding to 14C-F6P. The orange shaded area represents to integrated area 
corresponding to 14C-FBP. 
3.4.3. IP-RPC separation of the glycolytic intermediates prepared from 14C-Glycerol for the 
determination of retention times 
A sample containing 14C-GLY and an excess amount of ATP and NAD+ was prepared for 
the synthesis of radiolabelled glycolytic intermediates as illustrated in Figure 3.6. IP-RPLC 
analysis of the sample resulted in a single peak at 44 seconds assigned to GLY. The peak at a 
retention time of 44 seconds is close to the dead time of the column and shows that GLY is not 
retained by IP-RPLC separation method. The sample containing 14C-GLY was treated with GK 
and a representative sample was injected onto the column. The resulting chromatographic trace 
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showed the emergence of a peak at a retention time of 202 seconds assigned to G3P with a near 
full conversion of 14C-GLY to 14C-G3P.  
 
Figure 3.6: Schematic illustration of the enzymatic reactions used for the synthesis of the radiolabelled 
glycolytic intermediates. 14C-GLY was converted to 14C-G3P, 14C-DHAP, 14C-GAP, 14C-P3G and  
14C-P2G and separation with the IP-RPLC method coupled to a radiolabelled detector for the 
determination of the corresponding retention times of each glycolytic intermediate. The corresponding 
retention rimes are listed in Table 3.3. 
The sample containing 14C-G3P was subsequently treated with G3PDH for the conversion 
of 14C-G3P to 14C-DHAP. The presence of any NADH in the sample, produced by the 
enzymatic reaction of G3PDH, strongly inhibits G3PDH. Therefore, the reaction was coupled 
with LDH in the presence of unlabelled PYR to convert NADH back to NAD+. The addition of 
G3PDH and LDH resulted in the formation of a peak at 195 seconds assigned to DHAP. The 
sample containing 14C-DHAP was treated with TPI for the conversion of 14C-DHAP to 14C-
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GAP and a representative sample was injected into the column. The resulting chromatographic 
trace showed the emergence of a very small peak at a retention time of 185 seconds assigned to 
GAP, along with a peak at a retention time of 195 seconds corresponding to DHAP. The 
chromatographic trace was integrated and the ratio of the areas of the peaks corresponding to 
GAP and DHAP yielded a value of 0.078 which compares well with the equilibrium constant 
reported for TPI (Keq = 0.089)27 further supporting our assignment of the 2 chromatographic 
peaks to DHAP and GAP respectively. Due to the unfavourable equilibrium state of BPG the 
conversion of 14C-GAP to 14C-BPG was not attempted. 14C-GAP was directly converted to 14C-
P3G by treating the sample containing 14C-GAP and 14C-DHAP with GAPDH and PGK. 
Additional ADP was added during this reaction step to ensure complete conversion of DHAP 
to P3G. The presence of TPI in the sample facilitated the conversion of 14C-DHAP to 14C-GAP 
and the resulting chromatographic trace showed the emergence of a peak at retention time of 
445 seconds, assigned to P3G, and near full conversion of 14C-DHAP and 14C-GAP. The sample 
containing 14C-P3G was treated with PGM for the conversion of 14C-P3G to 14C-P2G and a 
representative sample was injected into the column. The resulting chromatographic trace 
showed the emergence of a small peak at 482 seconds assigned to P2G. Due to the unfavourable 
Keq for PGM (Keq = 0.49)27, full conversion is not expected and the ratio of the integrated 
areas for the peaks assigned to P3G and P2G yielded a value of 0.270 which is about half of the 
equilibrium constant reported for PGM. The sample containing 14C-P3G and 14C-P2G was 
treated with ENO for the conversion of 14C-P2G to 14C-PEP and a representative sample was 
injected into the column. The conversion of 14C-P2G to 14C-PEP proved difficult. However, 
emergence of a small peak was observed at a retention time of 254 seconds. The 
chromatographic trace was integrated, and the ratio of the peak areas were correlated to the Keq 
values of PGM and ENO. The ratio of the peak areas corresponding to P3G and P2G yielded a 
value of 0.327 and is comparable to the Keq reported for PGM, but the ratio of the peak areas 
for P2G and PEP yielded a value of 0.450, which does not correlate to the equilibrium constant 
reported for ENO (Keq = 6.7)28. Therefore, the peak observed at a retention time of 254 seconds 
will be tentatively assigned to PEP however, further support for this assignment is necessary. 
Due to the presence of LDH and unlabelled PYR added for the conversion of 14C-G3P to  
14C-DHAP the further conversion of the sample containing 14C-P3G, 14C-P2G and 14C-PEP was 
not attempted and the determination of the retention times of the remaining glycolytic 
intermediates will be determined through the conversion starting with 14C-PYR. The 
chromatographic traces and the integrated area corresponding to 14C-GLY and the glycolytic 




Figure 3.7: Stacked plot of the chromatographic traces and integrated areas corresponding to the 
species; GLY, G3P, DHAP, GAP, P3G, P2G and PEP synthesised by the step-wise enzymatic reaction 
of 14C-GLY with GK, G3PDH, TPI, GAPDH, PGK, PGM and ENO as discussed in the text above. The 
grey dots represent the chromatographic traces. The black shaded area represents to integrated area 
corresponding to 14C-GLY. The pink shaded area represents to integrated area corresponding to 14C-
G3P. The green shaded area represents to integrated area corresponding to 14C-DHAP. The brown 
shaded area represents to integrated area corresponding to 14C-GAP. The purple shaded area 
represents to integrated area corresponding to 14C-P3G. The mustard shaded area represents to 
integrated area corresponding to 14C-P2G. The red shaded area represents to integrated area 
corresponding to 14C-PEP. 
3.4.4. IP-RPC separation of the glycolytic intermediates prepared from 14C-Pyruvate for the 
determination of retention times 
A sample containing 14C-PYR in the presence of excess NADH was prepared for the 
synthesis of the remaining radiolabelled glycolytic intermediates as illustrated in Figure 3.8.  
IP-RPLC analysis of a representative sample containing 14C-PYR showed a large peak at a 
retention time of 210 seconds assigned to PYR, along with impurity peaks at retention times of 
41, 302 and 401 seconds. The sample containing 14C-PYR was treated with LDH and a 
representative sample was injected into the column. The chromatographic trace showed near 
full conversion of 14C-PYR, resulting in the emergence of a peak at a retention time of 120 




Figure 3.8: Schematic illustration of the enzymatic reactions used for the synthesis of the radiolabelled 
glycolytic intermediates. 14C-PYR was converted to 14C-LAC, 14C-ACA and 14C-ETOH and separation 
with the IP-RPLC method coupled to a radiolabelled detector for the determination of the corresponding 
retention times of each glycolytic intermediate. The corresponding retention rimes are listed in Table 
3.3. 
For the conversion of 14C-PYR to 14C-acetaldehyde (ACA) and 14C-ethanol (ETOH), a 
sample of 14C-PYR containing an excess amount of NADH was prepared. The radioactive 
carbon atom is in the C1 position of the
14C-Pyruvate and will be converted to ACA and ETOH 
and all CO2 produced by pyruvate decarboxylase (PDC) is expected to be unlabelled. The 
sample containing 14C-PYR was treated with yeast extract to convert the 14C-PYR to 14C-ACA 
and 14C-ETOH. A sample was taken shortly after addition of yeast extract and the resulting 
chromatographic trace showed the emergence of 2 peaks at retention times of 76 seconds and 
121 seconds. Another sample was taken after approximately an hour afterwards and the 
resulting chromatographic trace showed the emergence of a peak at a retention time of 76 
seconds. Therefore, we have assigned the peak at 76 seconds to ETOH and the peak at 121 
seconds to ACA. The chromatographic traces and the integrated area corresponding to 14C-
GLY and the glycolytic intermediates derived from 14C-GLY are shown in Figure 3.9. The 
retention times determined for each of the glycolytic intermediates via the stepwise enzymatic 




Figure 3.9: Stacked plot of the chromatographic traces and integrated areas corresponding to the 
species; PYR, LAC, ACA and ETOH synthesised by the step-wise enzymatic reaction of 14C-PYR with 
LDH obtained commercially, and PDC and ADH from yeast extract as discussed in the text above. 
The grey dots represent the chromatographic traces. The black shaded area represents to integrated 
area corresponding to 14C-PYR. The brown shaded area represents to integrated area corresponding 
to 14C-LAC. The red shaded area represents to integrated area corresponding to 14C-ACA. The blue 




Table 3.3: Summary of the determined retention times of the glycolytic intermediated obtained through 
the IP-RPLC analysis coupled with radiolabelled detection. The glycolytic intermediates were 
synthesised by enzymatically converting 14C-GLC, 14C-GLY and 14C-PYR to a subset of the glycolytic 




















3.4.5. IP-RPLC method application: Quantification of glucose in the 14C-GLC starting 
material 
The IP-RPLC method developed in this chapter, allows for the separation and 
quantification of the adenosine and nicotinamide moieties, summarised in Table 3.1, and the 
separation of the glycolytic intermediates, as summarised in Table 3.3. However, the 
chromatographic traces obtained from the radiolabelled detector represents the counts measured 
per second in response to the concentration of each glycolytic intermediate, as illustrated by 
Eq. 3.7. The 14C-GLC starting material contains both 14C-GLC and unlabelled GLC at unknown 
concentrations and the relative concentrations of 14C-GLC and unlabelled GLC cannot be 
distinguished from one another. Therefore, a response factor (rf) needs to be calculated to 
correlate the 14C-signal obtained in the chromatographic trace to concentration. 
To determine the rf that relates the concentration of glycolytic intermediates to the 
corresponding area obtained from the chromatographic trace, both the concentration and the 
corresponding area must be known. Area = 𝑟  ∙ concentration                                                                                                     Eq. .  
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The response factor that relates the area obtained from the chromatographic trace of GLC 
to the corresponding GLC concentration (see Section 3.3.5), was determined from a 
commercially obtained 14C-GLC stock solution. The 14C-GLC concentration of the stock 
solution was reported to be between 3.3 and 4.3 mM, whereas the concentration of unlabelled 
GLC in the stock solution was unknown. Samples from the 14C-GLC stock solution was 
prepared at 2 times (x 2), 4 times (x 4) and 8 times (x 8) dilution. 5 μL of each dilution sample 
was injected into the column for IP-RPLC analysis and the chromatographic traces were 
integrated to yield the areas relating to each dilution sample, listed in Table 3.4. 
To verify the measured GLC concentrations, the dilution samples prepared from the 14C-
GLC stock solution were treated with HK in the presence of excess ATP and 5μL of each 
sample was injected into the column. In the presence of HK, GLC is converted to G6P 
associated with a conversion of ATP to ADP at a stoichiometric ratio of 1:1. The corresponding 
conversion of ATP to ADP was quantified from the chromatographic traces obtained via UV-
Vis detection, using an ADP calibration curve as discussed in Section 3.4.1 and the resulting 
concentrations are listed in Table 3.4. Furthermore, the chromatographic traces obtained via 
radiolabelled detection was integrated and the resulting areas are listed in Table 3.4.  
Table 3.4: Summary of the results obtained for the concentration determination of GLC in dilution 
samples of the 14C-GLC stock solution. GLC concentration was determined spectrophotometrically with 
the aid of a GLC calibration curve (Figure 3.1). ADP concentration was determined from the 
chromatographic traces obtained via UV-Vis detection. The area describing the GLC peaks and the 
G6P peaks were obtained from the integration of the chromatographic traces obtained via radiolabelled 
detection. 










x 2 5.90 5.66 85 467 85180 
x 4 2.72 2.96 31 217 31541 
x 8 1.46 1.38 15 815 15836 
The concentrations measured via the 2 independent methods correlated well and the total 
concentration of GLC in the 14C-GLC stock solution was determined to be 11.42 (± 0.42) mM. 
Determination of the area for the GLC and G6P peaks for each dilution sample also correlated 
well with each other. From the data summarised in Table 3.4 we can determine the rf for each 
dilution as given in Eq.3.7. The rf values were determined for each dilution sample and resulted 
in the values of 14 768 (± 355), 11 069 (± 544) and 11 154 (± 363) respectively. There is a 
Stellenbosch University https://scholar.sun.ac.za
55 
discrepancy between the rf value determined for the x 2 dilution sample in comparison with the 
lower dilutions. This is most likely due to an overestimation of the area obtained in this dilutions 
sample. Therefore, it is suggested that a rf value is determined for each experimental data set 
and not be taken as a constant for different 14C-stock solutions. The reaction catalysed by ALD 
results in the fractionation of the 6-carbon FBP into the 3-carbon molecules of GAP and DHAP. 
Furthermore, TPI catalyses the reversible conversion of DHAP to GAP, resulting in a 2-fold 
increase in the concentration of lower down glycolytic intermediates. However, the number of 
14C-labeled molecules remains the same. This results in a 2-fold increase of the number of 
molecules leading to the same radiolabelled signal obtained as for upper glycolysis resulting in 
a rf value that is halved for the lower glycolytic intermediates. 
3.4.6. IP-RPLC method application: Determining time-dependent metabolite concentrations 
of glycolytic intermediates and glycolytic flux in extracts of yeast strain X2180 
The IP-RPLC method was tested in biological cell extracts in collaboration with  
Dr. Theresa Kourili. Yeast strain X2180 was cultured and harvested during the log growth 
phase. Lysate of the yeast culture was prepared via glass bead extraction, as described in Section 
3.3.6. The supernatant, containing the glycolytic enzymes of interest, was analysed at a final 
protein concentration of 5 mg/ mL in time course incubations. The cell lysate of the X2180 
yeast strain was incubated at 30ºC in the presence of 2.4 mM ATP and 2.0 mM NAD+. A 
mixture containing 14C-GLC and unlabelled GLC was prepared with a final GLC concentration 
of approximately 10 mM. The time course experiment was initialised by adding this GLC 
solution to the cell lysate incubation, containing ATP and NAD+. Samples were collected at 
timepoints; 0 min, 4 min, 8 min, 12 min, 16 min, 20 min, 25 min, 30 min and 40 min and 
quenched by adding the timepoint samples into a unlabelled solution of 50% perchloric acid 
(PCA) followed by neutralisation with a 1 M K2CO3 solution to pH 7 (method as described by 
Teusink et. al.29). Samples were centrifuged and the supernatant was injected into the column 
for IP-RPLC analysis. The integrated chromatographic trace of the yeast time-course sample at 
a timepoint of 20 min is shown in Figure 3.10. 
 
i  All culturing of yeast strain X2180 and the preparation and conduction of the required time course 
experiment was carried out by Dr. Theresa Kouril. Concentration determinations on the UV-Vis 




Figure 3.10: Integrated 14C-chromatographic trace of the time-course experiment conducted in yeast 
at a timepoint of 20 min. The grey dots represent the experimentally obtained chromatographic trace. 
The black line represents GLC, the red line represents ETOH, the orange line represents ACA, the blue 
line represents G6P, the green line represents F6P, the yellow line represents P3G, the purple line 
represents FBP. P2G is present at low levels represented by the orange-dashed line. 
The IP-RPLC analysis of the yeast time course samples resulted in chromatographic 
traces for the chemical species; GLC, G6P, F6P, FBP, DHAP, P3G, ACA and ETOH via 
radiolabelled detection and the chemical species NAD+, NADH, AMP, ADP and ATP via UV-
Vis detection. No peaks for the species GAP, PEP and PYR were detected in the 
chromatographic trace and these species are expected to be present at undetectable 
concentration levels. P2G is present at low levels but was not quantified. The chromatographic 
traces showed a clear time dependent decrease in GLC associated with an increase in the signal 
associated with ETOH. Of note was the appearance of large peaks associated with FBP and 
DHAP in the chromatographic traces. The chromatographic traces were quantified using the 
methods laid out in Sections 3.3.3 and 3.3.4 and the time dependent concentrations of each 
species was determined. The time dependent concentrations of the glycolytic intermediates and 





Figure 3.11: Time dependent concentrations of the glycolytic intermediates separated via IP-RPLC and 
measured by radio-labelled detection in a yeast extract time course incubation. Top: Concentrations of 
the glycolytic intermediates of upper glycolysis; GLC, G6P, F6P and FBP as quantified by integration 
of the chromatographic traces obtained. Bottom: Concentrations of the glycolytic intermediates of 






























































Figure 3.12: Time dependent concentrations of the adenosine and nicotinamide moieties determined 
via IP-RPLC and measured by UV/Vis detection in a yeast extract time course incubation. Top: 
Concentrations of the cofactors; ATP, ADP and AMP quantified from the chromatographic traces 
obtained. Bottom: Concentrations of the cofactors; NAD+ and NADH quantified from the 
chromatographic traces obtained. 
IP-RPLC analysis of the time dependent change in the concentrations of the glycolytic 
intermediates and cofactors (Figure 3.11 and Figure 3.12) clearly displays the analytical 
capacity of this technique. In total, 8 of the possible 12 glycolytic intermediates (Excluding the 
glycolytic intermediates; GAP, P2G, PEP and PYR) and the 5 cofactors could be quantified in 
the time-course samples. The relative high concentration of AMP in the initial half of the time-


















































with the expected behaviour of glycolysis in yeast with relatively high activity in upper 
glycolysis in comparison to lower glycolysis29. After the consumption of GLC at t = 16 min, 
FBP gradually decreases with a corresponding increase in ATP and production of ETOH. 
3.4.7. IP-RPLC method application: Comparing quantification via the novel IP-RPLC 
analytical technique to quantification using established coupled enzyme assay 
techniques 
To test how well the IP-RPLC quantification of the glycolytic intermediates and 
adenosine and nicotinamide moieties compare to established methods, the concentrations of the 
chemical species were quantified via a UV-Vis coupled assay technique. The concentrations of 
ATP, DHAP and FBP were determined in representative samples of each time point in the yeast 
incubation experiment as described in Section 3.3.6. The concentrations of ATP, DHAP and 
FBP obtained by enzyme coupled assays and by IP-RPLC analysis were compared, as shown 
in Figure 3.13 to determine how well the novel IP-RPLC is able to quantify these chemical 
species. 
The concentrations determined via the IP-RPLC analysis of the yeast extract time course 
samples compares well with the concentrations determined via the enzyme coupled assays 
using UV-Vis spectroscopy as illustrated in Figure 3.13. The concentrations determined for 
FBP and DHAP show a systematic increase in concentration to a maximum concentration 
measured at 16 min, followed by a systematic decrease in concentration. The concentrations 
measured for ATP in the initial phase of the time course incubation are very low and only 
increase after approximately 12 min. The very good correlation in the quantification of the 
chemical species using the 2 independent quantification techniques, suggests that the IP-RPLC 
quantification technique is on par with quantification of glycolytic intermediates using an 




Figure 3.13: Comparison of the concentrations determined for DHAP, FBP and ATP in yeast extract 
time course samples. The concentrations were determined via 2 independent methods. Concentrations 
determined via the IP-RPLC method developed in this chapter are illustrated in Black. Concentrations 
determined via coupled enzyme assay techniques using UV-Vis spectroscopy are illustrated in Blue. 
3.5 Discussion 
There is a need for the development of metabolomic techniques to identify and investigate 
the regulation of metabolic pathways in biochemistry. Using metabolomic analysis in tandem 
with bottom-up modelling approaches creates a powerful tool to test our understanding of the 
regulatory processes associated with metabolic pathways. Furthermore, reliable data of the 
metabolome expressed under specific conditions allows for high resolution validation of 
bottom-up metabolic models. This allows for the determination of the predictive accuracy of 
metabolic models which increases the reliability and usefulness of such models. Previously, 
there has been some success in using an IP-RPLC technique for the gathering of metabolome 
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data22 and we have set out to develop a similar technique tailored to our needs for investigating 
the metabolic regulation of glycolysis.  
The IP-RPLC technique developed here relies on 2 modes of detection to quantify the 
chemical species present in glycolysis. The conserved adenosine and nicotinamide moieties are 
detected via UV-Vis spectroscopy with little to no interference observed from the glycolytic 
intermediates or cellular matrix and can be quantified with reasonable confidence. 
Quantification of the adenosine and nicotinamide moieties were done by means of calibration 
curves constructed for each moiety. From these calibration curves the LOD and LOQ for each 
conserved moiety was determined. The LOQ for the adenosine moieties are much lower than 
for the nicotinamide moieties. However, the IP-RPLC system is sensitive enough to quantify 
all conserved moieties within the concentration range of interest.  
The glycolytic intermediates are quantified by using a 14C-label and are detected via 
radiolabelled counting with no interference from the cellular matrix. The 14C-label is sourced 
from a commercially obtained 14C-GLC stock solution containing an unspecified amount of 
unlabelled GLC. The 14C-GLC stock solution was analysed to quantify the total GLC 
concentration present in the stock solution and the rf value was determined by correlating the 
total GLC concentration to the signal obtained from the chromatographic trace. The GLC 
concentration was measured with 2 independent methods and resulted in a total GLC 
concentration of 11.42 (± 0.42) mM for the 14C-GLC stock solution. The peak area described 
by the 14C-GLC samples were determined in 2 independent ways from the GLC 
chromatographic trace and the G6P chromatographic trace which results from treating the GLC 
samples with HK. There was a good correlation between the area describing GLC and the area 
describing G6P for each dilution sample. However, determination of the rf values yielded 
different values for the different dilutions of the 14C-GLC stock solution. It is therefore 
suggested that a rf value be determined for each experimental setup. This allows for some 
flexibility as the concentration of total GLC can be increased in analysis setups, without 
increasing the 14C-GLC fraction by simply adding unlabelled GLC as required. The 
radiolabelled signal obtained in the chromatographic traces measures the 14C-GLC but represent 
the total GLC concentration used and the relationship between the glycolytic intermediate 
concentration and chromatographic signal was determined by calculating a rf value for each 
experimental setup independently. The rf value remains constant for the different glycolytic 
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intermediates. However, the rf value is halved for the lower glycolytic intermediates due to the 
fractionation of FBP into GAP and DHAP catalysed by ALD.  
The IP-RPLC metabolomics technique developed here can separate and quantify 20 
chemical species, present in glycolysis. However, some chemical species do show peak overlap 
in the chromatographic traces. Significant overlap of the chromatographic traces obtained for 
F6P and GAP, as well as G3P, DHAP and PYR are present. These chemical species show 
similar retention behaviours and it is not possible to deconvolute the peaks from one another. 
Assuming that the enzymes of PGI and TPI have reached equilibrium in each sample, the 
concentrations of the overlapping species of F6P and GAP can be determined from the 
concentrations of G6P and DHAP. PYR can be determined by subtracting the estimated 
concentration of DHAP from the experimentally obtained peak. 
The novel IP-RPLC method developed here, was applied to the investigation of glycolysis 
in the extract of yeast strain X2180. The time dependent change in the concentrations of the 
glycolytic intermediates and conserved adenosine and nicotinamide moieties were measured by 
analysing time course samples taken at different time points of a yeast extract incubation. The 
resulting concentration obtained from the chromatographic traces of the time point samples are 
shown in Figure 3.11 and Figure 3.12. There is a near instantaneous decrease in the 
concentration of ATP to almost zero. This decrease in ATP is associated with an increase in the 
concentration of AMP. This rapid conversion of ATP to AMP can be attributed to the high 
activity of adenylate kinase (AK) in yeast30. AK catalyses the conversion of ADP to form ATP 
and AMP via a phosphate transfer from one molecule of ADP to another molecule of ADP. The 
adenosine conversion catalysed by AK increases the effective concentration of ATP that is 
required for upper glycolysis and the conversion of GLC to FBP. The rapid formation of 
additional ATP, and consumption of ATP via upper glycolysis, continues until the total 
adenosine pool is converted to AMP. The IP-RPLC dynamics shown in Figure 3.12 beautifully 
highlights this rapid process where high concentrations of AMP are observed during the early 
stages of the incubation. This is associated with the formation of an exceptionally large pool of 
FBP with a maximum concentration measured at about 5 mM.  
The IP-RPLC analytical data compares favourably with the well-established method of 
quantifying glycolytic intermediates using coupled enzyme assay techniques as shown in  
Figure 3.13. The concentrations of ATP, DHAP and FBP were independently quantified via the 
IP-RPLC method and via enzyme coupled assays and the resulting data compared well. This 
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suggests that the quantifiability of the IP-RPLC method developed here is comparable to the 
quantifiability of coupled enzyme assay techniques. There are some limitations to the 
applicability of this novel IP-RPLC metabolomics technique. The availability and quality of 
14C-GLC starting material is an obstacle to consider. 14C-impurities are present in the 
commercially obtained 14C-GLC starting material that should be accounted for when correlating 
peak area to concentration in the analysis of the IP-RPLC radiolabelled data. Furthermore, the 
limited commercial availability of 14C-glycolytic intermediates limits the identification of 
chemical species present in the chromatographic traces. Here we have resorted to convert the 
commercially available 14C-GLC, 14C-GLY and 14C-PYR enzymatically to the other 14C-
glycolytic intermediates. However, this cumbersome process limits confidence in our 
assignment of some of the 14C-glycolytic intermediates. 
The novel IP-RPLC technique developed for the quantification of glycolytic 
intermediates and cofactors address some of the disadvantages associated with metabolomic 
studies performed using NMR or MS analysis. The strengths of this metabolomics method lie 
in the robustness of the separation technique and that the radiolabelled detection is free from 
matrix effects. This allows for routine analysis to be performed in complex cell matrices with 
limited sample preparation required. Furthermore, the higher sensitivity of radio-isotope 
detection compared to the sensitivity of NMR allows for quantitative analysis on small cell 
samples. The quantifiability of this method is comparable to that of enzyme coupled assays. 
This novel metabolomics technique can separate the majority of the glycolytic intermediates 
and quantify all cofactors in a single HPLC run of 20 mins, making this technique ideal for 
targeted studies of glycolysis in combination with modelling studies.  
Reliance on the limited availability and quality of 14C-starting material available, is one 
of the weaknesses associated with this technique. Furthermore, the 14C-starting material and 
analysis via radiolabelled detection is costly in comparison to other metabolomic techniques, 
such as MS or NMR. However, it should be noted that the cost of equipment required for the 
establishment of NMR or MS analysis is far greater in comparison to the cost requirements of 
establishing this technique. Peak overlap and the limited number of metabolites that can be 
separated using this technique are also drawbacks that needs to be considered. This limits the 
usefulness of this technique to targeted metabolomic analysis of glycolytic intermediates for 
bottom-up studies of glycolysis. 
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In this chapter we have discussed the development of a novel IP-RPLC metabolomic 
technique and application in yeast extract. However, the applicability of the technique is not 
limited to yeast extracts. Metabolomic analysis of cell lines using this technique depends on the 
pre-analysis preparation of time-course samples and not on modification of the IP-RPLC 
analytical technique. Therefore, cellular extract of any cell line can be analysed via the  
IP-RPLC technique discussed here. We aim to employ this metabolomics technique in Chapter 
5 of this thesis for the metabolomic analysis of C2C12 skeletal muscle extract as a technique for 
validating a detailed kinetic model describing glycolysis in C2C12 skeletal muscle extract, 
constructed in Chapter 4 of this thesis. 
3.6 Conclusion 
A novel IP-RPLC technique with UV-Vis and radio-labelled detection was developed 
here for the separation of the glycolytic intermediates and cofactors. The novel metabolomics 
technique was successfully applied to determine the concentration of glycolytic intermediates 
and cofactors in yeast extract. Furthermore, the quantifiability of this technique was shown to 
be comparable to that of enzyme coupled assays. The ability to follow the dynamic behaviour 
of the glycolytic intermediates and cofactors is of great value to system biology studies focusing 
on the characterisation of glycolysis, as this method enables the comparison of model 
simulations to experimental concentration profiles for a large number for metabolites. 
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Chapter 4  
Constructing a detailed mechanistic model of glycolysis in 
differentiated C2C12 muscle cells 
4.1. Preamble 
In this chapter the construction of a detailed kinetic model describing glycolysis in 
differentiated C2C12 skeletal muscle cells using a bottom-up modelling approach is presented. 
4.2. Introduction 
Skeletal muscle cells play a major role in maintaining blood glucose homeostasis within 
the body. Dietary glucose introduced into the body is metabolised mainly in skeletal muscle1,2. 
Glycolysis is a central catabolic pathway and results in the production of ATP and forms lactate 
as a by-product3,4. Defects within the glycolytic pathway of muscle cells will have a direct 
impact on the regulation of blood glucose homeostasis, which can lead to chronic 
hyperglycaemia, the predominant metabolic state attributed to type 2 diabetes mellitus. A 
mechanistic model of glycolysis in skeletal muscle is important to understand metabolic defects 
that may arise from dysfunctional glucose regulation. The current metabolic understanding of 
skeletal muscle focusses on describing metabolism under exercise conditions56-78. Literature 
points out that the major determining factor regulating metabolism in skeletal muscle is based 
on a high demand for ATP to drive muscle activity. However, it is of importance to consider 
how glucose metabolism in skeletal muscle behaves under conditions where there is a low 
demand for ATP and a high supply of glucose. Under insulin stimulated conditions it is 
postulated that the rate of glycolysis in skeletal muscle will not be dictated by the rate of ATP 
consumption. Therefore, we seek to investigate how glycolysis will behave when there is an 
oversupply of both glucose and ATP.  
Insulin stimulation of skeletal muscle leads to an increased influx of glucose into the cell 
due to the activation of GLUT4 translocation from the cytosol to the cell membrane. Once 
glucose enters the cell, glycolysis converts it through a series of linearly connected enzyme 
catalysed reactions to form lactate, referred to as the glycolytic pathway9. There are 11 main 
reactions that make up the glycolytic pathway converting glucose to lactate. Each glucose 
molecule yields in total 2 molecules of ATP and 2 molecules of lactate, if no branches of 
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glycolysis are active. Apart from the 10 main reactions, adenylate kinase interconverts the 
adenosine moieties via the reversible reaction 2 ADP ↔ ATP + AMP. It is of importance to 
note that the upper part of glycolysis uses ATP as a substrate, whereas the lower part of 
glycolysis yields ATP as a product. This results in interesting metabolic behaviours that are 
strongly dependent on the concentrations of the adenosine metabolites present and their relative 
ratios. When considering the dynamics of muscle cell metabolism under insulin stimulated 
conditions it is important to consider the basal demand for ATP to drive cellular maintenance 
processes. In the model an ATPase rate is used to describe the basal conversion of ATP to ADP 
caused by the presence of ATP-dependent reactions associated with cellular maintenance and 
muscle contraction. A schematic illustration representing the glycolytic pathway considered in 
this chapter is given in Figure 4.1. 
Lambeth and Kushmeric noted that a lack of standardised kinetic data in a specified cell 
line is a limiting factor that needs to be addressed to improve the existing models available for 
glycolysis in skeletal muscle6. Van Eunen et. al.10 discussed in detail how to systematically 
investigate glycolysis under physiologically representative conditions. This includes measuring 
enzyme activity at a physiological pH and temperature, in a buffer matrix that mimics the 
chemical composition of the cytosol. Similarly, Teusink et. al.11 investigated glycolysis in yeast 
through a series of enzyme coupled reactions which enabled them to measure the activity of 
specific enzymes photometrically at 340 nm by observing the change in NADH concentration. 
In short, the enzyme under investigation is coupled to excess amounts of subsequent enzymes 
until a reaction that is dependent on a nicotinamide is reached. It is important to ensure that the 
enzyme under investigation is rate limiting so that the change in concentration of the 
nicotinamide moiety is equivalent to the rate of the enzyme under investigation.  
The investigation of glycolysis in skeletal muscle will be conducted in differentiated 
C2C12 skeletal muscle cells as model cell line. The C2C12 cell line is an immortalised mouse 
skeletal muscle cell line extensively used to research muscle development, differentiation, 
myofibrilogenesis and sarcomere development and the procedures for culturing and 
differentiating C2C12 skeletal muscles are well established
12
1314-1516. Furthermore, Kanzaki and 
Nedachi17 have shown that the glucose transport machinery required for insulin induced 
GLUT4 translocation is present in C2C12 muscle myofibers. Therefore, C2C12 skeletal muscle 
cells are a good representative cell line to investigate the insulin dependent metabolism of 
skeletal muscle. However, significant differences in the metabolic behaviour of cultured C2C12 
Stellenbosch University https://scholar.sun.ac.za
69 
myotubes vs human tissue are expected. Preliminary measurements of the glucose and lactate 
flux (data not shown) in glucose starved cells suggests a stoichiometric relationship of 2 
molecules of lactate formed per molecule of glucose consumed, suggesting that little to no 
glycogen is produced during the 48-hour timeframe measured. Furthermore, the reported rate 
of glycogen synthesis in differentiated C2C12 muscle cells is 11 nmol of glucose units.h
-1. mg 
total protein-1, compared to a glucose uptake and phosphorylation rate of approximately 250 
nmol.h-1.mg total protein-1 under basal conditions18. The maximal outflow of glucose to 
glycogen synthesis can be estimated to be lower than 5 %, which is small enough to be excluded 
in this study. Therefore, the production and consumption of glycogen will not be included in 
the model. 
To investigate the behaviour of glycolysis in skeletal muscle cells a detailed kinetic model 
describing glycolysis in C2C12 myofibers will be constructed. The activity of each enzyme in 
the glycolytic pathway will be measured at varying concentrations of its substrates to derive a 
mathematical equation that describes the activity of the enzyme. A bottom-up modelling 
approach was employed by setting up a series of ordinary differential equations (ODE’s) from 
the mathematically derived rate equations. The glycolytic model was then used to predict the 




Figure 4.1: Schematic representation of glycolysis in C2C12 skeletal muscle extract. The enzymes 
marked in blue notes the enzymes of interest in this study and will form the 13 reactions used to construct 
a detailed kinetic model of glycolysis in C2C12 skeletal muscle extract. NADH marked in red can be 




4.3. Materials and Methods 
4.3.1. C2C12 Culturing Protocol 
C2C12 myocyte freezer stocks were obtained from ATCC
i and was stored under liquid 
nitrogen. The C2C12 freezer stocks were seeded in a T75 culturing flask (Nest Biotech Co., 
nonpyrogenic polystyrene flasks) and maintained in Delbecco’s modified Eagle’s medium 
(DMEM, gibco) containing 1 g/L (5.55 mM) glucose, L-glutamine and sodium pyruvate. For 
proliferation of the C2C12 myocytes, the DMEM was augmented with 10% fetal calf serum 
(FBS, gibco), 100 U/mL penicillin and 100 μg/mL streptomycin (penstrep, Sigma-Aldrich). 
Initial growth in low glucose DMEM (LG-DMEM) containing 1 g/L glucose, resulted in very 
slow growth rates. Furthermore, differentiation was found to be poor and unreliable. Much 
better growth rates and differentiation was obtained when the proliferation media (LG-DMEM, 
10% FBS, penstrep) was augmented with 1% of a 100 g/L glucose solution (Sigma-Aldrich) to 
give a final glucose concentration of 10 mM, abbreviated as MG-DMEM. Cells were grown at 
37 ºC under a humidified atmosphere maintained at 5% CO2 in an incubator. Proliferation 
conditions were maintained until a confluence of between 70 – 80% was reached (approx. 2 – 
3 days). The cell cultures were kept below a confluence of 80% to ensure that the cultured cells 
remained in the log growth phase. Once the cultured cells had reached a confluence of 70 – 
80%, the cultured cells were split by treating the cells with trypsin (Sigma-Aldrich) and equal 
fractions of the suspended cells were transferred into 3 new T75 flasks. The cultured cells were 
again grown to 70 – 80% confluence and each T75 were split into three T175 culturing flasks. 
The T175 culturing flasks were grown to 95% confluence upon which the culturing media was 
changed to differentiation media consisting of MG-DMEM augmented with penstrep and 2% 
horse serum (Sigma-Aldrich). The cells were grown under differentiation media for a total of 7 
days. Images of the progression of differentiation are shown in Figure 4.2. On day 7 C2C12 
myofibers were clearly visible and the cells were harvested stored in an assay buffer that mimics 
of skeletal muscle cytosolic conditions. 
4.3.2. Deriving a standardised buffer to mimic cytosolic conditions 
To ensure that the enzyme activities measured in vitro reflect activities within the cell, it 
was important to measure the enzyme activities in a matrix that mimics the cytosolic conditions 
 




in which the enzymes function. Therefore, an approach similar to the approach taken by van 
Eunen et. al.10 was taken to construct a cytosolic representative buffer system. The buffer 
system was constructed from the elemental analysis performed on the cytosol of frog toe muscle 
and consisted of the following chemical components: 50 mM Tris-HCl, 30 mM KH2PO4, 10 
mM NaCl, 130 mM KCl and 10 mM MgCl2
19. The assay buffer was heated to 37 ºC and the pH 
was adjusted to 7.4 at the operating temperate of the buffer. Harvesting of the C2C12 myofibers 
along with all assays performed of the C2C12 myofibers were performed in this buffer. 
4.3.3. Harvesting and preparation of differentiated C2C12 cell lysate 
Once a large amount of differentiated C2C12 myofibers were visible in the culturing flasks 
(approx. 7 days of differentiation, refer to Figure 4.2 G and H) the C2C12 myofibers were serum 
starved overnight by refreshing the fibres with LG-DMEM. After overnight serum starvation 
the cells were washed 3 times with assay buffer by adding an approximate 5 mL of assay buffer 
to the flask, swirling the flask to ensure that the LG-DMEM is rinsed off and then discarding 
the assay buffer. After the final wash step 1mL of a harvesting buffer was added. The harvesting 
buffer was prepared by adding a protease inhibitor cocktail to 10 mL of the assay buffer. The 
cells were scraped from the surface of each flask, suspended in the harvesting buffer and 









Figure 4.2: Images of the C2C12 muscle cells during differentiation; A: Image on day 0 of differentiation 
at 400 μm scale. B: Image on day 0 of differentiation at 200 μm scale. C: Image on day 2 of 
differentiation at 400 μm scale. D: Image on day 2 of differentiation at 200 μm scale. E: Image on day 
4 of differentiation at 400 μm scale. F: Image on day 4 of differentiation at 200 μm scale. G: Image on 
day 7 of differentiation at 400 μm scale. H: Image on day 7 of differentiation at 200 μm scale. 
When required the cells were thawed to prepare lysate. 2 protocols for the preparation 
were attempted and will briefly be discussed here: (1) the thawed aliquot of cells was added to 
fine glass beads (≤ 106 μm diameter, Sigma-Aldrich) at a ratio of 25 mg glass beads to 1 mL of 
cell suspension. Lysis was performed by vortexing the cell suspension for 1 minute followed 
by resting the suspension on ice for 15 seconds and repeating this cycle 6 times. The cell 
solution was then centrifuged at 20 800 x g at 4ºC for 15 minutes to pellet the cell debris. After 
centrifugation the supernatant was removed and stored on ice. (2) 20μL of a 10% solution of 
Triton X-100 (Unitek) was added to the thawed aliquot of harvested C2C12 fibres and left to 
react on ice for 30 minutes, shaking every 5 minutes. Triton X-100 is a non-ionic surfactant that 
is widely used to lyse cells by disrupting the integrity of the cell membrane to release the 
cytosolic content20. After the 30-minute treatment with Triton X-100 is done the cell solution 
was then centrifuged at 20 800 x g at 4ºC for 15 minutes to pellet the cell debris. After 
centrifugation the supernatant was removed and stored on ice. The supernatant prepared from 





enzymes. Preliminary investigation of the enzyme activity of hexokinase (HK) and 
Phosphoglucoisomerase (PGI) showed little difference in the results obtained from the 2 lysis 
protocols (data not shown). However, lysing the cells with Triton X-100 resulted in a higher 
recovery of the volume of supernatant containing the cell lysate. Therefore, all enzyme assays 
were performed on lysate obtained via Triton X-100 treatment of the C2C12 fibres. Coupled 
enzyme assays for the determination of glycolytic enzyme rates. 
4.3.4. Kinetic characterisation of the glycolytic enzymes using coupled enzyme assays 
The glycolytic enzymes were characterised in terms of their maximal specific activity 
(Vmax) and affinity for each substrate and product (Km) in cell lysate. Characterisation of the 
kinetic parameters (Vmax, Km) for each glycolytic enzyme was done in a cytosolic 
representative assay buffer at a pH of 7.4 and temperature of 37 ºC to mimic the physiological 
operating conditions of the glycolytic enzymes. The kinetic parameters were determined by 
linking each glycolytic enzyme to the production or formation of NADH or NADPH, adapted 
from Teusink et. al.11, and measuring the change in NADH or NAPDH concentration 
spectrophotometrically at 340 nm on a BioTek PowerWave 340 or BMG Labtech 
SPECTROstarNano spectrophotometer. Measurement of glycolytic enzyme activity was done in 
a 96-well plate (Greiner bio-one F-Bottom microtiter plate) with a total volume of 100 μL.  
To ensure that the enzyme under investigation is rate limiting, each of the coupling 
enzymes were used at a final concentration of 5 U/mL. Furthermore, the activity of the linking 
enzymes was tested by performing an assay in the absence of the rate limiting enzyme and in 
the presence of its product to ensure that the activity of the series of linking enzymes are much 
faster than the enzyme under investigation. All enzymes and reactants were sourced from 
Sigma-Aldrich. Enzyme assays were performed under varying concentrations of enzyme 
substrates as 3 technical repeats to account for experimental and instrumental error. In the case 
of bi-substrate reactions, assays were performed under saturating concentrations of one 
substrate while varying the concentration of the other substrate. Concerning the coupled assays 
that are ATP or ADP dependent, a magnesium concentration equal to double the ATP or ADP 
concentration was added to ensure that the active MgATP or MgADP complex was present. 
The resulting rate obtained from the coupled assays represents the change in absorbance as a 
function of time. However, for modelling purposes it is necessary to convert this rate to describe 
the change in substrate as a function of time per protein concentration (μmol/ min. mg total 
protein-1). The relationship between concentration and absorbance is described by the Beer-
Stellenbosch University https://scholar.sun.ac.za
75 
Lambert law where the total protein concentration is determined by means a Bradford reaction. 
It is important to note that the pathlength of the sample is dependent on the volume in each 
well. Therefore, the relationship between absorbance and the concentration of substrate was 
rather established by means of a NADH calibration curve. The response factor representing the 
extinction coefficient of NADH and the pathlength of the assay was determined for the wells 
in the 96 well plate. The experimental description for the measurement of the enzyme activity 
for each enzyme investigated in this study is discussed below: 
Hexokinase (HK) catalyses the phosphorylation of glucose (GLC) to form glucose-6-
phosphate (G6P) through the transfer of phosphate from ATP. In so doing, ATP is converted to 
ADP as a product of this reaction. The activity of hexokinase was determined with various 
concentrations of the substrates and potential activators or inhibitors. The rate of hexokinase 
was quantified using a coupled assay technique and observing the formation of NADPH at 340 
nm as a function of time. To visualize the activity of hexokinase the enzyme was coupled to an 
excess amount of commercially obtained G6PDH to ensure that the rate of G6PDH vastly 
exceeds that of the hexokinase under investigation. G6PDH catalyses the conversion of the 
hexokinase product, G6P, to phosphor-D-glucono-1,5-lactone (PGL) accompanied with a 
conversion of NADP+ to NADPH. Therefore, the change in concentration of NADPH is 
stoichiometrically equivalent to the change in glucose concentration and reflects the activity of 
hexokinase. 
Phosphoglucoisomerase (PGI) catalyses the isomerization of G6P to fructose -6-
phosphate (F6P). The kinetic activity of PGI was determined in both the forward and reverse 
directions. Measurement of PGI in the forward direction was done by measuring the conversion 
of NADH to NAD+ by coupling the enzymatic reaction via phosphofructokinase (PFK), 
Aldolase (ALD) and Triosephosphate isomerase (TPI) to glycerol-3-phosphate dehydrogenase 
(G3PDH). G3PDH converts dihydroxyacetone phosphate (DHAP), a product of ALD, to 
glycerol-3-phosphate (G3P). The conversion of DHAP to G3P is associated with a conversion 
of NADH to NAD+, which is utilized to visualize the consumption of G6P by PGI. Therefore, 
an excess amount of the commercially obtained enzymes of PFK, ALD, TPI and G3PDH was 
added to each well to ensure that the conversion of F6P to G3P was always faster than the 
conversion of G6P to F6P through PGI supplied by the lysate of C2C12 muscle myotubes. It is 
important to note the 1:2 stoichiometric relationship between G6P consumption and NAD+ 
production and this relationship was taken into account when determining the rate of the 
Stellenbosch University https://scholar.sun.ac.za
76 
forward reaction of PGI. The kinetic activity of PGI in the reverse direction was measured by 
coupling the enzyme to an excess amount of commercially obtained G6PDH. Therefore, the 
conversion of F6P to G6P is measured spectrophotometrically at 340 nm by the conversion of 
NADP+ to NADPH. 
Phosphofructokinase (PFK) catalyses the phosphorylation of F6P to form fructose -1,6- 
bisphosphate (FBP), via the transfer of a phosphate from ATP, yielding ADP as a product. The 
kinetic activity of PFK was measured by coupling the enzyme to G3PDH via ALD and TPI. 
Excess amounts of commercially obtained ALD, TPI and G3PDH was used to ensure that PFK 
obtained from the lysate of C2C12 muscle myofibers was rate limiting. Therefore, the activity 
of PFK will be equal to half the conversion of NADH to NAD+ via G3PDH due to the 
stoichiometric relationship between FBP and G3P. PFK is monitored directly by measuring the 
consumption of NADH spectrophotometrically at 340 nm. 
Aldolase (ALD) catalyses the dissociation of FBP into dihydroxyacetone phosphate 
(DHAP) and glyceraldehyde -3- phosphate (GAP). The kinetic activity of ALD was measured 
in the forward direction under varying FBP concentrations by coupling the enzyme to G3PDH 
and measuring the conversion of NADH to NAD+. Excess amounts of commercially acquired 
G3PDH and TPI was added to ensure that the aldolase obtained from the lysate of C2C12 muscle 
myofibers is the rate limiting reaction. This will ensure that the conversion of NADH to NAD+ 
reflects 2 times the consumption rate of FBP. ALD is monitored directly by measuring the 
consumption of NADH spectrophotometrically at 340 nm. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyses the conversion of 
GAP to 1,3-bisphosphoglycerate (BPG) accompanied with the conversion of NAD+ to NADH. 
This entails incorporation of an additional phosphate group into GAP from the inorganic 
phosphate present in the matrix. Therefore, this reaction is expected to be dependent on the 
inorganic phosphate concentration of the matrix. However, the effect of inorganic phosphate 
concentration on GAPDH activity was not tested, and we assumed that the inorganic phosphate 
concentration in skeletal muscle cells remains saturating over time under non-exercising 
conditions. Since GAPDH activity entails the conversion of NAD+ to NADH, this reaction can 
be monitored directly by measuring the formation or consumption of NADH 
spectrophotometrically at 340 nm. 
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3-phosphoglycerate kinase (PGK) catalyses the conversion of BPG to P3G through the 
transfer of a phosphate from BPG to ADP. Therefore, the reaction is dependant on the 
availability of ADP and results in the production of ATP. The activity of PGK was measured 
in the reverse direction by coupling the enzyme to GAPDH. This reaction can be monitored 
directly by measuring the consumption of NADH spectrophotometrically at 340 nm.  
Pyruvate kinase (PK) catalyses the conversion of phosphoenol pyruvate (PEP) to 
pyruvate through the transfer of a phosphate from PEP to ADP resulting in the formation of 
ATP as a product of the reaction. The activity of PK was measured in the forward direction 
under varying concentrations of the substrates PEP and ADP as well as under varying 
concentrations of the product ATP to determine the inhibitory effect of ATP. The activity of 
PK was measured by coupling the PK obtained from the C2C12 myofiber extract to an excess 
amount of commercially obtained lactate dehydrogenase (LDH) to ensure that PK is the rate 
limiting enzyme. LDH converts the PK product, PYR, to LAC along with the conversion of 
NADH to NAD+ and the activity of PK can be monitored by measuring the consumption of 
NADH spectrophotometrically at 340 nm. 
Lactate dehydrogenase (LDH) catalyses the conversion of pyruvate (PYR) to lactate 
(LAC). This reaction is dependent on the availability of NADH as a substrate of the reaction 
and yields NAD+ as a product. Activity was measured by monitoring the change in the 
concentration of NADH spectrophotometrically at 340 nm as a function of time.  
Adenylate kinase (AK) catalyses the conversion of ADP to ATP and AMP via the 
transfer of a phosphate group from one ADP molecule to another ADP molecule. The activity 
of AK was measured in the forward, and the reverse direction at varying concentrations of ATP, 
ADP and AMP. AK activity was measured in the forward direction by coupling the enzyme to 
excess amounts of HK and G6PDH in the presence of excess amounts of GLC. This allows for 
the conversion of the product ATP to ADP, yielding an equivalent amount of G6P which gets 
converted by G6PDH along with the conversion of NAD+ to NADH. Activity was measured 
by monitoring the change in the concentration of NADH as a function of time. AK activity was 
measured in the reverse direction by coupling the enzyme to excess amounts of PK and LDH. 
This allowed for the conversion of ADP, as product of the reverse direction, along with the 
conversion of PEP to PYR. PYR will then rapidly be converted to LAC along with the 
conversion of NADH to form NAD+. Activity was measured by monitoring the change in the 
concentration of NADH spectrophotometrically at 340 nm as a function of time.  
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The ATPase reaction describes the time dependent conversion of ATP to ADP by cellular 
maintenance and reactions and muscle contraction in C2C12 skeletal muscle myotubes. The 
ATPase activity in cell extract is expected to be significantly less compared to intact muscle 
fibres due to the removal of the membrane fraction. The activity of ATPase was measured at 
varying ATP concentrations by coupling the reaction to commercially obtained PK and LDH 
in the presence of 10 mM PEP and 0.5 mM NADH. The time dependent conversion of ATP to 
ADP drives the conversion of PEP to PYR followed by the conversion of PYR to LAC. The 
conversion of PYR to LAC corresponds with an equivalent conversion of NADH to NAD+. 
Therefore, the decrease in NADH concentration is equivalent to the decrease in ATP 
concentration. Activity was measured by monitoring the change in the concentration of NADH 
spectrophotometrically at 340 nm as a function of time. 
The resulting series of initial rates obtained for each glycolytic enzyme at varying product 
and substrate concentrations form an experimental dataset describing the activity of each 
enzyme. Each glycolytic enzyme was described with a single rate equation. Therefore, the 
complete dataset for a specific enzyme was used as a single data array for fitting its rate 
equation. The NonLinearModelFit function of Wolfram Mathematica was performed on the 
combined multidimensional dataset to determine the optimal kinetic parameters describing the 
activity of each enzyme. The resulting kinetic parameters obtained for each enzyme was 
compared to kinetic parameters in literature. It should be noted that a direct comparison cannot 
be made since the values obtained for the kinetic parameters will be different if different rate 
equations are used. Therefore, our criteria for considering the comparison of kinetic parameter 
values to published values as good, is when the values are within the same order of magnitude, 
acceptable when the values are within 2 orders of magnitude and not good when the difference 
between values are further than 2 orders of magnitude apart. 
4.3.5. Constructing a glycolytic model of differentiated C2C12 extract 
The resulting rate equations were arranged in a series of ordinary differential equations 
(ODE’s) describing the change in concentration of each variable (chemical species) as a 
function of time. The set of ODE’s was solved using the NDSolve function of Wolfram 




4.4.1. Kinetic characterisation of HK 
Hexokinase activity was measured in the forward direction, as discussed in Section 4.3.4 
with various concentrations of the substrates; glucose and ATP as well as with varying AMP 
concentrations. A non-reversible bi-substrate reaction with allosteric inhibition by AMP and 
ATP, described by Eq.4.1, was found to describe the activity of hexokinase well. The non-
linear model fit function of mathematica was used to fit Eq.4.1 to the complete experimental 
dataset acquired with the coupled enzyme assays. The non-linear model fit function determines 
the best set of kinetic parameters (VfHK, Katp, Kglc, Kiamp and Kiatp) to mathematically 
describe the activity of hexokinase within the experimental boundaries tested, shown in Figure 
4.3. A summary of the kinetic parameters is given in Table 4.1. 
𝑣HK = 𝑉 ∙ atp ∙ glc+ atp𝐾atp ∙ 𝐾atp ∙ + glc𝐾glc ∙ 𝐾glc ∙ + amp𝐾𝑖amp ∙ + atp𝐾𝑖atp ∙ + atp𝐾𝑖atp     Eq. .  
Table 4.1: Summary of the kinetic parameters determined for the forward reaction of hexokinase in 
C2C12 mouse muscle myotubes. Eq.4.1 was fitted to the experimental dataset obtained for hexokinase. 
The fitted values (± standard error) are compared to values reported in literature for similar tissue types 
where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfHK 0.0129 ± 0.0019 U/mg total protein ̵  
Katp 3.0646 ± 0.7116 mM 0.5 - 1.0 21 
Kglc 0.0663 ± 0.0168 mM 0.003 - 0.3 21 
Kiatp 21.0749 ± 3.3200 mM   
Kiamp 2.3713 ± 0.2604 mM 2.5 22 




Figure 4.3: Kinetic characterisation of hexokinase in C2C12 muscle myotubes under varying substrate 
concentrations: (top-left) - Saturation of hexokinase with glucose at 5 mM ATP and 0 mM AMP.  
(top-right) - Saturation of hexokinase with glucose at 5 mM ATP and 2.5 mM AMP. (centre-left) - 
Saturation of hexokinase with ATP at 6 mM glucose and 0 mM AMP. (centre-right) - Saturation of 
hexokinase with ATP at 6 mM glucose and 2.5 mM AMP. (bottom-left) - Inhibition of hexokinase with 
AMP at 6 mM glucose and 1.25 mM ATP. (bottom-right) - Inhibition of hexokinase with AMP at 6 mM 
glucose and 1.25 mM ATP. The blue dots represent the experimental data obtained; the black line 
represents the simulated fit of the complete dataset (95% confidence represents by the shaded area). 
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The mathematical description of hexokinase illustrated in Eq.4.1 describes a non-
reversible bi-substrate reaction with allosteric inhibition by AMP and ATP. The inhibitory 
effect of AMP was well described assuming a single binding site on the enzyme. However, the 
inhibition afforded by ATP assumes one active site and 3 inhibitory sites for ATP on the 
enzyme. This mechanism resulted in a better description of the experimental dataset compared 
to either one or four inhibitory binding sites for ATP. Overall, Eq.4.1 accurately described the 
kinetic data and a good correlation between the kinetic data and the mathematical description 
given by Eq.4.1 is obtained as shown in Figure 4.3. Limited data is available in literature for 
comparison of the kinetic parameters and the values obtained are dependent on the rate equation 
used, and comparison should be made with care. The value reported for Katp is lower in 
literature compared to our determination, but within the same order of magnitude. The value 
for Kglc compares very well with what is reported in literature.  
4.4.2. Kinetic characterisation of PGI 
PGI activity was measured in the forward and reverse direction as discussed in Section 
4.3.4, with varying concentrations of its substrate (G6P) and product (F6P). The non-linear 
model fit function of Mathematica was used to fit a reversible Michealis-Menten equation 
shown in Eq.4.2 to determine the kinetic parameters (VfPGI, VrPGI, Kg6p, Kf6p) that best 
describe the experimental dataset used for PGI in C2C12 muscle myotubes. The non-linear 
model fit of the experimental dataset is shown in Figure 4.4 and the determined parameters are 
listed in Table 4.2. 





Figure 4.4: Kinetic characterisation of PGI in C2C12 muscle myotubes under varying substrate 
concentrations. (top-left) - Saturation of PGI in the forward direction with G6P. (top-right) - Saturation 
of PGI in the forward direction with G6P. (bottom-left) - Saturation of PGI in the reverse direction with 
F6P. (bottom-right) - Saturation of PGI in the reverse direction with F6P. The blue dots represent the 
experimental data obtained; the black line represents the simulated fit of the complete dataset (95% 




Table 4.2: Summary of the kinetic parameters determined for the forward and reverse reactions of PGI 
in C2C12 mouse muscle myotubes. Eq.4.2 was fitted to the experimental dataset obtained for PGI. The 
fitted values (± standard error) are compared to values reported in literature for similar tissue types 
where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfPGI 0.1098 ± 0.0036 U/mg total protein   
VrPGI 0.0589 ± 0.0039 U/mg total protein   
Kg6p 0.8353 ± 0.1282 mM 0.48 23 
Kf6p 0.1845 ± 0.0523 mM 0.031 24 
Keq 0.3607 - 0.4437  0.314 25 
The rate equation for PGI is a reversible Michealis-Menten equation. The negative rate 
observable in Figure 4.4 denotes the rate of the reaction in the reverse direction. The reversible 
Michealis-Menten equation given in Eq.4.2 accurately describes the kinetic data as shown in 
Figure 4.4. The parameters determined for PGI summarised in Table 4.2, can be used to 
determine the equilibrium constant (Keq) for the species G6P and F6P by using the Haldane 
relation. Given that the Keq is equal to the ratio of the product and the substrate at equilibrium 
for a given reaction, the equilibrium constant can be calculated with Eq.4.3.  
𝐾 PGI =  𝑉 ∙ 𝐾f p𝑉 ∙ 𝐾g p                                                                                                                        Eq. .  
The Keq for PGI as determined using the Haldane relation yields a slightly higher, but 
comparable value as compared to the referenced value for the Keq of PGI in literature (Table 
4.2).  
4.4.3. Kinetic characterisation of PFK 
The PFK activity was measured in the forward direction, as discussed in Section 4.3.4, 
with varying F6P and ATP concentrations. A non-reversible bi-substrate Michealis-Menten 
equation shown in Eq.4.4 was used to describe the experimental dataset and a non-linear model 
fit function was fitted to the complete experimental dataset to determine the kinetic parameters 
(VPFK, Katp, Kf6p) that best describe the data obtained. The non-linear model fit to the 
experimental data is shown in Figure 4.5 and the determined kinetic parameter are listed in 
Table 4.3. 




Figure 4.5:Kinetic characterisation of PFK in C2C12 muscle myotubes under varying substrate 
concentrations.(left) - Saturation of PFK with ATP at a F6P concentration of 10 mM. (right) - 
Saturation of PFK with F6P at an ATP concentration of 10 mM. The blue dots represent the 
experimental data obtained; the black line represents the non-linear model fit simulation of the complete 
dataset (95% confidence represents by the shaded area). 
Table 4.3: Summary of the kinetic parameters determined for the non-reversible Michaelis-Menten 
equation describing PFK activity in C2C12 muscle myotubes. Eq.4.3 was fitted to the complete 
experimental dataset obtained for PFK. The fitted values (± standard error) are compared to values 
reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfPFK 0.0036 ± 0.0003 U/mg total protein   
Katp 0.01827 ± 0.0116 mM 0.02654 26 
Kf6p 0.1926 ± 0.1351 mM 0.06849 26 
Keq   800 27 
The rate equation for PFK given in Eq.4.3 describes a non-reversible bi-substrate 
Michealis-Menten type of mechanism and gives a good fit to the data. Furthermore, comparison 
of the kinetic parameters obtained for PFK with the parameters given in literature is within the 
same order of magnitude. 
4.4.4. Kinetic characterisation of ALD 
ALD activity was measured in the forward direction, as discussed in Section 4.3.4, with 
varying FBP concentrations .A non-reversible mono-substrate Michealis-Menten equation 
given in Eq.4.5 was used to fit the activity of ALD in C2C12 muscle myofibers. A non-linear 
model fit function was fitted to the complete experimental dataset to determine the kinetic 
parameters (VALD, Kfbp) that best describe the data obtained. The experimental data and the 
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non-linear model fit of the experimental data is shown in Figure 4.6 and the determined kinetic 
parameter are listed in Table 4.4. 
𝑣ALD = 𝑉 A ∙ fbp( + fbp𝐾fbp) ∙ 𝐾fbp                                                                                                                      Eq. .  
 
Figure 4.6: Kinetic characterisation of ALD in C2C12 muscle myotubes under varying substrate 
concentrations. The experimental data gives the activity of ALD as a function of FBP concentration. 
The blue dots represent the experimental data obtained; the black line represents the non-linear model 
fit simulation of the complete dataset (95% confidence represents by the shaded area). 
Table 4.4: Summary of the kinetic parameters determined for the Michaelis-Menten equation describing 
ALD activity in C2C12 muscle myotubes in the forward direction. Eq.4.5 was fitted to the complete 
experimental dataset obtained for ALD. The fitted values (± standard error) are compared to values 
reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfALD 0.0477±0.0034 U/mg total protein   
Kfbp 0.4353±0.0933 mM 0.05 6 
Keq   0.052 28 
The mono-substrate Michealis-Menten equation given in Eq.4.5. accurately describes the 
kinetic data and a good fit is obtained between the experimental data set and the predicted fit 
as shown in Figure 4.6. The optimized parameters for ALD are summarised in Table 4.4. A 
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literature comparison for the kinetic parameters obtained in this study shows that our value for 
Kfbp is 10-fold larger compared to what is reported in literature.  
4.4.5. Kinetic characterisation of GAPDH 
The activity of GAPDH was measured in the reverse direction under varying 
concentrations of the substrates. BPG is not commercially available and to measure GAPDH in 
the reverse direction the reaction was coupled to an excess amount of the enzyme 
phosphoglycerate kinase (PGK) and the reaction was initialised with 3-phosphoglycerate (P3G) 
as substrate in the presence of excess ATP. GAPDH activity in the forward direction can be 
measured with the same experimental setup in the presence of NAD+ and GAP, however this 
experiment was not performed. In the presence of excess PGK, the conversion of P3G to BPG 
is assumed to be at equilibrium. The Keq for PGK is equal to 3 20011 and the corresponding 
initial concentration of BPG can be determined using Eq. 4.6. 
[BPG] = [P G] ∙ [ATP][ADP] ∙ 𝐾                                                                                                                                Eq. .  
A non-reversible bi-substrate Michealis-Menten equation, given in Eq.4.7, was used to 
fit the GAPDH activity. A non-linear model fit function was fitted to the complete experimental 
dataset to determine the kinetic parameters (VrGAPDH, Kbpg, Knadh) that best describe the data 
obtained. The experimental data and the non-linear model fit of the experimental data is shown 
in Figure 4.7 and the determined kinetic parameter are listed in Table 4.5. 





Figure 4.7: Kinetic characterisation of GAPDH in C2C12 muscle myotubes in the reverse direction under 
varying substrate concentrations. (left) - Saturation of GAPDH with BPG (25 mM P3G) at a NADH 
concentration of 0.5 mM and an ATP concentration of 10 mM. the effective concentration of BPG was 
determined using Eq.4.6. (right) – Activity profile of GAPDH under varying concentrations of NADH 
at a P3G concentration of 25 mM and an ATP concentration of 10 mM. The blue dots represent the 
experimental data obtained; the black line represents the non-linear model fit simulation of the complete 
dataset (95% confidence represents by the shaded area). 
Table 4.5: Summary of the kinetic parameters determined for the Michaelis-Menten equation describing 
GAPDH activity in C2C12 muscle myotubes in the reverse direction. Eq.4.7 was fitted to the complete 
experimental dataset obtained for GAPDH. The fitted values (± standard error) are compared to values 
reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VrGAPDH 0.0195 ± 0.0047 U/mg total protein   
Kbpg 0.0008 ± 0.0002 mM 0.0008 29 
Knadh 0.3333 ± 0.1586 mM 0.0033 29 
Keq   0.0056 30 
The rate equation for GAPDH in Eq.4.7 describes a non-reversible bi-substrate 
mechanism in the reverse direction. A good correlation between the mathematical description 
of GAPDH and the experimental dataset is obtained as illustrated in Figure 4.7. The optimised 
parameters of GAPDH are listed in Table 4.5. The fitted parameter estimations for Kbpg 
corresponds very well with what is reported in literature, but the fitted parameter for Knadh is 
much higher than reported in literature.  
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4.4.6. Kinetic characterisation of PGK 
PGK activity was measured in the reverse direction, as discussed in Section 4.3.4, under 
varying concentrations of the substrates, P3G and ATP, and under varying concentrations of 
ADP to determine the inhibitory effect of ADP on the activity of the enzyme. The activity of 
PGK was measured by coupling the enzyme to an excess amount of commercially obtained 
GAPDH and monitoring the consumption of NADH. This also ensured that the product BPG 
does not increase to inhibitory levels. A Michealis-Menten equation, given in Eq.4.8, was used 
to mathematically describe the activity profile of PGK. A non-linear model fit function was 
fitted to the complete experimental dataset to determine the kinetic parameters (VrPGK, Kp3g, 
Katp, Kiadp) that best describe the data obtained. The experimental data and the non-linear 
model fit of the experimental data is shown in Figure 4.8 and the determined kinetic parameter 
are listed in Table 4.6. 
𝑣PGK =  − 𝑉 ∙ p g ∙ atp𝐾atp ∙ + atp𝐾atp ∙ 𝐾p g ∙ ( + p g𝐾p g) ∙ + atp𝐾𝑖atp ∙ ( + adp𝐾𝑖adp)                        Eq. .  
Table 4.6: Summary of the kinetic parameters determined for the Michaelis-Menten equation describing 
PGK activity in C2C12 muscle myotubes in the reverse direction. Eq.4.8 was fitted to the complete 
experimental dataset obtained for PGK. The fitted values (± standard error) are compared to values 
reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VrPGK 0.5889 ± 0.07176 U/mg total protein   
Kp3g 1.0116 ± 0.1716 mM 1.37 31 
Katp 0.4932 ± 0.1602 mM 0.42 31 
Kiatp 39.7968 ± 22.2315 mM   
Kiadp 1.994 ± 0.3839 mM   





Figure 4.8: Kinetic characterisation of PGK in C2C12 muscle myotubes in the reverse direction under 
varying substrate concentrations. (top-left) - Saturation of PGK with P3G at an ATP concentration of 
1.5 mM. (top-right) - Saturation of PGK with P3G at an ATP concentration of 10 mM. (bottom-left) - 
Saturation of PGK with ATP at a P3G concentration of 10 mM. (bottom-right) – Evaluation of ADP 
product inhibition at a P3G concentration of 10 mM and an ATP concentration of 10 mM. The blue dots 
represent the experimental data obtained; the black line represents the non-linear model fit simulation 
of the complete dataset (95% confidence represents by the shaded area). 
The rate equation for PGK given in Eq.4.8 describes a non-reversible bi-substrate 
mechanism for the reverse direction. A good correlation between the mathematical fit and the 
experimental datasets are obtained and is illustrated in Figure 4.8. The fitted kinetic parameters 
for the PGK reverse reaction correspond well to the values reported in literature as summarised 
in Table 4.6. 
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4.4.7. Kinetic characterisation of PK 
PK activity was measured in the forward direction, as discussed in Section 4.3.4, under 
varying concentrations of its substrates (PEP and ADP) and under varying concentrations of 
ATP to determine the inhibitory effect of ATP on PK activity. A non-reversible bi-substrate 
Michealis-Menten equation with allosteric inhibition by ATP and PEP is given in Eq.4.9 was 
fitted to the experimental dataset and the kinetic parameters (VfPK, Kpep, Kadp, Kipep, Kiatp) 
were determined. The experimental data and the non-linear model fit of the experimental data 
is shown in Figure 4.9 and the determined kinetic parameter are listed in Table 4.7. 
𝑣PK =  𝑉 ∙ pep ∙ adp𝐾pep ∙ + pep𝐾pep ∙ 𝐾adp ∙ ( + adp𝐾adp) ∙ + pep𝐾𝑖pep ∙ + atp𝐾𝑖atp                          Eq. .  
Table 4.7: Summary of the kinetic parameters determined for the Michaelis-Menten equation describing 
PK activity in C2C12 muscle myotubes in the forward direction. Eq.4.9 was fitted to the complete 
experimental dataset obtained for PK. The fitted values (± standard error) are compared to values 
reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfPK 0.4732 ± 0.0301 U/mg total protein   
Kpep 0.1254 ± 0.0287 mM 0.08 32 
Kadp 0.3039 ± 0.0483 mM 0.3 32 
Kipep 30.6690 ± 11.2451 mM   
Kiatp 5.1256 ± 1.6347 mM   




Figure 4.9: Kinetic characterisation of PK in C2C12 muscle myotubes in the forward direction under 
varying substrate concentrations. (top-left) - Saturation of PK with PEP at an ADP concentration of 
0.625 mM. (top-right) - Saturation of PK with PEP at an ADP concentration of 2.5 mM. (bottom-left) - 
Saturation of PK with ADP at a PEP concentration of 5 mM. (bottom-right) – Evaluation of ATP 
product inhibition at a PEP concentration of 5 mM and an ATP concentration of 1.25 mM. The blue 
dots represent the experimental data obtained; the black line represents the non-linear model fit 
simulation of the complete dataset (95% confidence represents by the shaded area). 
The rate equation for PK given in Eq.4.9 describes a non-reversible bi-substrate 
Michealis-Menten equation with allosteric inhibition by ATP and PEP for the forward direction. 
A good correlation between the mathematical fit and the experimental datasets are obtained as 
illustrated in Figure 4.9. The fitted kinetic parameters for the PK reaction are summarised in 
Table 4.7. The fitted value determined for Kadp correlates very well with what is reported in 
literature. The optimised value obtained for Kpep is slightly higher compared to literature. 
Stellenbosch University https://scholar.sun.ac.za
92 
4.4.8. Kinetic characterisation of LDH 
The activity of LDH was measure in the forward and reverse direction, as discussed in 
Section 4.3.4, at varying concentrations of the substrates, PYR and NADH and varying 
concentrations of the products, LAC and NAD+. A reversable bi-substrate Michealis-Menten 
equation with allosteric inhibition by PYR and NADH, given in Eq.4.10, was fitted to the 
experimental dataset and the kinetic parameters (VfLDH, VrLDH, Kpyr, Klac, Knadh, Knad, Kipyr, 
Kinadh) were determined. The experimental data and the non-linear model fit of the 
experimental data is shown in Figure 4.10 and the determined kinetic parameter are listed in 
Table 4.8. 
𝑣LDH =  𝑉 ∙ pyr𝐾pyr ∙ nadh𝐾nadh − 𝑉 ∙ lac𝐾lac ∙ nad𝐾nad+ lac𝐾lac + pyr𝐾pyr ∙ + nad𝐾nad + nadh𝐾nadh ∙ + pyr𝐾𝑖pyr ∙ ∏ + nadh𝐾𝑖nadh 𝑛4𝑛= Eq. .  
Table 4.8: Summary of the kinetic parameters determined for the Michaelis-Menten equation describing 
LDH activity in C2C12 muscle myotubes in the forward and reverse directions. Eq.4.10 was fitted to the 
complete experimental dataset obtained for LDH. The fitted values (± standard error) are compared to 
values reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfLDH 26.8931 ± 8.0206 U/mg total protein   
VrLDH 3.1797 ± 0.3903 U/mg total protein   
Kpyr 0.3469 ± 0.0821 mM 0.1 - 0.35 34 
Klac 12.4493 ± 6.6165 mM 9.34 - 23.0 34 
Knadh 0.5678 ± 0.2166 mM 0.008 35 
Knad 0.6489 ± 0.2528 mM 0.253 36 
Kipyr 4.3823 ± 1.0727 mM   
Kinadh 2.1107 ± 0.2765 mM   




Figure 4.10: Kinetic characterisation of LDH in C2C12 muscle myotubes in the forward and reverse 
directions under varying substrate concentrations. (top) - Saturation of LDH with PYR at a NADH 
concentration of 0.6 mM (left) and 0.3 mM (right) respectively. (center-left) - Saturation of LDH with 
NADH at a PYR concentration of 1.25 mM. (center-right) - Saturation of LDH with NAD+ at a LAC 
concentration of 100 mM. (bottom) - Saturation of LDH with LAC at a NAD+ concentration of 0.4 mM 
(left) and 2 mM (right) respectively. The blue dots represent the experimental data obtained; the black 
line represents the non-linear model fit simulation of the complete dataset (95% confidence represents 
by the shaded area). 
Stellenbosch University https://scholar.sun.ac.za
94 
The rate equation for LDH given in Eq.4.10 describes a reversable bi-substrate Michealis-
Menten equation with allosteric inhibition by PYR and NADH for the forward and reverse 
directions. A good correlation between the mathematical fit and the experimental datasets are 
obtained as illustrated in Figure 4.10. The fitted kinetic parameters for the LDH reaction 
correspond very well to the values reported in literature as summarised in Table 4.8. The values 
determined for Kpyr and Klac falls within the range reported in literature. The values 
determined for Knadh and Knad are higher as compared to the values reported in literature with 
2 orders of magnitude difference in the case of Knadh. 
𝐾 LDH =  𝑉 ∙ 𝐾lac ∙ 𝐾nad𝑉 ∙ 𝐾pyr ∙ 𝐾nadh                                                                                                   Eq. .  
Using the Haldane relation represented by Eq.4.11, we can determine the estimated Keq 
for LDH from the optimized parameters given in Table 4.8. This yields a value range between 
168 - 500 which falls within the range determined by Teusink et al.11 for LDH in yeast. 
4.4.9. Kinetic characterisation of AK 
The activity of AK was measure in the forward and reverse direction, as discussed in 
Section 4.3.4, at varying concentrations of the substrate ADP and varying concentrations of the 
products, ATP and AMP.A reversible Michealis-Menten equation given in Eq.4.12 was fitted 
to the experimental dataset and the kinetic parameters (VfAK, VrAK, Kadp, Katp, Kamp, Kiadp, 
Kiatp) were determined. The experimental data and the non-linear model fit of the experimental 
data is shown in Figure 4.11 and the determined kinetic parameter are summarised in Table 4.9. 




Figure 4.11: Kinetic characterisation of AK in C2C12 muscle myotubes in the forward and reverse 
directions under varying substrate concentrations. (top-left) – incomplete saturation of AK with ADP 
(top-right) - Saturation of AK with ADP. (bottom-left) - Saturation of AK with AMP at an ATP 
concentration of 1.25 mM. (bottom-right) – Saturation of AK with ATP at an AMP concentration of 1.25 
mM. The blue dots represent the experimental data obtained; the black line represents the non-linear 




Table 4.9: Summary of the kinetic parameters determined for the Michaelis-Menten equation describing 
AK activity in C2C12 muscle myotubes in the forward and reverse directions. Eq.4.12 was fitted to the 
complete experimental dataset obtained for AK. The fitted values (± standard error) is compared to 
values reported in literature for similar tissue types where values are available. (U = µmol/min) 
Parameter Fitted Value Units Literature Value Reference 
VfAK 0.1522 ± 0.0134 U/mg total protein   
VrAk 0.0046 ± 0.0018 U/mg total protein   
Kadp 0.5967 ± 0.0549 mM 0.35 37 
Katp 0.1116 ± 0.2054 mM 0.27 37 
Kamp 0.2193 ± 0.2609 mM 0.32 37 
Kiadp 7.1708 ± 1.2167 mM   
Kiatp 12.7666 ± 22.7975 mM   
Keq 0.66 - 9.28  0.45 33 
The rate equation for AK given in Eq.4.12 describes a random order mechanism for the 
forward and reverse directions. A good correlation between the mathematical fit and the 
experimental datasets are obtained as illustrated in Figure 4.11. The fitted kinetic parameters 
for the AK reaction are summarised in Table 4.9. The correlation between the kinetic 
parameters determined in this study and values reported in literature is fair. 
𝐾 AK =  𝑉 A ∙ 𝐾atp ∙ 𝐾amp𝑉 A ∙ 𝐾adp                                                                                                           Eq. .  
Using the Haldane relation represented by Eq.4.13, we can determine the estimated Keq 
for AK from the optimized parameters given in Table 4.9. This yields a value range between 
0.66 – 9.28 which is higher than the value reported by Bergmeyer33 for AK. There are large 
uncertainties in the optimised values of Katp and Kamp which can be addressed by increasing 
the amount of dataset used for parameter optimisation. 
4.4.10. Kinetic characterisation of ATPase 
ATPase activity was measured, as discussed in Section 4.3.4, under varying 
concentrations of ATP. The ATPase reaction was described by an irreversible mass action rate 
equation given in Eq. 4.14 was fitted to the experimental dataset and the rate constant (VfATPase) 




Figure 4.12: Kinetic characterisation of ATPase in C2C12 muscle myotubes under varying ATP 
concentrations. The blue dots represent the experimental data obtained; the black line represents the 
non-linear model fit simulation of the complete dataset (95% confidence represents by the shaded area). 
The rate equation for ATPase given in Eq. 4.14 describes an irreversible mass action 
relation. A good correlation between the mathematical fit and the experimental data is obtained 
as illustrated in Figure 4.12. The fitted rate constant is VfATPase = 0.0021 ± 0.0002 U/mg total 
protein. This rate constant is significantly lower compared to the value reported by Lambeth et. 
al. in resting skeletal muscle (ATPase coefficient = 0.075)6. However, it is expected that C2C12 
skeletal muscle cell extract have significantly lower ATPase activity when compared to active 
human skeletal muscle. The value reported here is representative of skeletal muscle extract and 
is not directly comparable to skeletal muscle. 
4.4.11. Measuring the biological variance in enzyme activity 
The maximal activity for each enzyme, measured as µmol/ min/ mg total protein, gives 
the activity of each enzyme as measured within the cell extract. However, significant difference 
in the maximal activity of specific enzymes can be expected amongst different batches of 
cultured cells. The extent of differentiation of the C2C12 skeletal muscle cells cannot be 
quantified and only a qualitative estimate can be made based on a microscopic visualisation of 
the differentiated cells. Therefore, the maximal activity measured within a given batch of 
differentiated C2C12 skeletal muscle cells is a combination of the fractional maximal activity of 
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differentiated cells and a fractional maximal activity of undifferentiated cells, the fraction sizes 
of which cannot be determined. Furthermore, the level of enzyme expression in different 
culturing batches of the C2C12 skeletal muscle cells can also vary. 
Several batches of C2C12 skeletal muscle cells were grown and differentiated to determine 
the range of biological variation in the activity of the glycolytic enzymes. The activity of the 
glycolytic enzymes was measured via enzyme coupled assays with substrate concentrations at 
saturating or near saturating conditions for each enzyme in the different batches. The biological 
variance obtained is summarised in Table 4.10.  
Table 4.10: Comparison of the enzyme activities measured for the glycolytic enzymes in C2C12 muscle 
myotubes. The maximal specific activities of each enzyme were measured in several cultured batched of 
differentiated C2C12 myotubes (n = 3 – 5) to determine the expected biological variance of each enzyme. 
The biological variance was determined by measuring enzyme activity at saturating or near saturating 
substrate concentrations. The error bars represent the standard error to the mean (SEM) the annotation 
fwd and rev refer to the forward and reverse reactions respectively. 
Enzyme 
Average Measured Activity  
(µmol. min-1 .mg total protein-1) 
Biological Variance 
(SEM) 
HKfwd 0.0132 0.0017 
PGIfwd 0.1090 0.0027 
PGIrev 0.0545 0.0129 
PFKfwd 0.0023 0.0007 
ALDfwd 0.0278 0.0097 
GAPDHrev 0.0133 0.1284 
PGKrev 0.3051 0.1511 
PKfwd 0.4542 0.0657 
LDHfwd 24.0229 2.1102 
LDHrev 1.5496 0.8191 
4.4.12. Constructing a mechanistic model describing glycolysis in C2C12 myofibers 
The glycolytic model describing glycolysis in C2C12 skeletal muscle myofibers consist of 
13 reaction steps. The model describes the conversion of GLC to the product LAC in C2C12 cell 
extract and therefore does not account for a whole cell with the transport of GLC into the cell 
or the transport of LAC out of the cell. This model also includes the conserved adenosine (ATP, 
ADP, AMP) and nicotinamide (NAD+, NADH) moieties. In the above section kinetic rate 
equations were derived for each reaction steps in the model. The kinetic model was constructed 
from the kinetic parameters determined by performing a fit of the specified rate equation on the 
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experimental data set. In the case where rate equations were described for only the forward or 
reverse reaction, the rate equation was modified to describe a reversible rate equation by using 
the Keq of the specific reaction. The rate equations used to construct the model is given below: 
(Eq 4.15 – Eq. 4.27). 
𝑣HK = (𝑉 𝐻𝐾 ∙ atp[𝑡]𝐾atp ∙ glc[𝑡]𝐾glc ) ∙ − adp[𝑡] ∙ g p[𝑡]atp[𝑡] ∙ glc[𝑡] ∙ 𝐾( + atp[𝑡]𝐾atp + adp[𝑡]𝐾adp ) ∙ ( + glc[𝑡]𝐾glc + g p[𝑡]𝐾g p ) ∙ + amp[𝑡]𝐾𝑖amp ∙ + atp[𝑡]𝐾𝑖atp ∙ + atp[𝑡]𝐾𝑖atp    Eq. .  
𝑣PGI =  𝑉 ∙ g p[𝑡]𝐾g p − 𝑉 ∙ f p[𝑡]𝐾f p+ g p[𝑡]𝐾g p + f p[𝑡]𝐾f p                                                                                                                   Eq. .  
𝑣PFK = 𝑉 ∙ atp[𝑡] ∙ f p[𝑡]+ atp[𝑡]𝐾atp + adp[𝑡]𝐾adp ∙ 𝐾atp ∙ + f p[𝑡]𝐾f p + fbp[𝑡]𝐾fbp ∙ 𝐾f p                                                            Eq. .  
𝑣ALD = (𝑉 A ∙ fbp[𝑡]𝐾fbp ) ∙ − gap[𝑡] ∙ dhap[𝑡]fbp[𝑡] ∙ 𝐾 A+ gap[𝑡]𝐾gap + dhap[𝑡]𝐾dhap + fbp[𝑡]𝐾fbp + gap[𝑡] ∙ dhap[𝑡]𝐾gap ∙ 𝐾dhap                                                                             Eq. .  
𝑣TPI =  𝑉 T ∙ gap[𝑡]𝐾gap ∙ − 𝐾 T ∙ dhap[𝑡]gap[𝑡]+  gap[𝑡]𝐾gap + dhap[𝑡]𝐾dhap                                                                                                   Eq. .  
𝑣GAPDH =  −𝑉 ∙ bpg[𝑡]𝐾bpg ∙ nadh[𝑡]𝐾nadh ∙ (𝐾 A ∙ gap[𝑡] ∙ nad[𝑡]bpg[𝑡] ∙ nadh[𝑡] − )( + nad[𝑡]𝐾nad + nadh[𝑡]𝐾nadh ) ∙ ( + bpg[𝑡]𝐾bpg + gap[𝑡]𝐾gap )                                               Eq. .  
𝑣PGK =  −𝑉 ∙ p g[𝑡]𝐾p g ∙ atp[𝑡]𝐾atp ∙ (𝐾 ∙ bpg[𝑡] ∙ adp[𝑡]p g[𝑡] ∙ atp[𝑡] − )( + atp[𝑡]𝐾atp + adp[𝑡]𝐾adp ) ∙ ( + p g[𝑡]𝐾p g + bpg[𝑡]𝐾bpg ) ∙ ( + atp[𝑡]𝐾𝑖atp) ∙ ( + adp[𝑡]𝐾𝑖adp)                          Eq. .  
𝑣PGM =  𝑉 ∙ p g[𝑡]𝐾p g ∙ −∙ p g[𝑡]p g[𝑡] ∙ 𝐾+  p g[𝑡]𝐾p g + p g[𝑡]𝐾p g                                                                                              Eq. .  
𝑣ENO =  𝑉 ∙ p g[𝑡]𝐾p g ∙ −∙ pep[𝑡]p g[𝑡] ∙ 𝐾+  p g[𝑡]𝐾p g + pep[𝑡]𝐾pep                                                                                               Eq. .  
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𝑣PK =  𝑉 ∙ pep[𝑡]𝐾pep ∙ adp[𝑡]𝐾adp ∙ − pyr[𝑡] ∙ atp[𝑡]pep[𝑡] ∙ adp[𝑡] ∙ 𝐾( + pep[𝑡]𝐾pep + pyr[𝑡]𝐾pyr ) ∙ ( + adp[𝑡]𝐾adp + atp[𝑡]𝐾atp ) ∙ ( + pep[𝑡]𝐾𝑖pep) ∙ ( + atp[𝑡]𝐾𝑖atp)                             Eq. .  
𝑣LDH =  𝑉 ∙ pyr[𝑡]𝐾pyr ∙ nadh[𝑡]𝐾nadh − 𝑉 ∙ lac[𝑡]𝐾lac ∙ nad[𝑡]𝐾nad( + lac[𝑡]𝐾lac + pyr[𝑡]𝐾pyr ) ∙ ( + nad[𝑡]𝐾nad + nadh[𝑡]𝐾nadh ) ∙ ( + pyr[𝑡]𝐾𝑖pyr) ∙ ∏ ( + nadh[𝑡]𝐾𝑖nadh)𝑛4𝑛=          Eq. .  
𝑣AK =  𝑉 A ∙ adp[𝑡]𝐾adp − 𝑉 A ∙ atp[𝑡]𝐾atp ∙ amp[𝑡]𝐾amp( + adp[𝑡]𝐾adp + amp[𝑡]𝐾amp ) ∙ ( + adp[𝑡]𝐾adp + atp[𝑡]𝐾atp ) ∙ ( + adp[𝑡]𝐾𝑖adp) ∙ ( + atp[𝑡]𝐾𝑖atp)                           Eq. .  
𝑣ATPase = 𝑉 AT ase ∙ atp[𝑡]                                                                                                                                     Eq. .  
The parameterised rate equations dictate the rate of change of the specified variables 
(chemical species). A summary of the kinetic parameters used for the construction of the kinetic 
model describing glycolysis in differentiated C2C12 skeletal muscle extract is given in Table 
4.11 and Table 4.12. The rate measured for GAPDH in the reverse direction is significantly 
lower than is expected for GAPDH. Lambeth and Kushmerick6 noted an activity for GAPDH 
that is comparable to that of PGK. Therefore, we have decided to increase the activity of 
GAPDH to reflect the relationship with PGK (VrGAPDH = 1.13 x VrPGK) as noted by Lambeth 
and Kushmerick6 yielding a value of VrGAPDH = 0.6651 U/mg total protein
-1. The activity of the 
glycolytic enzymes of TPI, PGM and ENO was not determined experimentally. Values for the 
activity of these enzymes (VfTPI, VfPGM and VfENO) were obtained from similar published studies 
in rat and mice skeletal muscle as M/min38,39. If we assume an average density of 1.06 kg/ L40 
for skeletal muscle, the values can be converted to µmol. min-1. mg total protein-1 The kinetic 
parameters (Km values) pertaining to the half-reactions that were not experimentally 
characterised (e.g. Kadp for HK) were obtained from literature sources as indicated in Table 
4.12. The same literature sources as the study performed by Lambeth and Kushmeric6 were 
used for the required Km values. 
During model construction, it is important to indicate the relationship between the 
specified variable and its relevant rate equations that. This is done by setting up a series of 
ordinary differential equations (ODE’s) as illustrated by Eq. 4.28 – 4.44. The ODE’s comprise 
of three factors, namely; a direction that dictates an increase or decrease in concentration noted 
as a negative sign for a decrease and positive sign for an increase, a stoichiometric factor 
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indicating the relative amount of the variable formed or consumed by the reaction, and the 
specified rate equation that determines the change in variable concentration. 
Table 4.11: Summary of the maximal specific activities measured as μmol.min-1.mg total protein-1 used 
for the construction of a detailed kinetic model describing glycolysis is C2C12 skeletal muscle myotubes. 
The maximal specific activities for each enzyme was determined by performing a fit of the relevant rate 
equation on the experimentally obtained kinetic data where possible. In the cases where data was not 
obtained for certain enzymes, maximal specific activities were obtained from literature for similar cell 
types. 
 Maximal Specific Activity (μmol.min-1.mg total protein-1)  
Enzyme Forward Value Reverse Value Keq 
HK VfHK 0.0129 VrHK - 3800
(11) 
PGI VfPGI 0.1098 VrPGI 0.0589 0.36 - 0.44 
PFK VfPFK 0.0036   800
(27) 
ALD VfALD 0.0477 VrALD - 0.052
(28) 
TPI VfTPI 0.726
(38) VrTPI - 0.089
(28) 
GAPDH VfGAPDH - VrGAPDH 0.6651
† 0.0056(30) 
PGK VfPGK - VrPGK 0.5889 0.18
(28) 
PGM VfPGM 0.434
(38) VrPGM - 0.49
(28) 
ENO VfENO 0.070
(39) VrENO - 6.7
(33) 
PK VfPK 0.4732 VrPK - 6500
(33) 
LDH VfLDH 26.8931 VrLDH 3.1797 168 - 500 
AK VfAK 0.1522 VrAK 0.0046 0.66 - 9.28 
ATPase VfATPase 0.0021       
† - The activity of GAPDH was increased to reflect the relationship between the activities of GAPDH and PGK 




Table 4.12: Summary of the Michealis-Menten constant (Km) values used for the construction of a 
detailed kinetic model describing glycolysis is C2C12 skeletal muscle myotubes. The Km values for each 
enzyme was determined by performing a fit of the relevant rate equation on the experimentally obtained 
kinetic data where possible. In the cases where data was not obtained for certain enzymes, Km values 
were obtained from literature for similar cell types. 
  Kinetic Parameters 
Enzyme Parameter Value (mM) Parameter Value (mM) 
HK Kglc 0.0663 Katp 3.0646 
 Kadp 1.9(41) Kg6p 0.065(41) 
 Kiatp 21.0749 Kiamp 2.3713 
PGI Kg6p 0.8353   
 Kf6p 0.1827   
PFK Kf6p 0.1926 Katp 0.0159 
 Kfbp 4.02(42) Kadp 2.71(42) 
ALD Kfbp 0.4353   
 Kgap 1.1(43) Kdhap 2.1(43) 
TPI Kgap 0.32(44)   
 Kdhap 0.61(45)   
GAPDH Kgap 0.0025(29) Knad 0.09(29) 
 Kbpg 0.0008 Knadh 0.3333 
PGK Kbpg 0.0022(31) Kadp 0.05(46) 
 Kp3g 1.0116 Katp 0.4932 
 Kiatp 39.7968 Kiadp 1.994 
PGM Kp3g 0.2(47)   
 Kp2g 0.014(47)   
ENO Kp2g 0.12(48)   
 Kpep 0.37(48)   
PK Kpep 0.1254 Kadp 0.3039 
 Kpyr 7.05(49) Katp 0.82–1.13(49) 
 Kipep 30.6690 Kiatp 5.1256 
LDH Kpyr 0.3469 Knadh 0.5678 
 Klac 12.4493 Knad 0.6489 
 Kipyr 4.3823 Kinadh 2.1107 
AK Kadp 0.5967   
 Kamp 0.2193 Katp 0.1116 




GLC′[𝑡] =  − . ∗ 𝑣HK                                                                                                                                              Eq. .  
G P′[𝑡] =  + . ∗ 𝑣HK −  . ∗ 𝑣PGI                                                                                                                   Eq. .  
F P′[𝑡] =  + . ∗ 𝑣PGI −  . ∗ 𝑣PFK                                                                                                                  Eq. .  
FBP′[𝑡] =  + . ∗ 𝑣PFK −  . ∗ 𝑣ALD                                                                                                                Eq. .  
DHAP′[𝑡] =  + . ∗ 𝑣ALD +  . ∗ 𝑣TPI                                                                                                             Eq. .  
GAP′[𝑡] =  + . ∗ 𝑣ALD −  . ∗ 𝑣TPI −  . ∗ 𝑣GAPDH                                                                              Eq. .  
BPG′[𝑡] =  + . ∗ 𝑣GAPDH −  . ∗ 𝑣PGK                                                                                                         Eq. .  
P G′[𝑡] =  + . ∗ 𝑣PGK −  . ∗ 𝑣PGM                                                                                                               Eq. .  
P G′[𝑡] =  + . ∗ 𝑣PGM −  . ∗ 𝑣ENO                                                                                                              Eq. .  
PEP′[𝑡] =  + . ∗ 𝑣ENO −  . ∗ 𝑣PK                                                                                                                  Eq. .  
PYR′[𝑡] =  + . ∗ 𝑣PK −  . ∗ 𝑣LDH                                                                                                                  Eq. .  
LAC′[𝑡] =  + . ∗ 𝑣LDH                                                                                                                                            Eq. .  
ATP′[𝑡] = − . ∗ 𝑣HK − . ∗ 𝑣PFK + . ∗ 𝑣PGK + . ∗ 𝑣PK + . ∗ 𝑣AK − . ∗ 𝑣ATPase            Eq. .  
ADP′[𝑡] = + . ∗ 𝑣HK + . ∗ 𝑣PFK − . ∗ 𝑣PGK − . ∗ 𝑣PK − . ∗ 𝑣AK + . ∗ 𝑣ATPase            Eq. .  
AMP′[𝑡] =  + . ∗ 𝑣AK                                                                                                                                             Eq. .  
NADH′[𝑡] =  + . ∗ 𝑣GAPDH −  . ∗ 𝑣LDH                                                                                                     Eq. .  
NAD′[𝑡] =  − . ∗ 𝑣GAPDH +  . ∗ 𝑣LDH                                                                                                        Eq. .  
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The model consists of 17 ODE’s describing the change in concentration of the 17 
variables in the model. The ODE’s are constructed from 13 rate equations corresponding to the 
13 enzymatic reactions involved in the glycolytic pathway. Each ODE gives the change in 
concentration of each of the corresponding variables as a function of time. This yields a 
dynamic concentration profile for each of the 17 chemical species of interest. The initial 
concentrations of each of the 17 variables are assigned as an input value in the model. The 
initial concentrations generally correspond to the concentration of each chemical species as 
measured experimentally within a sample of cells. 
4.4.13. Steady state analysis 
To compare the model constructed here with the model published by Schmitz et. al.50 the 
same set of initial concentrations were used as an input to the model and the steady state values 
were compared to the published values50. The model published by Schmitz et. al.50 described 
the conversion of glycogen to LAC in skeletal muscle, whereas we are investigating the 
conversion of GLC to LAC in skeletal muscle extract. Their study investigated the behaviour 
of glycolysis in silico under various scenarios pertaining to the effect of PFK and PK 
inhibition50. The steady state value determined for the model constructed here was compared 
to the steady state values determined in the scenario where PFK and PK inhibition is included. 
The initial concentration of GLC was set to the initial value of G1P in the Schmitz model. 
All other initial values were set to the same value. Steady state concentrations of the glycolytic 
intermediates and cofactors were determined by fixing the concentrations of GLC and LAC to 
0.059 mM and 1.3 mM respectively and allowing the model to reach a steady state. The current 
model was not able to reach a steady state since all adenosine metabolites would convert to 
AMP. Therefore, we decreased the value describing the ATPase activity (VfATPase = 0.0021 
U/mg) to 12% of the original value to reach a steady state. This ATPase rate gave the best 
comparison to the steady state values reported by Schmitz et. al.50. The comparison of the steady 
state values calculated by the model constructed here with the steady state values published by 




Table 4.13: Comparison of the steady state values calculated by the model constructed here (van Dyk 
2019) and the steady state values published by Schmitz et. al. (Schmitz 2009)50. The initial values of the 
variables described in the model was set to the same values reported by Schmitz et. al. to reflect an 





Schmitz (2009)50 van Dyk (2019) 
Steady-State (mM) Steady-State (mM) 
GLC 0,059 - - 
G1P 0,059 0,025 - 
G6P 0,75 0,41 0.205 
F6P 0,23 0,18 0.079 
FBP 0,072 0,18 0.266 
DHAP 0,076 0,02 0.506 
GAP 0,036 0,39 0.044 
BPG 0,065 0,0032 0.001 
P3G 0,052 0,2 0.034 
P2G 0,005 0,036 0.016 
PEP 0,019 0,018 0.076 
PYR 0,099 0,012 0.128 
LAC 1,3 0,84 - 
ATP 8,2 8,2 8.106 
ADP 0,013 0,0098 0.104 
AMP 1.13 x 10-6 6.49 x 10-6 0.003 
NAD 0,5 0,47 0.485 
NADH 0 - 0.015 
Comparison of the steady state concentrations calculated by the van Dyk (2019) model 
and the Schmitz (2009)50 model predict similar values for the adenosine moieties. The steady 
state concentrations of AMP and ADP as predicted by the van Dyk (2019) model is higher in 
comparison to the steady state concentrations predictions of the Schmitz (2009)50 model. The 
steady state concentrations of FBP, DHAP, PEP and PYR as predicted to be higher and the 
steady state concentrations of G6P, F6P, GAP, BPG, P3G and P2G are predicted to be lower in 
comparison to the steady state concentrations predictions of the Schmitz (2009)50 model. 
However, there is less than an order of magnitude difference for half of the steady state 
concentrations predicted by the 2 models and most of the steady state values are predicted 
within the same 2 orders of magnitude. 
4.5. Discussion 
In recent years, several research groups have focussed their attention on describing the 
metabolic behaviours observed for skeletal muscle5,6,26,51. These studies were predominantly 
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focussed on understanding the dynamic interplay between muscle contraction and glucose 
consumption. This has led to the construction of several in silico models describing the 
regulatory effect that increased ATP demand has on glycolysis. It was found that the 
predominant driving force dictating the metabolic activity of skeletal muscle is the generation 
of ATP for muscle activity6. Furthermore, a minimal mechanistic model describing the cellular 
energy balance regulatory process in individuals transitioning from a resting state to an 
activated state and back to a resting state has been constructed by Vicini and Kushmerick5. 
Their model successfully described the time dependent concentrations of PCR and Pi by 
focussing on the interplay between oxidative phosphorylation, ATP utilization and creatine 
kinase activity. However, there has been a universal agreement that kinetic parameters, 
determined under standardised physiologically relevant conditions, is lacking in order to further 
improve our understanding on the regulatory characteristics of glycolysis in skeletal 
muscle5,6,51. 
For our model construction, emphasis was placed on studying enzyme activities under 
conditions that mimic cytosolic conditions. A standardised buffer system was derived from 
knowledge of the molecular make-up of the skeletal muscle cytosol and all enzyme activities 
were measured in this buffer. Furthermore, all enzyme activities were measured at a 
physiological pH (7.4) and physiological temperature (37ºC) to ensure that the activities 
measured were representative of the enzyme activities expected inside the intact cell. The 
glycolytic enzyme activities were described by Michealis-Menten type kinetics, which were 
fitted to the data. This resulted in the characterisation of the glycolytic enzymes in terms of their 
maximal specific activities (Vmax) and affinity for each substrate and product (Km) in 
differentiated C2C12 extract. We were not so interested in the best fit observed for each 
individual experimental dataset, but rather for the best set of kinetic parameters that describe 
the total dataset for an enzyme the best. By employing a larger dataset and measurements of 
enzyme activities under various substrate and product concentrations, a better description of the 
enzyme from a mechanistic point of view can be obtained albeit at the cost of perfect fits to the 
data. In the cases of PGI, LDH and AK, experimental data were obtained for both the forward 
and the reverse half reactions and the fitted rate equation described both the forward and reverse 
half reactions. Experimental data for only the forward half reaction of HK, PFK, ALD and PK 
was obtained, and the fitted rate equations described only the forward half reaction of these 
enzymes. Similarly, experimental data for GAPDH and PGK were obtained for only the reverse 
half reaction and the fitted rate equation only described the reverse half reaction for these 2 
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enzymes. We were unable to obtain experimental data for the enzymes; TPI, PGM and ENO 
and literature data were used to model these enzymes. It should be noted that these enzymes are 
generally very active and are often described by equilibrium reactions in modelling studies. 
Overall, the fitted kinetic parameters compared fairly well with what is reported in literature, 
with the exceptions of the Knadh value obtained for GAPDH (0.333 ± 0.1586) and the Knadh 
value obtained for LDH (0.5678 ± 0.2166) where a 2 orders of magnitude difference is seen 
between our results and what is reported in literature. GAPDH was measured in the reverse 
direction by coupling GAPDH to the downstream enzyme PGK and initialising the reaction 
with P3G. In this study the activity of GAPDH could only be measured up to a concentration 
of 8 µM of BPG, which corresponds to the Kbpg value obtained for this enzyme. Lambeth and 
Kushmeric6 have used a value comparable to the rate of PGK for the activity of GAPDH and 
this was considered in the construction of our model. The value was determined by correlating 
the relative activities of PGK and GAPDH in the Lambeth and Kushmeric6 model with the 
activity measured for PGK. This yielded a value of VrGAPDH = 0.6651 U/mg total protein, which 
is slightly higher than the value for VrPGK = 0.5889 U/ mg total protein. The assumption 
regarding GAPDH activity will be evaluated in Chapter 5. 
HK was inhibited by both its substrate ATP (at high concentrations), as well as by AMP. 
The finding that AMP inhibits HK was surprising since one would expect that HK should be 
activated under high energy demands where AMP concentrations are elevated. AMP inhibition 
has been reported to be present in cerebral-cortex hexokinase22. Other inhibitory behaviours of 
note are; ADP inhibition of PGK in the reverse direction, ATP inhibition of PK in the forward 
direction and substrate inhibition of LDH by PYR. The rate equations were modified to describe 
these inhibitory behaviours where applicable and the inhibitory behaviours were described very 
well by the fitted rate equations. Choi et. al.52 hypothesised feedback inhibition of glycolysis 
by LAC results in insulin resistance, associated with a decreased activity in the glycolytic 
enzyme PFK. Therefore, we have tested whether PFK is directly inhibited by the presence of 
LAC by measuring the activity of PFK at a constant concentration of F6P and ATP and varying 
the concentration of LAC present. However, no difference in the activity of PFK was observed 
at varying concentrations of LAC (data not shown) and therefore conclude that LAC does not 
directly inhibit PFK. 
The resulting rate equations describing the activity of the glycolytic enzymes obtained 
from the cell extract of differentiated C2C12 muscle were compiled into a bottom-up mechanistic 
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model. In this manner we can investigate the functional properties of glycolysis that arise from 
different environmental constraints experienced by skeletal muscle. By having a high level of 
mechanistic detail about the molecular processes involved in the glycolytic system and the 
interactions thereof, the behaviour of the system can be replicated in silico and then compared 
to what is observed in the laboratory. Our purpose to the construction of a detailed mechanistic 
model is two-fold; (1) to understand the underlying principles that constrains the system to 
behave as it does, and (2) to be able to replicate the glycolysis in differentiated C2C12 extract to 
a modest degree of accuracy. However, some modifications to the descriptions of the 
experimental data were necessary to construct this mechanistic model. With the exception of 
PFK, all enzymatic reactions in the model were described as reversible reactions. The rate 
equations for the enzymes where experimental data was obtained for only the forward or reverse 
reaction was modified to describe the reaction as a reversible reaction. This was done by 
modifying the fitted rate equations with the use of the Haldane relationship to describe the rate 
equations as reversible reactions (Eq.4.14-4.26). Furthermore, shortages in the experimental 
determination of kinetic parameters were addressed by obtaining values for these kinetic 
parameters from literature sources of studies done on mammalian cell lines. We have treated 
the conserved adenosine and nicotinamide moieties as free metabolic variables rather than 
parameters to monitor the changes in concentration of the species under different conditions as 
well as to better describe the model on a mechanistic foundation. This results in 17 ODE’s to 
describe the changes in variable concentrations as a function of time. The ODE’s were 
constructed from the 13 rate equations describing the activities of the 12 enzymes present in the 
glycolytic pathway along with a rate equation describing ATPase. 
Steady state analysis of the kinetic model describing glycolysis in C2C12 skeletal muscle 
extract was performed to compare the resulting steady state concentrations of the glycolytic 
intermediates and cofactors to the steady state concentrations published by Schmitz et. al.50. 
Although, there are significant differences in the construction and purpose of the models, 
comparison of the steady state concentrations calculated by the van Dyk model and the Schmitz 
model50 are satisfactory when the ATPase rate is adjusted. 
The mechanistic model describing glycolysis in differentiated C2C12 muscle extract 
showed some interesting results. The most prominent is the low activity observed for HK and 
PFK. HK and PFK are present in upper glycolysis and require ATP for catalytic activity. The 
restriction of glucose influx into glycolysis by HK and PFK regulates the concentration of 
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glycolytic intermediates present in the system. In contrast, the rates associated with lower 
glycolysis, specifically PGK and PK, are more than an order of magnitude larger in comparison. 
This results in a phenomenon where the flux through the upper glycolysis, that utilises ATP as 
a substrate, is much slower than the flux through lower glycolysis, that produces ATP as a 
product. This is contradictory to what is observed in other cell types such as yeast where the 
flux through upper glycolysis is much faster and high concentrations of FBP are observed11. 
Another observation of importance is the regulatory behaviours exerted on the glycolytic 
pathway by the adenosine metabolites. The initial concentrations of ATP, ADP and AMP have 
a significant effect on the model predicted concentrations of the glycolytic intermediates. This 
is in line with the findings of other research groups5,6,8,26,51,53 who found that the flux control 
through glycolysis regulated by the demand for ATP could be as high as 99%53. Metabolic 
control analysis for the glycolytic model constructed in this chapter will be performed and 
compared to related models in chapter 5. 
The mechanistic model constructed here predicts the time dependent concentration 
profiles of glycolytic intermediates as a result of how glycolysis operates in differentiated C2C12 
muscle extract. One of the aims in the construction of the model was to replicate the behaviour 
of glycolysis in this cell line. Therefore, the question put forth is how well this mechanistic 
model can predict the time dependent trends of the glycolytic intermediates. To determine this 
the model needs to be validated. This entails comparing the model predictions to experimental 
data obtained for the same set of initial conditions. This will be discussed in the subsequent 
chapters of this thesis.  
4.6. Conclusion 
We have determined a complete set of kinetic parameters for glycolytic enzymes in 
differentiated C2C12 muscle fibres. These findings address some of the concerns expressed in 
literature5,6,51. The kinetic description of the glycolytic enzymes was compiled into a bottom-
up model of the glycolytic pathway. The low activity of the ATP dependent enzymes of upper 
glycolysis have shown comparatively low activity even under conditions where high levels of 
ATP is present, whereas the activity of lower glycolytic enzymes, such as PGK and PK are 
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Chapter 5  
Validation and analysis of the mechanistic model describing glycolysis in 
differentiated C2C12 muscle extract 
5.1 Preamble 
In this chapter we apply the IP-RPLC method developed in Chapter 3 to quantify the 
time-dependent concentrations of glycolytic intermediates and cofactors in C2C12 skeletal 
muscle extracts. For model validation we compare the model simulations to time-dependent 
concentrations of glycolytic intermediates and cofactors. Metabolic control analysis of the 
detailed kinetic model describing glycolysis in skeletal muscle was performed to evaluate 
which reaction steps have control over the pathway. 
5.2 Introduction 
Bottom-up modelling approaches aim to combine the mechanistic knowledge of the 
isolated components of a system into a mathematical model and test its ability to make 
predictions for the system`s behaviour. Therefore, one of the main concerns faced by bottom-
up modelling approaches is to consider how accurate the model predicts what is observed 
experimentally1. The need for and conceptualisation of how models in both natural and social 
sciences ought to be validated has been a controversial topic for many years2. Tropsha et. al.3 
stated in their research on the essential need for validation of quantitative structure property 
relationship (QSPR) models that a prerequisite for QSPR models to be reliable is that these 
models should be statistically significant and robust, and should be accurate in predicting 
external data sets that were not used in model development. Furthermore, the application 
boundaries of these models should be limited to the areas that they have been validated in. 
Estimating the true predictive capabilities of a model necessitates the comparison of model 
predictions to observed trends of a sufficiently large set of external tests that were not used in 
model construction3. The complexity of bottom-up modelling often requires incorporation of 
kinetic parameters from various sources. Due to limited availability of experimental data to 
determine kinetic parameters under a standardised set of cytosolic representative conditions, 
gaps are filled by relying on studies performed under non-cytosolic representative conditions, 
or by fitting kinetic parameters to simplified catalytic mechanisms.  
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Determining the predictive accuracy of bottom-up models relies on the availability of 
analytical techniques that can quantify variables specified and predicted in the model. In the 
context of metabolic models, these analytical techniques need to construct a metabolomic 
picture of the biological system being simulated. Metabolome analysis allows for the direct 
access to the phenotype expressed under specific environmental conditions. The outcome of 
cellular regulatory processes present at different levels of expression is reflected in the 
metabolomic phenotype of the system4,5. In essence, a picture of the whole is obtained without 
any information of the mechanisms that lead to the formation of the whole. This can then be 
compared to the outcomes of the mechanistic layout described in the model. Metabolomic 
techniques hold significant value to molecular systems biologists to compare bottom-up 
mechanistic model predictions with metabolome data. The ability to utilise a metabolomic 
approach in tandem with dynamic metabolic modelling approaches have further benefits. 
Employing an iterative approach between mechanistic modelling and experimental 
metabolomic analysis allows for the identification and elucidation of new metabolic pathways 
as well as a better understanding of regulatory processes involved in existing metabolic 
pathways6,7.  
There are several examples in literature of how metabolomic data were used to validate 
the predictive accuracy of mechanistic models of glycolysis. Penkler et. al.8 constructed a 
detailed kinetic model of glycolysis in Plasmodium falciparum. In total the model described 
the change in concentration of 17 chemical species including the conserved adenosine and 
nicotinamide moieties. The detailed kinetic model was validated by quantifying the time 
dependent concentrations of GLC, LAC, PYR and GLY enzymatically and via HPLC-MS 
analysis and comparing the resulting data to model predictions. 4 out of the 17 variables 
described by the model were correlated to dynamic experimental data and several other 
metabolites were determined under steady state conditions. Similarly, Lambeth and 
Kushmeric9,10 constructed a bottom-up computational model of glycogenolysis in skeletal 
muscle relying on kinetic parameters obtained from literature sources. The computational 
model described 19 variables in total and the model was validated by obtaining quantitative 
concentrations of PCr and Pi as a function of time by performing 31P-NMR analysis on 
anesthetised male Swiss Webster mice. This resulted in validating the model by correlating 2 
variables to the total 19 described in the model. Schmitz et. al.11 further investigated the 
predictive accuracy of the computational model constructed on glycogenolysis in skeletal 
muscle, by Lambeth and Kushmeric9. 31P-NMR measurements of hexose monophosphates were 
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performed on human leg muscle. 31P-NMR is a powerful technique for the in vivo determination 
of metabolites in whole organisms. In contrast, the metabolomics method developed in Chapter 
3 is more applicable for targeted metabolomic studies in in vitro samples The endeavours 
pointed out here indicate the need for the development of analytical metabolomic techniques 
that can quantify a large amount of corresponding chemical species in a time dependent manner 
in in vitro biochemical samples.  
Once a mathematical model has been constructed and validated, metabolic control 
analysis can be performed. Metabolic control analysis is a powerful tool for investigating the 
systematic properties of a pathway, such as steady state fluxes and metabolite concentrations 
in terms of enzyme rates and kinetic parameters. The degree to which a small change in a local 
rate property exerts a change in the systematic properties of the pathway can be investigated by 
deriving flux and concentration control coefficients. Metabolic control analysis determines 
which reaction in the pathway exerts most control over the flux through and concentrations of 
metabolites in the pathway. Modelling studies on the metabolic activity of skeletal muscle 
performed by Lambeth et. al.9 and Choi et. al.12 demonstrated that the flux control in glycolysis 
lies largely with the demand for ATP (ATPase) with a contribution of between 95% and 99%. 
In Chapter 3 of this thesis we developed an ion-pairing reverse phase liquid 
chromatographic (IP-RPLC) method coupled to UV/Vis detection in tandem with radiolabelled 
isotope detection for the separation and quantification of glucose derived intermediates formed 
in glycolysis along with the separation and quantification of the adenosine and nicotinamide 
moieties. This chapter will focus on utilising this newly developed technique to quantify the 
glycolytic intermediates and adenosine and nicotinamide moieties formed by the glycolytic 
pathway in differentiated C2C12 muscle extract under various experimental conditions as a 
function of time. The resulting time dependent concentration traces will then be compared to 
model predictions using the glycolytic model constructed in Chapter 4 of this thesis. 
Construction and validation of the glycolytic model describing glycolysis in C2C12 muscle fibre 
extract was limited to investigating the pathway in extracts and not to whole muscle fibres. This 
has the benefit that a series of different starting conditions can be selected to provide rigorous 
and thorough testing of model capabilities. Whole cells are limited by the rate of glucose uptake. 
In contrast, with cellular extracts the glycolytic pathway can be initialised with different initial 
concentrations of the adenosine and nicotinamide moieties or any of the glycolytic 
intermediates available. The disadvantage of the in vitro analysis is that the physiological 
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relevance is not as good compared to in vivo intact cell or organism approaches. The predictive 
accuracy of the glycolytic model describing glycolysis in C2C12 muscle fibre extract will be 
validated here using 3 different sets of initial conditions. Model predictions and experimentally 
obtained data, determined for the same set of initial conditions will be overlaid to determine 
how well the model predicts the experimental data. 
5.3 Materials and Methods 
5.3.1. C2C12 muscle fibre lysis protocol 
Extract of differentiated C2C12 muscle fibres were prepared by lysing the cells with Triton 
X-100 as per the protocol given in Chapter 4 of this thesis. In short: an aliquot of differentiated 
C2C12 muscle fibres were thawed and treated with 20µL of a 10% Triton X-100 solution. The 
cell suspension was left to rest on ice for 30 min. After the 30 min treatment the cell suspension 
was centrifuged at 20 800 x g at 4ºC for 15 minutes to pellet the cell debris. After centrifugation 
the supernatant was removed and stored on ice. 
5.3.2. HPLC methodology 
HPLC analysis was done using the method developed in Chapter 3 of this thesis. In short, 
low pressure mixing of mobile phase A, consisting of 25 mM TBA in water adjusted to a pH 
of 7.3 (± 0.1) and mobile phase B consisting of 97.5% acetonitrile and 2.5% water at a ratio of 
95% A and 5% B. a gradient was employed to expedite the analysis of higher retaining chemical 
species. The gradient is a follow: at 0 min 95% A and 5% B; 5 min 70% A and 30% B; 12 min 
95% A and 5% B. The column eluent was detected by UV/Vis detection at 254 nm followed by 
radiolabelled detection. 
5.3.3. Time-course sampling protocol 
Differentiated C2C12 extract was prepared in assay buffer for the time dependent 
quantification of the glycolytic intermediates and adenosine and nicotinamide moieties by 
means of HPLC analysis. A cocktail containing the specified concentrations of ATP and NAD+ 
was added to the C2C12 muscle fibre extract, the sample was heated to 37ºC and was kept at 
37ºC for the duration of the experiment. A mixture of 14C-glucose and non-radiolabelled 
glucose (cold-glucose) was added to the cell extract to initialise the incubation and a 50 µL 
sample was taken at this timepoint (t = 0 min). Further sampling was performed at the specified 
Stellenbosch University https://scholar.sun.ac.za
117 
timepoints. Directly after the acquisition of each sample it was treated with 7.5 µL 50% PCA, 
neutralised with 42.5 µL of a 1M K2CO3 solution and stored on ice. This resulted in the 
deactivation and precipitation of the glycolytic enzymes, along with the precipitation of KClO4. 
The precipitate was removed via centrifugation at 20 800 x g for 15 min at 4ºC. 5µL of each 
sample was injected into the HPLC column and quantified.  
The resulting chromatographic traces obtained from the radiolabelled detector were 
integrated using an in-house developed script (described below). The chromatographic traces 
obtained from the UV/Vis detector corresponds to the adenosine and nicotinamide moieties and 
were quantified by means of a calibration curve.  
5.3.4. Integration of chromatographic traces and data analysis 
The concentrations of the adenosine and nicotinamide metabolites in the time-course 
samples were determined by integration of the UV/Vis chromatographic traces as described in 
Section 3.4.1 of Chapter 3 in this thesis. In short, calibration curves for the metabolites ATP, 
ADP, AMP, NAD+, and NADH were constructed. The concentrations of the adenosine and 
nicotinamide metabolites were determined by correlating the integrated area of the 
chromatographic traces obtained for the time-course experiments to the calibration function.  
The concentrations of the glycolytic intermediates in the time-course samples were 
determined by integration of the radiolabelled chromatographic traces as described in Section 
3.3.3 of Chapter 3 in this thesis. In short, a response factor correlating the integrated area of the 
GLC chromatographic trace to concentration was determined for each time-course incubation. 
Data analysis entailed fitting a series of skewed normal distribution functions to the 
chromatograms using an in-house developed script in Wolfram Mathematica. The integration 
of each skewed normal distribution function yielded the area under the peak. In cases where 
excessive tailing was present the peak was described by fitting 2 skewed normal distribution 
functions and summing the resulting areas. The data was normalised to the total counts in each 
run, and a baseline subtraction was performed to eliminate the contribution of the radiolabelled 
impurities present in the starting material. 
5.3.5. Performing metabolic control analysis. 
Metabolic control analysis was performed on the detailed kinetic model describing 
glycolysis in differentiated C2C12 skeletal muscle. To obtain a steady state the ATPase activity 
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was decreased 10-fold as explained in Section 4.4.13. The concentration of GLC was clamped 
at 10 mM to reflect the culturing conditions of the C2C12 cells (see Section 4.3.1), and the LAC 
was clamped at 1.3 mM in correspondence with Schmitz et al.11 Metabolic control analysis was 
performed in Wolfram Mathematica 12.0 by perturbing each Vmax by 0.1 % and evaluating 
the effect on flux and concentrations. 
5.4 Results 
5.4.1. Validating the predictive accuracy of the glycolytic model in differentiated C2C12 muscle 
extract 
To validate the detailed kinetic model describing glycolysis in differentiated C2C12 
skeletal muscle extract, model predictions were compared to experimental data obtained via IP-
RPLC analysis of C2C12 muscle extracts. Three time-course experiments (named Exp 1, Exp 2 
and Exp 3) were conducted at different initial conditions to see how the model behaves in 
different scenarios. Exp 1 and Exp 2 are very similar in setup. Exp 1 and Exp 2 were performed 
in different cell lysates and differ in the initial concentrations of GLC, ATP and NAD+. 
1. Exp 1 (Section 5.4.2) was initiated with 0.815 mM GLC, 2.616 mM ATP and 1.110 mM 
NAD+. This allows for the presence of excess cofactors to ensure complete consumption 
of GLC. 
2. Exp 2 (Section 5.4.3) was initiated with approximately 0.5 mM GLC, 4 mM ATP and 2 
mM NAD+. The experiment was designed to observe how the system behaves in the 
presence of excess cofactors, in comparison with what is required to consume the amount 
of GLC present. 
3. Exp 3 (Section 5.4.4) was initiated with approximately 3.077 mM FBP, 0.644 mM ADP 
and 1.010 mM NAD+. The experiment was designed to observe how the system behaves 
when initialised in the middle of the glycolytic pathway.  
The initial metabolite concentrations of Exp 1, Exp 2 and Exp 3 are listed in Table 5.1 
and these values were used as input value for model simulations, which were compared to the 
experimentally obtained time-course data. Time-course incubations of differentiated C2C12 
muscle fibres were carried out at 37ºC in duplicate by dividing the cell extract in 2 equal parts 
and performing the time-course experiment in both fractions simultaneously. The adenosine 
and nicotinamide cofactors were added to the incubations prior to initialisation with GLC or 
FBP. This resulted in the conversion of some of the ATP to ADP and AMP in the cases of Exp1 
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and Exp 2. Regarding Exp 1 and Exp 2, the initial GLC concentration was determined via a 
coupled assay technique by adding commercially obtained HK and G6PDH as described in 
Section 3.4.5 of this thesis. The time-course incubation was initialised by adding the glucose to 
the differentiated C2C12 muscle extract containing the adenosine and nicotinamide cofactors 
and samples were prepared and injected onto the column for HPLC analysis as described in 
Section 5.3.3.  
For Exp 3, 14C-glucose was reacted with commercially obtained HK and PGI in the 
presence of ATP and NAD+ to convert the 14C-GLC to 14C-FBP. The extend of conversion was 
tested by injecting a representative sample into the HPLC, which indicated that the conversion 
has reached completion. Cold FBP was added to the 14C-FBP sample and the total FBP 
concentration was determined by a coupled assay technique by adding commercially obtained 
ALD, TPI and G3PDH. The time-course incubation was initialised by adding the FBP stock 
solution to the differentiated C2C12 muscle extract and samples were prepared and injected into 
the column for HPLC analysis as described in Section 5.3.3. 
It was not possible to determine the concentrations of AMP and NADH via HPLC-
UV/Vis detection in the time-course samples of Exp 2 and Exp 3, due to significant peak 
overlap between AMP and NADH. Therefore, the concentrations of NADH and AMP was 
estimated by using Eq.5.1 and Eq.5.2 which assumes that the total adenosine and nicotinamide 




Table 5.1: Summary of the initial concentrations as obtained from the chromatographic analysis of the 
time-course incubation of differentiated C2C12 muscle extract taken at 0 min for the time course 
experiments Exp 1, Exp 2 and Exp 3. The initial concentrations served as the input values for the model 
predictions correlated to the experimentally obtained time dependent traces. 
  Initial concentrations (mM) 
Metabolite Exp 1 Exp 2 Exp 3 
GLC 0.815 0.471 0,005 
G6P 0.026 0.010 0.000 
F6P 0.008 0.005 0.000 
FBP 0.000 0.000 3,077 
LAC 0.002 0.026 0,089 
NAD+ 1.110 1.710 0,771 
NADH 0.000 0.290 0,239 
ATP 1.468 2.220 0,263 
ADP 1.148 1.390 0,226 
AMP 0 0.390 0,155 
Tprot (mg) 3.893 2.184 1,878 
Tvol (mL) 0.6 0.6 0,6 
The model constructed in Chapter 4 of this thesis was compared to the time dependent 
concentration trends obtained from the HPLC analysis of the time-course samples. The initial 
concentrations of each variable in the model was determined from the first chromatographic 
result at time point 0 min. With regards to Exp 3 the chromatographic peak corresponding to 
GLC at 0 min was large and does not compare to the GLC concentrations observed in the later 
time points. Therefore, the initial concentration of GLC was set to the chromatographic peak 
corresponding to GLC at 5 min .To correlate model predictions to the time course experimental 
data we needed to modify the model to describe enzyme activities as mM/ min as opposed to 
μmol.min-1.mg total protein-1 in the model constructed in Chapter 4. Therefore, the kinetic 
parameter describing the maximal specific activity (Vmax) for each enzyme was modified by 
multiplying it by the protein concentration (determined via a Bradford assay) and dividing by 





5.4.2. Comparing the glycolytic model in differentiated C2C12 muscle extract with IP-RPLC 
time-course data initialised with GLC (Exp 1) 
Exp 1 was carried out as discussed in Section 5.4.1. The experimentally obtained 
chromatographic traces were obtained via IP-RPLC analysis of differentiated C2C12 skeletal 
muscle extract in duplicate, and was correlated with model predictions and are given in Figure 
5.1. The integrated chromatographic traces of Exp 1 are shown in the attached Appendix  
(Figure A.1 and Figure A.2) 
In total 15 variables present in the model describing glycolysis in differentiated C2C12 
muscle extract were compared to experimentally determined time-course data. There is a good 
correlation between the model predicted and experimentally obtained time dependent 
concentration traces of GLC, G6P, F6P and FBP. With regards to the LAC and PYR trends, the 
predictive trends show a similar shape as compared to the experimental data. However, there is 
an overestimation of the concentration of LAC and an underestimation of the concentration of 
PYR by the model. The predictions for the adenosine moieties show similar trends compared 
with the experimental data but does not perfectly describe the experimental data. The 
experimentally determined trends of the nicotinamide moieties suggests that there are other 
reactions present that influence the concentrations of these chemical species. Furthermore, the 
model significantly underpredicts the concentrations of the intermediates in the bottom part of 






















Figure 5.1: Correlation of model predictions to the experimentally determined time dependent 
concentrations as obtained via IP-RPLC analysis of the time-course experiment initialised with 0.853 
mM GLC, 2.616 mM ATP and 1.11 mM NAD+. The data points represent the concentrations as 
determined via IP-RPLC analysis. The blue line represents the model predictions using the model 
constructed in chapter 4 of this thesis describing glycolysis in differentiated C2C12 muscle extract. The 
subfigures represent the model predicted flux and experimentally measured flux of the variables. A: 
experimental data and model simulation of GLC, B: experimental data and model simulation of G6P, 
C: experimental data and model simulation of F6P, D: experimental data and model simulation of FBP, 
E: experimental data and model simulation of DHAP, F: experimental data and model simulation of 
P3G, G: experimental data and model simulation of P2G, H: experimental data and model simulation 
of PEP, I: experimental data and model simulation of PYR, J: experimental data and model simulation 
of LAC,K: experimental data and model simulation of NAD+, L: experimental data and model simulation 
of NADH, M: experimental data and model simulation of ATP, N: experimental data and model 






5.4.3. Comparing the glycolytic model in differentiated C2C12 muscle extract with IP-RPLC 
time-course data initialised with GLC (Exp 2) 
Exp 2 was carried out as discussed in Section 5.4.1. The experimentally obtained 
chromatographic traces were obtained via IP-RPLC analysis of differentiated C2C12 skeletal 
muscle extract in duplicate, and was correlated with model predictions and are given in Figure 
5.2. The integrated chromatographic traces of Exp 1 are shown in the attached Appendix  
(Figure A.3 and Figure A.4) 
The model describing glycolysis in differentiated C2C12 muscle fibre extract was 
compared with the experimentally determined concentrations. The time dependent 
concentrations of 15 variables were quantified via IP-RPLC analysis and compared to the 
corresponding model predictions. The experimentally obtained traces for GLC, G6P, F6P, FBP 
and DHAP correlates well with model predictions. The model predictions overestimate the 
concentration of LAC and underestimates the concentration of PYR, similar to the previous 
experiment. The initial trends in the adenosine moieties as predicted by the model, correlate 
well with experimental data, however model predictions deviate from the experimental data in 






















Figure 5.2: Correlation of model predictions to the experimentally determined time dependent 
concentrations as obtained via IP-RPLC analysis of the time-course experiment initialised with 0.512 
mM GLC, 4 mM ATP and 2 mM NAD+. The data points represent the concentrations as determined via 
IP-RPLC analysis. The blue line represents the model predictions using the model constructed in 
chapter 4 of this thesis describing glycolysis in differentiated C2C12 muscle extract. The subfigures 
represent the model predicted flux and experimentally measured flux of the variables: A: experimental 
data and model simulation of GLC, B: experimental data and model simulation of G6P, C: experimental 
data and model simulation of F6P, D: experimental data and model simulation of FBP, E: experimental 
data and model simulation of DHAP, F: experimental data and model simulation of P3G, G: 
experimental data and model simulation of P2G, H: experimental data and model simulation of PEP, 
I: experimental data and model simulation of PYR, J: experimental data and model simulation of 
LAC,K: experimental data and model simulation of NAD+, L: experimental data and model simulation 
of NADH, M: experimental data and model simulation of ATP, N: experimental data and model 






5.4.4. Comparing the glycolytic model in differentiated C2C12 muscle extract with IP-RPLC 
time-course data initialised with FBP (Exp 3) 
Exp 3 was carried out as discussed in Section 5.4.1. The experimentally obtained 
chromatographic traces were obtained via IP-RPLC analysis of differentiated C2C12 skeletal 
muscle extract in duplicate, and was correlated with model predictions and are given in Figure 
5.3. The integrated chromatographic traces of Exp 1 are shown in the attached Appendix  
(Figure A.5 and Figure A.6) 
The model describing glycolysis in differentiated C2C12 muscle fibre extract was 
compared with the experimentally determined concentrations. The time dependent 
concentrations of 10 variables were quantified via IP-RPLC analysis and compared to the 
corresponding model predictions. There is a good comparison between the model predicted 
trends and experimentally obtained traces for FBP and LAC. Due to the absence of G6P and 
F6P, the GAP peak was clearly visible and could easily be quantified. However, the model 
significantly underestimates the concentration of GAP and overestimates the concentration of 
DHAP. Comparison of the model predicted trends and experimental traces for the adenosine 
moieties show similar behaviour. The traces corresponding to P3G, P2G, PEP and PYR were 













Figure 5.3: Correlation of model predictions to the experimentally determined time dependent 
concentrations as obtained via IP-RPLC analysis of the time-course experiment initialised with 3.596 
mM FBP, 0.263 mM ATP, 0.226 mM ADP and 0.771 mM NAD+. The data points represent the 
concentrations as determined via IP-RPLC analysis. The blue line represents the model predictions 
using the model constructed in chapter 4 of this thesis describing glycolysis in differentiated C2C12 
muscle extract. The subfigures represent the model predicted flux and experimentally measured flux of 
the variables: A: experimental data and model simulation of GLC, B: experimental data and model 
simulation of FBP, C: experimental data and model simulation of DHAP, D: experimental data and 
model simulation of GAP, E: experimental data and model simulation of LAC, F: experimental data 
and model simulation of NAD+, G: experimental data and model simulation of NADH, H: experimental 
data and model simulation of ATP, I: experimental data and model simulation of ADP, J: experimental 






5.4.5. Model analysis and metabolic control analysis 
Metabolic control analysis was performed on the kinetic model describing glycolysis in 
differentiated C2C12 skeletal muscle cells to quantify the control that each enzyme has over the 
system. The concentrations of GLC and LAC were clamped at 10 mM and 1.3 mM respectively 
to simulate the physiological blood concentrations of these compounds in mice. To obtain a 
steady state the ATPase activity was decrease 10-fold as discussed in Section 4.4.13. The 
complete matrix of flux and concentration control coefficients are given in Table 5.2 and Table 
5.3. The ATPase reaction has most of the flux control at 99.4 % whereas minor control over the 
flux of the system is held by PK (0.5 %) and GAPDH (0.1 %). This corresponds to the findings 
of published in literature9,11 stating that ATPase has between 95 % and 99 % of the flux control 




Table 5.2: Complete set of flux control coefficients as determined for the kinetic model describing glycolysis in differentiated C2C12 skeletal muscle extract. 
ATPase accounts for most of the flux control, with minor flux control by GAPDH and PK, highlighted in Bold. The flux control coefficients were determined in 
Wolfram Mathematica 12.0, through a perturbation method. 
 vHK vPGI vPFK vALD vTPI vGAPDH vPGK vPGM vENO vPK vLDH vAK vATPase 
JHK 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JPGI 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JPFK 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JALD 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JTPI 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JGAPDH 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JPGK 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JPGM 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JENO 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JPK 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JLDH 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 
JAK 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 0.994 





Table 5.3: Complete set of concentration control coefficients as determined for the kinetic model describing glycolysis in differentiated C2C12 skeletal muscle 
extract. Concentration control coefficients with a value above 0.5 or below -0.5 are highlighted in bold. The concentration control coefficients were determined 
in Wolfram Mathematica 12.0. 
 vHK vPGI vPFK vALD vTPI vGAPDH vPGK vPGM vENO vPK vLDH vAK vATPase 
ATP 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.000 0.005 0.000 0.000 -0.006 
AMP -0.008 0.000 -0.010 0.000 0.000 -0.320 -0.003 0.000 0.000 -1.978 0.000 0.000 2.320 
NADH 0.030 0.001 0.034 0.000 0.000 1.142 0.008 0.000 0.000 -0.062 0.000 0.000 -1.153 
G6P 1.174 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 -1.173 
F6P 1.174 0.022 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 -1.196 
FBP 1.177 0.022 1.342 0.000 0.000 -0.001 0.000 0.000 0.000 -0.008 0.000 0.000 -2.532 
DHAP 0.588 0.011 0.671 0.009 0.000 -0.001 0.000 0.000 0.000 -0.004 0.000 0.000 -1.275 
GAP 0.588 0.011 0.671 0.009 0.000 -0.001 0.000 0.000 0.000 -0.004 0.000 0.000 -1.275 
P3G 0.017 0.000 0.019 0.000 0.000 0.630 0.007 0.000 0.000 -0.050 0.000 0.000 -0.623 
P2G 0.017 0.000 0.019 0.000 0.000 0.630 0.007 0.000 0.000 -0.050 0.000 0.000 -0.623 
PEP 0.017 0.000 0.019 0.000 0.000 0.630 0.007 0.000 0.000 -0.050 0.000 0.000 -0.623 
PYR -0.067 -0.001 -0.076 -0.001 0.000 -2.543 -0.018 0.000 0.000 0.139 -0.034 0.000 2.601 
LAC x x x x x x x x x x x x x 





The aim of this chapter was to use this newly developed metabolomic technique to 
validate the predictive accuracy of the mechanistic model describing glycolysis in C2C12 muscle 
fibre extract, constructed in Chapter 4. The model describing glycolysis in differentiated C2C12 
muscle extract predicts the time dependent concentrations of 17 variables. The variables 
comprise of GLC and the glycolytic intermediates, as well as the conserved adenosine and 
nicotinamide moieties. The IP-RPLC method developed during this study and described in 
Chapter 3 allows for the quantification of the conserved adenosine and nicotinamide moieties 
via UV/Vis detection, along with the quantification of the GLC and glycolytic intermediates 
via a radiolabelled detector. In total, all species described in the model, with the exception of 
BPG, were separated and quantified with this method. This enabled the comparison of 15, out 
of the total 17 species described in the model, to be compared to experimentally obtained time 
courses. The ability to compare most of the variables predicted by the model with experimental 
data allowed for a rigorous scrutiny of the behaviour of the glycolytic model. Furthermore, 
observation of the time dependent concentration trends of the glycolytic intermediates and 
conserved moieties under several different initial sets of conditions were performed (Exp 1, 
Exp 2 and EXP 3). It should be noted that the model predictions are obtained independent of 
the experimental data. The model predictions do not result from fitting the data, but by using 
the initial conditions and simulating the model in the absence of any experimental input. The 
resulting comparison (Figure 5.1, Figure 5.2 and Figure 5.3) are then generated by overlaying 
the experimentally obtained concentration trends with the corresponding model predictions.  
Establishing the criteria for whether a model is validated or invalidated is not a trivial 
endeavour. A model can never be fully validated since it is experimentally impossible to test 
the validity of all parameters used in model construction. Therefore, it is more accurate to 
consider a model as partially validated. A prerequisite for a reliable and useful model is that it 
should be able to accurately predict external datasets that were not used in model development3, 
and it is more accurate to state that we are evaluating the predictive accuracy of the glycolytic 
model constructed in C2C12 skeletal muscle. The process of assessing the predictive accuracy 
of a model requires a subjective or objective estimation of how closely the model simulates the 
behaviour in comparison to observations13. In the case presented here, considerations regarding 
the quality of the comparison between experimental data and model predictions were made 
subjectively as any objective measure of predictive accuracy would be meaningless without a 
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standard measure of what constitutes a good or bad result. Objective measures are only useful 
when comparing the predictive accuracy of several models to the same experimental dataset. In 
light of this, we can state that the predictive accuracy of the model constructed in C2C12 skeletal 
muscle is satisfactory, as explained below. 
The overlay of the model predicted trace and experimentally obtained trace for GLC 
compare very well for both Exp 1 and Exp 2 (Section 5.4.2 and Section 5.4.3). The change in 
concentration of GLC is catalysed by the enzyme HK. The good correlation between the 
experimentally obtained trace and model predicted trace suggests that the model description of 
HK dynamics accurately describes what happens experimentally. The comparison of model 
simulated fluxes of G6P and F6P and experimental measurements shows that the model slightly 
overestimates the concentration of G6P and underestimates the concentration of F6P. However, 
there is extensive overlap of the chromatographic peaks for G6P and F6P and deconvolution of 
these peaks are required during the analysis of the chromatographic traces. The respective 
difference observed between model simulation and experimental quantification could be due to 
inaccurate deconvolution of the chromatographic traces. The model simulation for FBP is in 
fair agreement, but slightly lower that what is observed in the experimentally obtained traces 
of Exp1 and Exp 2 in Section 5.4.2 and Section 5.4.3. The model simulated concentrations of 
FBP obtained for Exp 3 (Section 5.4.4) compares well with the experimentally obtained trace. 
The concentration of FBP towards the end of the reaction is estimated to be higher than the 
experimentally obtained results. However, this is most likely due to the inaccurate description 
of the DHAP and GAP traces, resulting in feedback inhibition in the model simulation that does 
not reflect the experimental reality. The relationship dictating the concentrations of DHAP and 
GAP is governed by TPI and the experimental results suggest that the activity of TPI is 
overestimated in the model. The model predicted flux of P3G is underestimated in comparison 
with the experimentally obtained data. This is likely due to the high activity attributed to PGM 
and ENO in the model. Integration of the P2G peak in the chromatographic traces is difficult 
due to the low area obtained for this species, resulting in large standard deviations among the 
measurements. Therefore, the experimentally obtained concentration traces cannot be assumed 
to accurately reflect reality. Regarding Exp 1 and Exp 2, there is a discrepancy between the 
model simulations and experimentally obtained traces of PYR and LAC (Figure 5.1 and Figure 
5.2). LAC is overpredicted and PYR is under predicted in the final half of the reaction. The 
conversion of PYR to LAC is determined by LDH activity. Comparison of the experimental 
and model simulated traces suggests that the equilibrium state described by the rate equation 
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for LDH is inaccurate and a higher concentration of PYR should be favoured in the description 
of the reaction. Overall, the model simulated trends of the conserved adenosine and 
nicotinamide moieties correlate well with the experimentally obtained concentration traces. The 
model simulated concentrations of NAD+ and NADH correlates well with the experimental 
data. It should be noted that the concentrations of NAD+ and NADH in several measured 
samples (Figure 5.1L and Figure 5.2L in the case of NADH and Figure 5.3G in the case of 
NAD+) are below the LOQ determined for these species, with LOQ values of 0.683 and 0.582 
for NAD+ and NADH respectively. Therefore, these measurements should be considered as 
unreliable and any observations corresponding to these measurements are made considering 
this. The model simulations of the adenosine moieties correlate well with the experimentally 
obtained traces, with the exception of the data obtained for Exp 3 in Section 5.4.4. Comparison 
of the model simulations and experimentally obtained adenosine traces in Section 5.4.3. 
suggests that the equilibrium state described by AK in the model does not accurately reflect 
what happens in the experimental setup.  
Metabolic control analysis was performed on the kinetic model describing glycolysis in 
C2C12 muscle extract and showed that ATPase has a 99% control over the flux through the 
pathway. This finding is in line with published results9,12 stating and ATPase flux control of 
between 95% and 99%.  
The simulations of the bottom-up model describing glycolysis in C2C12 muscle extract 
correlates well with the experimentally obtained data. This suggests that a degree of confidence 
can be placed on the predictive accuracy of the model. The glycolytic pathway is relatively 
small and linear when compared to other biological pathways. For future research we will 
expand on the mechanistic model describing glycolysis in C2C12 muscle extract to incorporate 
the insulin response and study insulin sensitivity. 
5.6 Conclusion 
3 time-course experiments were done under different sets of initial concentrations and 
compared to the corresponding model prediction traces. The model predicted the metabolite 
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Chapter 6  
General discussion and concluding remarks 
Several in silico models to describe the in vivo and in vitro behaviours of glycolysis in 
skeletal muscle, and the development of metabolic syndrome, have been developed123-456. Access 
to models capable of describing the metabolic changes and pathophysiological symptoms 
associated with the development of metabolic diseases aid in the clinical identification of such 
diseases. Understanding the biochemical mechanisms that give rise to the development of 
metabolic diseases is of critical importance for the development of treatment and precautionary 
intervention.  
Extensive in silico analysis on the in vivo behaviours of skeletal muscle glycolysis has 
been performed by Rozendaal et. al.1,2 on the development of metabolic syndrome, with great 
success. Furthermore, metabolomic analysis via the use of 31P-NMR on intact tissue and even 
living organisms, has the advantage of obtaining dynamic concentration profiles that accurately 
reflects the physiological state. However, making perturbations to analyse the underlying 
principles that give rise to the physiological state is very difficult. In contrast, in vitro analysis 
of a model cell-line, as presented in this thesis, generally gives an inaccurate description of in 
vivo observations, but is much easier to make perturbations for detailed analysis. 
The thesis presented here, focussed on the in vitro kinetic characterisation of the enzymes 
present in glycolysis under in vivo like conditions, and the construction of a mathematical model 
describing glycolysis is skeletal muscle cells using a bottom-up systems biology approach. 
C2C12 mouse skeletal muscle cells were used as model cell-line for investigating muscle cell 
glycolysis. A bottom-up systems biology approach to the characterisation of skeletal muscle 
glycolysis under basal conditions (the metabolic reference state) has value in understanding and 
analysing the regulatory behaviours of this pathway. The validation and determination of the 
predictive accuracy of mathematical models are key to the successful implementation of such 
models7. As discussed in Chapter 5 (Section 5.5), establishing criteria for whether a model is 
validated or invalidated is not trivial, since model validation relies on experimentally testing 
the validity of every single parameter used in model construction, which is an impossible 
endeavour. In actuality, a model can only be partially validated with regards to some of the 
parameters used in model construction model. Therefore, it is more accurate to state that we 
evaluated the predictive accuracy of the glycolytic model constructed in C2C12 skeletal muscle. 
Stellenbosch University https://scholar.sun.ac.za
140 
The process of assessing the predictive accuracy of a model requires a subjective or 
objective estimation of how closely the model simulates the behaviours observed in 
experiments8. One of the novel outcomes of this study was the development of an IP-RPLC 
metabolomics technique for the dynamic determination of glycolytic intermediate and cofactor 
concentrations. The dynamic concentration profiles of C2C12 muscle extract time-course 
experiments were compared to model simulations in Chapter 5 to determine the predictive 
accuracy to the mathematical model constructed in this thesis (Chapter 4). The similarities in 
the model simulations and the experimentally determined concentration profiles (see Figure 
5.1, Figure 5.2 and Figure 5.3) illustrates how accurately the model describes glycolysis in 
C2C12 skeletal muscle extract and the model describes the data to a satisfactory degree. The 
targeted metabolomics technique developed here enables quantification of glycolytic 
intermediates and cofactors in cellular extracts with minimal sample preparation. The strengths 
of this metabolomics method lie in the robustness of the separation technique and detection of 
glycolytic intermediates free from matrix effects. Using a reverse phase C18 column 
(Phenomenex Luna C18 column) for RPLC analysis makes this a robust separation technique. 
Furthermore, the 14C-tag of glycolytic intermediates is detected via radio-labelled detection and 
the resulting signal is not influenced by a change in the sample matrix. The IP-RPLC 
metabolomics technique developed here, have become a powerful and routine analytical 
technique in our laboratory for similar systems biology studies on glycolysis in different cell-
lines. 
Having constructed a mathematical model of glycolysis in skeletal muscle that can predict 
glycolytic behaviour to a satisfactory degree of accuracy, we can perform in silico 
investigations into the control mechanisms regulating glycolysis in skeletal muscle. Metabolic 
control analysis of the glycolytic model indicate that ATPase hold most of the control over the 
flux through glycolysis with a flux control coefficient of 99.4 %. These findings are in line with 
the findings of other in silico studies of glycolysis in skeletal muscle3,6. The control exerted by 
ATPase is subtle and operates largely by controlling the concentrations of the adenosine 
moieties. The relative concentrations of ATP regulate the activity the enzymes HK and PFK 
(using ATP as substrate) in upper glycolysis, and PGK and PK (Producing ATP as product) in 
lower glycolysis. As explained by Hofmeyr et. al.9 cellular metabolism can be functionally 
organised into supply and demand block that are linked by metabolic products and cofactors. 
With regards to the scenario described in skeletal muscle, glycolysis can be broken down into 
an ATP supply block (PGK and PK) and a demand block (HK, PFK and ATPase) with ATP 
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regulating the supply-demand dynamics. This approach was used by du Preez et. al.10 to 
compare kinetic models of erythrocytes and beautifully highlights the regulatory mechanisms 
of ATP supply-demand dynamics. 
The functionality of skeletal muscle relies on rapid changes in the activity of ATPase to 
allow for muscle movement (i.e. ATPase activity increases during exercise). This increase in 
the demand block will require an increase in the supply block to take place to accommodate a 
higher demand for ATP. An increase in the ATP demand block can partly be explained by an 
increase in glucose metabolism afforded by higher GLC transport activity. As discussed in 
Section 2.5 of the literature review in this thesis, The AMPK signalling cascade facilitates 
GLUT4 translocation to the cell membrane. AMPK is activated by low concentrations of ATP 
and high concentrations of AMP, the dynamics of which is regulated by AK. However, supply 
of ATP via an influx of GLC is throttled by the relative low activity of HK under high levels of 
AMP (refer to Section 4.4.1 for details). The increase supply of ATP most likely comes from 
an increased consumption of glycogen inside skeletal muscle cells, this will be discussed in 
more detail below. 
On the other side of ATP supply-demand dynamics, an increased supply of ATP 
facilitated by an increased need to dispose of excess GLC (i.e. insulin stimulation after a meal) 
will require an increase in the ATP demand block to accommodate a higher supply of ATP. 
Insulin stimulation of skeletal muscle facilitates an increase in GLC transport over the cell 
membrane facilitated by insulin mediated GLUT4 translocation, as discussed in Section 2.4 of 
the literature review (Chapter 2). The need for an increase in ATP demand is most likely 
accommodated by an increase in glycogen synthesis. A 2-fold increase in the production of 
glycogen was observed during insulin stimulation of C2C12 skeletal muscle cells
11 and this 
supports the above-mentioned hypothesis. Glycogen is produced via the glycogen synthesis 
pathway that branches from glycolysis after GLC has been phosphorylated by HK. Therefore, 
glycogen can be perceived as phosphorylated GLC. The ATP demand required to metabolise 
glycogen is less compared to GLC and only relies on phosphorylation by PFK before it can 
enter the ATP supply block (see Figure 6.1). In contrast, phosphorylation of GLC to form 
glycogen increases the demand block when ATP supply is high, and this corresponds with a 
slow and gradual production of glycogen when ATPase activity is low and a rapid consumption 




Figure 6.1: Schematic representation describing skeletal muscle glycolysis in terms of ATP supply-
demand dynamics. The enzymatic reactions of HK, PFK and ATPase form part of the ATP demand 
block. The enzymatic reactions of PGK and PK form part of the ATP supply block. The 2 blocks are 
connected via ATP. 
The study lined out in this thesis was performed in partnership with a sister-study 
performed by Stefan Kuhn on characterising the insulin signalling pathway, and GLC transport 
under insulin stimulated conditions. The combined endeavours of these 2 studies will improve 
our understanding of skeletal muscle glycolysis under basal and insulin stimulated conditions.  
With regards to this combined research endeavour, we consider how an individual’s 
physiological state will impact muscle glycolysis, we will postulate 4 hypothetical modes in 
which ATP supply-demand dynamics in skeletal muscle glycolysis can operate, as listed below: 
1. The glycolytic activity of skeletal muscle at rest can be described as muscle 
glycolysis operating under normal (physiological) GLC levels with low (basal) 
glucose transport (GT) activity and low ATPase activity. 
2. The glycolytic activity of insulin stimulated skeletal muscle at rest can be 
described as muscle glycolysis operating under high GLC levels with high GT 
activity and low ATPase activity. 
3. The glycolytic activity of skeletal muscle during exercise can be described as 
muscle glycolysis operating under normal (physiological) GLC levels with low 
(basal) GT activity and high ATPase activity. 
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4. The glycolytic activity of insulin stimulated skeletal muscle during exercise can 
be described as muscle glycolysis operating under high GLC levels with high GT 
activity and high ATPase activity. 
Analysing the ATP supply-demand dynamics of the 4 hypothetical modes lined out here 
will form part of our future research endeavours. We speculate that the flux control of glycolysis 
in the 4 hypothetical modes will differ significantly, with high flux control by ATPase in mode 
2and possibly mode 1, and high flux control by GLC transport in modes 3 and 4 and possibly 
in mode 1. A description of skeletal muscle metabolism under basal, insulin stimulated and 
exercise conditions3,6 will greatly improve our understanding of how skeletal muscle 
metabolism behaves in healthy individuals. Understanding this behaviour in terms of ATP 
supply-demand dynamics could potentially lead to a descriptive understanding of the 
underlying mechanisms that give rise to metabolic disorders such as insulin resistance. 
6. 1. Future studies 
As described above, future endeavours will entail the combination of the study presented 
here with the sister-study performed by Stefan Kuhn for a description of GLC metabolism under 
basal and insulin stimulated conditions. Including glycogen production and consumption in the 
model and analysing the model in terms flux control and ATP supply-demand dynamics under 
basal and insulin stimulated conditions will need to be performed 
Future studies pertaining to the study presented here should focus on expanding the 
kinetic characterisation of the glycolytic enzymes in differentiated C2C12 skeletal muscle cells. 
Characterisation of the enzymes TPI, PGM and ENO will aid to a better understanding of 
glycolysis in skeletal muscle. Furthermore, testing the effect of well-known inhibitors (e.g. 
AMP, fructose-2,6-bisphosphate and citrate as inhibitors of PFK, inorganic phosphate as 
inhibitor of GAPDH) will aid in improving the glycolytic model of C2C12 skeletal muscle. 
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Chromatographic Traces of the time-course experiments  
presented in Chapter 5 
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C: t = 10 min 
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Figure A. 1: The integrated chromatographic traces of the time-course experiment discussed in Section 
5.4.2 of this thesis (Exp 1).The experiment was carried out in duplicate and the chromatographic traces 
shown here is from the first repeat. The grey dots represent the chromatographic data, the Black line 
represents GLC, Grey represents the Impurity, Blue represents G6P, Green Represents F6P, Purple 
represents FBP, Orange represents DHAP, Yellow represents P3G, Blue-Dash represents PEP, Brown 
represents PYR, Red represents LAC, A: analysis performed at t = 0 min, B: analysis performed at t = 
5 min, C: analysis performed at t = 10 min, D: analysis performed at t = 20 min, E: analysis performed 
at t = 40 min, F: analysis performed at t = 60 min, G: analysis performed at t = 90 min, H: analysis 
performed at t = 120 min, I: analysis performed at t = 180 min, J: analysis performed at t = 240 min. 
  
I: t = 180 min 
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Figure A. 2: The integrated chromatographic traces of the time-course experiment discussed in Section 
5.4.2 of this thesis (Exp 1). The experiment was carried out in duplicate and the chromatographic traces 
shown here is from the second repeat. The grey dots represent the chromatographic data, the Black line 
represents GLC, Grey represents the Impurity, Blue represents G6P, Green Represents F6P, Purple 
represents FBP, Orange represents DHAP, Yellow represents P3G, Orange-Dash represents P2G, 
Blue-Dash represents PEP, Brown represents PYR, Red represents LAC, A: analysis performed at t = 
0 min, B: analysis performed at t = 5 min, C: analysis performed at t = 10 min, D: analysis performed 
at t = 20 min, E: analysis performed at t = 40 min, F: analysis performed at t = 60 min, G: analysis 
performed at t = 90 min, H: analysis performed at t = 120 min, I: analysis performed at t = 180 min, J: 
analysis performed at t = 240 min. 
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Figure A. 3: The integrated chromatographic traces of the time-course experiment discussed in Section 
5.4.3 of this thesis (Exp 2). The experiment was carried out in duplicate and the chromatographic traces 
shown here is from the first repeat. The grey dots represent the chromatographic data, the Black line 
represents GLC, Grey represents the Impurity, Blue represents G6P, Green Represents F6P, Purple 
represents FBP, Orange represents DHAP, Yellow represents P3G, Orange-Dash represents P2G, 
Blue-Dash represents PEP, Brown represents PYR, Red represents LAC, A: analysis performed at t = 
0 min, B: analysis performed at t = 5 min, C: analysis performed at t = 10 min, D: analysis performed 
at t = 20 min, E: analysis performed at t = 40 min, F: analysis performed at t = 60 min, G: analysis 
performed at t = 90 min, H: analysis performed at t = 120 min, I: analysis performed at t = 180 min, J: 
analysis performed at t = 240 min. 
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Figure A. 4: The integrated chromatographic traces of the time-course experiment discussed in Section 
5.4.3 of this thesis (Exp 2). The experiment was carried out in duplicate and the chromatographic traces 
shown here is from the second repeat. The grey dots represent the chromatographic data, the Black line 
represents GLC, Grey represents the Impurity, Blue represents G6P, Green Represents F6P, Purple 
represents FBP, Orange represents DHAP, Yellow represents P3G, Orange-Dash represents P2G, 
Blue-Dash represents PEP, Brown represents PYR, Red represents LAC, A: analysis performed at t = 
0 min, B: analysis performed at t = 5 min, C: analysis performed at t = 10 min, D: analysis performed 
at t = 20 min, E: analysis performed at t = 40 min, F: analysis performed at t = 60 min, G: analysis 
performed at t = 90 min, H: analysis performed at t = 120 min, I: analysis performed at t = 180 min, J: 
analysis performed at t = 240 min. 
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Figure A. 5: The integrated chromatographic traces of the time-course experiment discussed in Section 
5.4.4 of this thesis (Exp 3). The experiment was carried out in duplicate and the chromatographic traces 
shown here is from the first repeat. The grey dots represent the chromatographic data, the Black line 
represents GLC, Grey represents the Impurity, Purple represents FBP, Orange represents DHAP, 
Green-Dash represents GAP, Red represents LAC, A: analysis performed at t = 0 min, B: analysis 
performed at t = 5 min, C: analysis performed at t = 10 min, D: analysis performed at t = 15 min, E: 
analysis performed at t = 20 min, F: analysis performed at t = 30 min, G: analysis performed at t = 45 
min, H: analysis performed at t = 60 min, I: analysis performed at t = 90 min. 
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Figure A. 6: The integrated chromatographic traces of the time-course experiment discussed in Section 
5.4.4 of this thesis (Exp 3). The experiment was carried out in duplicate and the chromatographic traces 
shown here is from the second repeat. The grey dots represent the chromatographic data, the Black line 
represents GLC, Grey represents the Impurity, Purple represents FBP, Orange represents DHAP, 
Green-Dash represents GAP, Red represents LAC, A: analysis performed at t = 0 min, B: analysis 
performed at t = 5 min, C: analysis performed at t = 10 min, D: analysis performed at t = 15 min, E: 
analysis performed at t = 20 min, F: analysis performed at t = 30 min, G: analysis performed at t = 45 
min, H: analysis performed at t = 60 min, I: analysis performed at t = 90 min. 
I: t = 90 min 
Stellenbosch University https://scholar.sun.ac.za
